{
 "version": "https://jsonfeed.org/version/1.1",
 "title": "OnCo Edge",
 "home_page_url": "https://onco.cc/edge/",
 "feed_url": "https://onco.cc/edge/feed.json",
 "description": "The freshest signals in cancer: new papers, trial results, approvals and law, ranked newest first with a modest weight for approvals, phase 3 results and the leading journals.",
 "language": "en-GB",
 "authors": [
  {
   "name": "OnCo",
   "url": "https://onco.cc/"
  }
 ],
 "items": [
  {
   "id": "https://doi.org/10.1200/jco-25-02737#onco-edge-paper",
   "url": "https://doi.org/10.1200/jco-25-02737",
   "title": "Association Between Patient-Reported Outcomes and Health Care Resource Utilization: Toward Developing Patient-Centered Value Measures in Cancer Care.",
   "content_text": "Published in J Clin Oncol on 18 September 2026; matched the OnCo record for Early-stage classical Hodgkin lymphoma.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Clin Oncol",
    "doi": "10.1200/jco-25-02737",
    "records": [
     {
      "id": "early-stage-classical-hodgkin-lymphoma",
      "kind": "cancer",
      "name": "Early-stage classical Hodgkin lymphoma",
      "url": "https://onco.cc/cancers/early-stage-classical-hodgkin-lymphoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1158/2159-8290.cd-nw2026-0090#onco-edge-paper",
   "url": "https://doi.org/10.1158/2159-8290.cd-nw2026-0090",
   "title": "Phase III Trials Test First-Line Options in Advanced NSCLC.",
   "content_text": "Published in Cancer Discov on 18 September 2026; matched the OnCo record for Amivantamab.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Cancer Discov",
    "doi": "10.1158/2159-8290.cd-nw2026-0090",
    "records": [
     {
      "id": "amivantamab",
      "kind": "drug",
      "name": "Amivantamab",
      "url": "https://onco.cc/drugs/amivantamab/"
     },
     {
      "id": "ivonescimab",
      "kind": "drug",
      "name": "Ivonescimab",
      "url": "https://onco.cc/drugs/ivonescimab/"
     },
     {
      "id": "zipalertinib",
      "kind": "drug",
      "name": "Zipalertinib",
      "url": "https://onco.cc/drugs/zipalertinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ccell.2026.08.015#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ccell.2026.08.015",
   "title": "γδ T cells modulate anti-tumor immunity in small cell lung cancer.",
   "content_text": "Published in Cancer Cell on 18 September 2026; matched the OnCo record for Zoledronic acid.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Cancer Cell",
    "doi": "10.1016/j.ccell.2026.08.015",
    "records": [
     {
      "id": "zoledronic-acid",
      "kind": "drug",
      "name": "Zoledronic acid",
      "url": "https://onco.cc/drugs/zoledronic-acid/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1126/science.aec6129#onco-edge-paper",
   "url": "https://doi.org/10.1126/science.aec6129",
   "title": "An expert-level generalist AI for abdominal CT diagnosis.",
   "content_text": "Published in Science on 17 September 2026; matched the OnCo record for RaDaR.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Science",
    "doi": "10.1126/science.aec6129",
    "records": [
     {
      "id": "radar-mrd",
      "kind": "drug",
      "name": "RaDaR",
      "url": "https://onco.cc/drugs/radar-mrd/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1158/2159-8290.cd-nw2026-0088#onco-edge-paper",
   "url": "https://doi.org/10.1158/2159-8290.cd-nw2026-0088",
   "title": "Anti-B7-H3 ADCs Take Center Stage against SCLC at WCLC.",
   "content_text": "Published in Cancer Discov on 17 September 2026; matched the OnCo record for YL201.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Cancer Discov",
    "doi": "10.1158/2159-8290.cd-nw2026-0088",
    "records": [
     {
      "id": "yl201",
      "kind": "drug",
      "name": "YL201",
      "url": "https://onco.cc/drugs/yl201/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41591-026-04646-6#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41591-026-04646-6",
   "title": "Levetiracetam therapeutically targets GABAergic synapses in diffuse midline glioma.",
   "content_text": "Published in Nat Med on 17 September 2026; matched the OnCo record for Diffuse midline glioma, H3 K27-altered.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Nat Med",
    "doi": "10.1038/s41591-026-04646-6",
    "records": [
     {
      "id": "dipg-dmg",
      "kind": "cancer",
      "name": "Diffuse midline glioma, H3 K27-altered",
      "url": "https://onco.cc/cancers/dipg-dmg/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.annonc.2026.09.005#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.annonc.2026.09.005",
   "title": "Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.",
   "content_text": "Published in Ann Oncol on 17 September 2026; matched the OnCo record for Goserelin / leuprolide.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Ann Oncol",
    "doi": "10.1016/j.annonc.2026.09.005",
    "records": [
     {
      "id": "goserelin",
      "kind": "drug",
      "name": "Goserelin / leuprolide",
      "url": "https://onco.cc/drugs/goserelin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1200/jco-26-01914#onco-edge-paper",
   "url": "https://doi.org/10.1200/jco-26-01914",
   "title": "Bridging the Gap: From Molecular Residual Disease to Curative Opportunity: Circulating Tumor DNA-Guided Surveillance After Curative Resection for Stage I to III Colorectal Cancer.",
   "content_text": "Published in J Clin Oncol on 16 September 2026; matched the OnCo record for Localised anal squamous cell carcinoma.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "J Clin Oncol",
    "doi": "10.1200/jco-26-01914",
    "records": [
     {
      "id": "localised-anal-cancer",
      "kind": "cancer",
      "name": "Localised anal squamous cell carcinoma",
      "url": "https://onco.cc/cancers/localised-anal-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ccell.2026.08.012#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ccell.2026.08.012",
   "title": "Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer.",
   "content_text": "Published in Cancer Cell on 16 September 2026; matched the OnCo record for Adebrelimab.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Cancer Cell",
    "doi": "10.1016/j.ccell.2026.08.012",
    "records": [
     {
      "id": "adebrelimab",
      "kind": "drug",
      "name": "Adebrelimab",
      "url": "https://onco.cc/drugs/adebrelimab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1200/jco-26-02254#onco-edge-paper",
   "url": "https://doi.org/10.1200/jco-26-02254",
   "title": "Erratum: Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.",
   "content_text": "Published in J Clin Oncol on 16 September 2026; matched the OnCo record for Trastuzumab rezetecan.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "J Clin Oncol",
    "doi": "10.1200/jco-26-02254",
    "records": [
     {
      "id": "trastuzumab-rezetecan",
      "kind": "drug",
      "name": "Trastuzumab rezetecan",
      "url": "https://onco.cc/drugs/trastuzumab-rezetecan/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-sevabertinib-locally-advanced-or-metastatic-non-squamous-non-small#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-sevabertinib-locally-advanced-or-metastatic-non-squamous-non-small",
   "title": "FDA grants accelerated approval to sevabertinib for locally advanced or metastatic non-squamous non-small cell lung cancer",
   "content_text": "On September 9, 2026, the Food and Drug Administration granted accelerated approval to sevabertinib (Hyrnuo, Bayer Healthcare Pharmaceuticals Inc.), a kinase inhibitor, for adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) whose tumors have HER2 (ERBB2) tyrosine kinase domain (TKD) activating mutations, as detected by an FDA-authorized test.",
   "date_published": "2026-09-09T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-09-09",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "sevabertinib",
      "kind": "drug",
      "name": "Sevabertinib",
      "url": "https://onco.cc/drugs/sevabertinib/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     },
     {
      "id": "her2-mutant-nsclc",
      "kind": "cancer",
      "name": "HER2-mutant non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/her2-mutant-nsclc/"
     },
     {
      "id": "her2",
      "kind": "target",
      "name": "HER2",
      "url": "https://onco.cc/targets/her2/"
     }
    ]
   }
  },
  {
   "id": "https://onco.cc/newsletter/2026-09-22/#onco-edge-issue",
   "url": "https://onco.cc/newsletter/2026-09-22/",
   "title": "OnCo weekly, 2026-09-22",
   "content_text": "416 changelog entries, 1 regulatory event, 2 upcoming dates, 2 corrections.",
   "date_published": "2026-09-22T00:00:00Z",
   "tags": [
    "issue"
   ],
   "_onco": {
    "kind": "issue",
    "date": "2026-09-22",
    "precision": "day",
    "venue": "OnCo weekly issue",
    "records": []
   }
  },
  {
   "id": "https://doi.org/10.1515/jpem-2026-0398#onco-edge-paper",
   "url": "https://doi.org/10.1515/jpem-2026-0398",
   "title": "Successful management of paediatric chronic SIAD with oral urea: report of two cases.",
   "content_text": "Published in J Pediatr Endocrinol Metab on 22 September 2026; matched the OnCo record for Paediatric low-grade glioma.",
   "date_published": "2026-09-22T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-22",
    "precision": "day",
    "venue": "J Pediatr Endocrinol Metab",
    "doi": "10.1515/jpem-2026-0398",
    "records": [
     {
      "id": "paediatric-low-grade-glioma",
      "kind": "cancer",
      "name": "Paediatric low-grade glioma",
      "url": "https://onco.cc/cancers/paediatric-low-grade-glioma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41586-026-11137-8#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41586-026-11137-8",
   "title": "Author Correction: Erythropoietin receptor on cDC1s dictates immune tolerance.",
   "content_text": "Published in Nature on 15 September 2026; matched the OnCo record for Erythropoietin receptor.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Nature",
    "doi": "10.1038/s41586-026-11137-8",
    "records": [
     {
      "id": "epor",
      "kind": "target",
      "name": "Erythropoietin receptor",
      "url": "https://onco.cc/targets/epor/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41591-026-04559-4#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41591-026-04559-4",
   "title": "Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRAS<sup>G12D</sup> mutations: a phase 1 trial.",
   "content_text": "Published in Nat Med on 15 September 2026; matched the OnCo record for GFH375.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Nat Med",
    "doi": "10.1038/s41591-026-04559-4",
    "records": [
     {
      "id": "gfh375",
      "kind": "drug",
      "name": "GFH375",
      "url": "https://onco.cc/drugs/gfh375/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1158/2643-3230.bcd-26-0115#onco-edge-paper",
   "url": "https://doi.org/10.1158/2643-3230.bcd-26-0115",
   "title": "A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL.",
   "content_text": "Published in Blood Cancer Discov on 21 September 2026; matched the OnCo record for Acute lymphoblastic leukaemia.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Blood Cancer Discov",
    "doi": "10.1158/2643-3230.bcd-26-0115",
    "records": [
     {
      "id": "all-leukemia",
      "kind": "cancer",
      "name": "Acute lymphoblastic leukaemia",
      "url": "https://onco.cc/cancers/all-leukemia/"
     },
     {
      "id": "cd22",
      "kind": "target",
      "name": "CD22",
      "url": "https://onco.cc/targets/cd22/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/mus.70404#onco-edge-paper",
   "url": "https://doi.org/10.1002/mus.70404",
   "title": "Assessment of Lectin Staining Biomarkers for GNE Myopathy Gene Therapy.",
   "content_text": "Published in Muscle Nerve on 21 September 2026; matched the OnCo record for Small intestine cancer.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Muscle Nerve",
    "doi": "10.1002/mus.70404",
    "records": [
     {
      "id": "small-bowel",
      "kind": "cancer",
      "name": "Small intestine cancer",
      "url": "https://onco.cc/cancers/small-bowel/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/1545-5017.70678#onco-edge-paper",
   "url": "https://doi.org/10.1002/1545-5017.70678",
   "title": "Comparative Effectiveness of Antibiotic Prophylaxis Regimens in Pediatric Acute Myeloid Leukemia.",
   "content_text": "Published in Pediatr Blood Cancer on 21 September 2026; matched the OnCo record for Acute myeloid leukaemia in children.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Pediatr Blood Cancer",
    "doi": "10.1002/1545-5017.70678",
    "records": [
     {
      "id": "aml-paediatric",
      "kind": "cancer",
      "name": "Acute myeloid leukaemia in children",
      "url": "https://onco.cc/cancers/aml-paediatric/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1158/2326-6066.cir-26-0401#onco-edge-paper",
   "url": "https://doi.org/10.1158/2326-6066.cir-26-0401",
   "title": "IL-21 boosts T cell-therapy efficacy for solid tumors by enhancing mitochondrial Ca2+-mediated motility of effector CD8+ T cells.",
   "content_text": "Published in Cancer Immunol Res on 21 September 2026; matched the OnCo record for TCR-T cell therapy.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Cancer Immunol Res",
    "doi": "10.1158/2326-6066.cir-26-0401",
    "records": [
     {
      "id": "tcr-t",
      "kind": "technology",
      "name": "TCR-T cell therapy",
      "url": "https://onco.cc/technologies/tcr-t/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41392-026-02891-2#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41392-026-02891-2",
   "title": "Induction and concurrent aumolertinib with radiotherapy for EGFR-mutated stage III NSCLC: results of phase III ADVANCE trial and real-world validation.",
   "content_text": "Published in Signal Transduct Target Ther on 21 September 2026; matched the OnCo record for Aumolertinib.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Signal Transduct Target Ther",
    "doi": "10.1038/s41392-026-02891-2",
    "records": [
     {
      "id": "aumolertinib",
      "kind": "drug",
      "name": "Aumolertinib",
      "url": "https://onco.cc/drugs/aumolertinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1177/19450265261488655#onco-edge-paper",
   "url": "https://doi.org/10.1177/19450265261488655",
   "title": "Integrative Genetic and Bioinformatic Analysis of Androgen Pathway Gene Polymorphisms, Testosterone, and PSA Levels in Prostate Cancer.",
   "content_text": "Published in Genet Test Mol Biomarkers on 21 September 2026; matched the OnCo record for CYP17A1.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Genet Test Mol Biomarkers",
    "doi": "10.1177/19450265261488655",
    "records": [
     {
      "id": "cyp17a1",
      "kind": "target",
      "name": "CYP17A1",
      "url": "https://onco.cc/targets/cyp17a1/"
     },
     {
      "id": "srd5a2",
      "kind": "target",
      "name": "5-alpha-reductase type 2",
      "url": "https://onco.cc/targets/srd5a2/"
     }
    ]
   }
  },
  {
   "id": "https://onco.cc/newsletter/2026-09-21/#onco-edge-issue",
   "url": "https://onco.cc/newsletter/2026-09-21/",
   "title": "OnCo weekly, 2026-09-21",
   "content_text": "310 changelog entries, 1 upcoming date, 7 publications, 2 corrections.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "issue"
   ],
   "_onco": {
    "kind": "issue",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "OnCo weekly issue",
    "records": []
   }
  },
  {
   "id": "https://doi.org/10.1002/acr.80167#onco-edge-paper",
   "url": "https://doi.org/10.1002/acr.80167",
   "title": "Real-world effectiveness and safety of secukinumab in giant cell arteritis: an Italian multicentre cohort study.",
   "content_text": "Published in Arthritis Care Res (Hoboken) on 21 September 2026; matched the OnCo record for Tocilizumab.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Arthritis Care Res (Hoboken)",
    "doi": "10.1002/acr.80167",
    "records": [
     {
      "id": "tocilizumab",
      "kind": "drug",
      "name": "Tocilizumab",
      "url": "https://onco.cc/drugs/tocilizumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/advs.77614#onco-edge-paper",
   "url": "https://doi.org/10.1002/advs.77614",
   "title": "Ribonucleotides Amplify Mitochondrial DNA-Driven cGAS-STING Activation via FdUMP-ribonucleotide Hybrid Particles to Potentiate Chemoimmunotherapy.",
   "content_text": "Published in Adv Sci (Weinh) on 21 September 2026; matched the OnCo record for Floxuridine.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Adv Sci (Weinh)",
    "doi": "10.1002/advs.77614",
    "records": [
     {
      "id": "floxuridine",
      "kind": "drug",
      "name": "Floxuridine",
      "url": "https://onco.cc/drugs/floxuridine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1158/1078-0432.ccr-26-1066#onco-edge-paper",
   "url": "https://doi.org/10.1158/1078-0432.ccr-26-1066",
   "title": "Safety and Efficacy of Ceralasertib plus Olaparib for Advanced/Metastatic Triple-Negative Breast Cancer in Three Molecular Strata: The Phase II VIOLETTE Study.",
   "content_text": "Published in Clin Cancer Res on 21 September 2026; matched the OnCo record for Adavosertib.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Clin Cancer Res",
    "doi": "10.1158/1078-0432.ccr-26-1066",
    "records": [
     {
      "id": "adavosertib",
      "kind": "drug",
      "name": "Adavosertib",
      "url": "https://onco.cc/drugs/adavosertib/"
     },
     {
      "id": "ceralasertib",
      "kind": "drug",
      "name": "Ceralasertib",
      "url": "https://onco.cc/drugs/ceralasertib/"
     },
     {
      "id": "wee1",
      "kind": "target",
      "name": "WEE1",
      "url": "https://onco.cc/targets/wee1/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1093/bjd/ljag418#onco-edge-paper",
   "url": "https://doi.org/10.1093/bjd/ljag418",
   "title": "Sustained response (ORR4) as an on-treatment prognostic marker in mogamulizumab-treated mycosis fungoides and Sézary syndrome: the FIL-MOGA study.",
   "content_text": "Published in Br J Dermatol on 21 September 2026; matched the OnCo record for Mogamulizumab.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Br J Dermatol",
    "doi": "10.1093/bjd/ljag418",
    "records": [
     {
      "id": "mogamulizumab",
      "kind": "drug",
      "name": "Mogamulizumab",
      "url": "https://onco.cc/drugs/mogamulizumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/hed.70417#onco-edge-paper",
   "url": "https://doi.org/10.1002/hed.70417",
   "title": "Toripalimab Plus TPF as Induction Chemoimmunotherapy for the Treatment of Locally Advanced Hypopharyngeal Carcinoma: A Prospective Phase II Study.",
   "content_text": "Published in Head Neck on 21 September 2026; matched the OnCo record for Toripalimab.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Head Neck",
    "doi": "10.1002/hed.70417",
    "records": [
     {
      "id": "toripalimab",
      "kind": "drug",
      "name": "Toripalimab",
      "url": "https://onco.cc/drugs/toripalimab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/art.70348#onco-edge-paper",
   "url": "https://doi.org/10.1002/art.70348",
   "title": "Treatment approaches to macrophage activation syndrome in real life and priorities for future research: results from the international METAPHOR project.",
   "content_text": "Published in Arthritis Rheumatol on 21 September 2026; matched the OnCo record for Emapalumab.",
   "date_published": "2026-09-21T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-21",
    "precision": "day",
    "venue": "Arthritis Rheumatol",
    "doi": "10.1002/art.70348",
    "records": [
     {
      "id": "emapalumab",
      "kind": "drug",
      "name": "Emapalumab",
      "url": "https://onco.cc/drugs/emapalumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s43018-026-01237-9#onco-edge-paper",
   "url": "https://doi.org/10.1038/s43018-026-01237-9",
   "title": "Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial.",
   "content_text": "Published in Nat Cancer on 14 September 2026; matched the OnCo record for FOLFIRI.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Nat Cancer",
    "doi": "10.1038/s43018-026-01237-9",
    "records": [
     {
      "id": "folfiri",
      "kind": "drug",
      "name": "FOLFIRI",
      "url": "https://onco.cc/drugs/folfiri/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1200/jco-26-00556#onco-edge-paper",
   "url": "https://doi.org/10.1200/jco-26-00556",
   "title": "P-Loop/αC-Helix Compressing Mutations and Exon 20 Insertions in <i>EGFR</i>-Mutant NSCLC: A Rapidly Evolving Therapeutic Landscape.",
   "content_text": "Published in J Clin Oncol on 14 September 2026; matched the OnCo record for Afatinib.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "J Clin Oncol",
    "doi": "10.1200/jco-26-00556",
    "records": [
     {
      "id": "afatinib",
      "kind": "drug",
      "name": "Afatinib",
      "url": "https://onco.cc/drugs/afatinib/"
     },
     {
      "id": "amivantamab",
      "kind": "drug",
      "name": "Amivantamab",
      "url": "https://onco.cc/drugs/amivantamab/"
     },
     {
      "id": "sunvozertinib",
      "kind": "drug",
      "name": "Sunvozertinib",
      "url": "https://onco.cc/drugs/sunvozertinib/"
     },
     {
      "id": "zipalertinib",
      "kind": "drug",
      "name": "Zipalertinib",
      "url": "https://onco.cc/drugs/zipalertinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1186/s42826-026-00298-2#onco-edge-paper",
   "url": "https://doi.org/10.1186/s42826-026-00298-2",
   "title": "Advancing neurofibromatosis research: a comparative review of animal models and their utility in dissecting the tumor microenvironment.",
   "content_text": "Published in Lab Anim Res on 20 September 2026; matched the OnCo record for Genetically engineered mouse models.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Lab Anim Res",
    "doi": "10.1186/s42826-026-00298-2",
    "records": [
     {
      "id": "genetically-engineered-mouse-models",
      "kind": "technology",
      "name": "Genetically engineered mouse models",
      "url": "https://onco.cc/technologies/genetically-engineered-mouse-models/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41388-026-03989-1#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41388-026-03989-1",
   "title": "Beyond the blood-brain barrier: humanised mice, the missing link in glioblastoma research.",
   "content_text": "Published in Oncogene on 20 September 2026; matched the OnCo record for Humanised mouse models.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Oncogene",
    "doi": "10.1038/s41388-026-03989-1",
    "records": [
     {
      "id": "humanised-mouse-models",
      "kind": "technology",
      "name": "Humanised mouse models",
      "url": "https://onco.cc/technologies/humanised-mouse-models/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s10552-026-02252-y#onco-edge-paper",
   "url": "https://doi.org/10.1007/s10552-026-02252-y",
   "title": "Bridging the data latency gap: automated extraction of genomic biomarkers from unstructured clinical documents to support real-world oncology data.",
   "content_text": "Published in Cancer Causes Control on 20 September 2026; matched the OnCo record for Oncotype DX.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Cancer Causes Control",
    "doi": "10.1007/s10552-026-02252-y",
    "records": [
     {
      "id": "oncotype-dx",
      "kind": "drug",
      "name": "Oncotype DX",
      "url": "https://onco.cc/drugs/oncotype-dx/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.critrevonc.2026.105608#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.critrevonc.2026.105608",
   "title": "Current Management and Investigational Therapeutic Strategies in Penile Squamous Cell Carcinoma: A Narrative Review.",
   "content_text": "Published in Crit Rev Oncol Hematol on 20 September 2026; matched the OnCo record for Penile cancer.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Crit Rev Oncol Hematol",
    "doi": "10.1016/j.critrevonc.2026.105608",
    "records": [
     {
      "id": "penile",
      "kind": "cancer",
      "name": "Penile cancer",
      "url": "https://onco.cc/cancers/penile/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.critrevonc.2026.105607#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.critrevonc.2026.105607",
   "title": "Emerging Patterns of Kidney Cancer in Young Adults: Where Do We Stand? Emerging Patterns of Kidney Cancer in Young Adults: Where Do We Stand?",
   "content_text": "Published in Crit Rev Oncol Hematol on 20 September 2026; matched the OnCo record for Belzutifan.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Crit Rev Oncol Hematol",
    "doi": "10.1016/j.critrevonc.2026.105607",
    "records": [
     {
      "id": "belzutifan",
      "kind": "drug",
      "name": "Belzutifan",
      "url": "https://onco.cc/drugs/belzutifan/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12012-026-10191-y#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12012-026-10191-y",
   "title": "Genetic and Molecular Determinants of Cancer Therapy-Related Cardiovascular Toxicity.",
   "content_text": "Published in Cardiovasc Toxicol on 20 September 2026; matched the OnCo record for HER4.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Cardiovasc Toxicol",
    "doi": "10.1007/s12012-026-10191-y",
    "records": [
     {
      "id": "erbb4",
      "kind": "target",
      "name": "HER4",
      "url": "https://onco.cc/targets/erbb4/"
     },
     {
      "id": "strain-echocardiography-gls",
      "kind": "technology",
      "name": "Strain echocardiography",
      "url": "https://onco.cc/technologies/strain-echocardiography-gls/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1111/bjh.70850#onco-edge-paper",
   "url": "https://doi.org/10.1111/bjh.70850",
   "title": "Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.",
   "content_text": "Published in Br J Haematol on 20 September 2026; matched the OnCo record for Acute lymphoblastic leukaemia.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Br J Haematol",
    "doi": "10.1111/bjh.70850",
    "records": [
     {
      "id": "all-leukemia",
      "kind": "cancer",
      "name": "Acute lymphoblastic leukaemia",
      "url": "https://onco.cc/cancers/all-leukemia/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.actbio.2026.09.035#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.actbio.2026.09.035",
   "title": "Leukemic Stem Cell-Targeted Liposomal Nanoimmunotherapy Reverses Immune Evasion and Inhibits Fusion Oncoprotein-Driven Acute Myeloid Leukemia by Silencing B-Cell Lymphoma 2.",
   "content_text": "Published in Acta Biomater on 20 September 2026; matched the OnCo record for CD123.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Acta Biomater",
    "doi": "10.1016/j.actbio.2026.09.035",
    "records": [
     {
      "id": "cd123",
      "kind": "target",
      "name": "CD123",
      "url": "https://onco.cc/targets/cd123/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/ijc.70745#onco-edge-paper",
   "url": "https://doi.org/10.1002/ijc.70745",
   "title": "Longitudinal Associations of Oxaliplatin Treatment With Chemotherapy-Induced Peripheral Neuropathy in Colorectal cancer Survivors up to 2 Years Post-Treatment.",
   "content_text": "Published in Int J Cancer on 20 September 2026; matched the OnCo record for CAPOX.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Int J Cancer",
    "doi": "10.1002/ijc.70745",
    "records": [
     {
      "id": "capox",
      "kind": "drug",
      "name": "CAPOX",
      "url": "https://onco.cc/drugs/capox/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s10552-026-02242-0#onco-edge-paper",
   "url": "https://doi.org/10.1007/s10552-026-02242-0",
   "title": "Predictors of perceived value of multi-cancer early detection testing: a national PRECEDE-PROCEED framework study.",
   "content_text": "Published in Cancer Causes Control on 20 September 2026; matched the OnCo record for Multi-cancer early detection.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Cancer Causes Control",
    "doi": "10.1007/s10552-026-02242-0",
    "records": [
     {
      "id": "mced",
      "kind": "technology",
      "name": "Multi-cancer early detection",
      "url": "https://onco.cc/technologies/mced/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/13543776.2026.2735861#onco-edge-paper",
   "url": "https://doi.org/10.1080/13543776.2026.2735861",
   "title": "Progress with FAK inhibitors in the patent literature (2020-present).",
   "content_text": "Published in Expert Opin Ther Pat on 20 September 2026; matched the OnCo record for Avutometinib + defactinib.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Expert Opin Ther Pat",
    "doi": "10.1080/13543776.2026.2735861",
    "records": [
     {
      "id": "avutometinib-defactinib",
      "kind": "drug",
      "name": "Avutometinib + defactinib",
      "url": "https://onco.cc/drugs/avutometinib-defactinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/14796694.2026.2732570#onco-edge-paper",
   "url": "https://doi.org/10.1080/14796694.2026.2732570",
   "title": "Translating avelumab maintenance into clinical practice: nationwide outcomes in Czech patients with advanced or metastatic urothelial carcinoma.",
   "content_text": "Published in Future Oncol on 20 September 2026; matched the OnCo record for Avelumab.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Future Oncol",
    "doi": "10.1080/14796694.2026.2732570",
    "records": [
     {
      "id": "avelumab",
      "kind": "drug",
      "name": "Avelumab",
      "url": "https://onco.cc/drugs/avelumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.clinme.2026.100643#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.clinme.2026.100643",
   "title": "Updates to contemporary care of glioblastoma.",
   "content_text": "Published in Clin Med (Lond) on 20 September 2026; matched the OnCo record for Tumour treating fields.",
   "date_published": "2026-09-20T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-20",
    "precision": "day",
    "venue": "Clin Med (Lond)",
    "doi": "10.1016/j.clinme.2026.100643",
    "records": [
     {
      "id": "ttfields",
      "kind": "technology",
      "name": "Tumour treating fields",
      "url": "https://onco.cc/technologies/ttfields/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bioorg.2026.110552#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bioorg.2026.110552",
   "title": "A pyridone-fused imidazo[1,2-a]pyridine hybrid binds to tubulin at the vinblastine site, depolymerizes microtubules and inhibits Cancer cell proliferation.",
   "content_text": "Published in Bioorg Chem on 19 September 2026; matched the OnCo record for Vinblastine.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Bioorg Chem",
    "doi": "10.1016/j.bioorg.2026.110552",
    "records": [
     {
      "id": "vinblastine",
      "kind": "drug",
      "name": "Vinblastine",
      "url": "https://onco.cc/drugs/vinblastine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12308-026-00734-1#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12308-026-00734-1",
   "title": "Acute myeloid leukemia arising in treated chronic lymphocytic leukemia/small lymphocytic lymphoma: a challenge in analysis of lineage relationship.",
   "content_text": "Published in J Hematop on 19 September 2026; matched the OnCo record for CD123.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "J Hematop",
    "doi": "10.1007/s12308-026-00734-1",
    "records": [
     {
      "id": "cd123",
      "kind": "target",
      "name": "CD123",
      "url": "https://onco.cc/targets/cd123/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/cco.0000000000001275#onco-edge-paper",
   "url": "https://doi.org/10.1097/cco.0000000000001275",
   "title": "Beyond poly(ADP-ribose) polymerase inhibition: emerging therapeutic strategies for germline BRCA1/2-mutated and PALB2-mutated breast cancers.",
   "content_text": "Published in Curr Opin Oncol on 19 September 2026; matched the OnCo record for Talazoparib.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Curr Opin Oncol",
    "doi": "10.1097/cco.0000000000001275",
    "records": [
     {
      "id": "talazoparib",
      "kind": "drug",
      "name": "Talazoparib",
      "url": "https://onco.cc/drugs/talazoparib/"
     },
     {
      "id": "wee1",
      "kind": "target",
      "name": "WEE1",
      "url": "https://onco.cc/targets/wee1/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/jha2.70385#onco-edge-paper",
   "url": "https://doi.org/10.1002/jha2.70385",
   "title": "Clinicopathologic Characteristics of Somatic <i>TP53</i> Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Systematic Review.",
   "content_text": "Published in EJHaem on 19 September 2026; matched the OnCo record for BCR::ABL1.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "EJHaem",
    "doi": "10.1002/jha2.70385",
    "records": [
     {
      "id": "bcr-abl",
      "kind": "target",
      "name": "BCR::ABL1",
      "url": "https://onco.cc/targets/bcr-abl/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ymthe.2026.09.020#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ymthe.2026.09.020",
   "title": "Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction.",
   "content_text": "Published in Mol Ther on 19 September 2026; matched the OnCo record for Plerixafor.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Mol Ther",
    "doi": "10.1016/j.ymthe.2026.09.020",
    "records": [
     {
      "id": "plerixafor",
      "kind": "drug",
      "name": "Plerixafor",
      "url": "https://onco.cc/drugs/plerixafor/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1136/bmjpo-2026-004903#onco-edge-paper",
   "url": "https://doi.org/10.1136/bmjpo-2026-004903",
   "title": "Distribution, socioeconomic inequalities and contributing factors of anaemia prevalence across wealth index among Indian adolescent girls: multivariate decomposition analysis of nationally representative survey.",
   "content_text": "Published in BMJ Paediatr Open on 19 September 2026; matched the OnCo record for HB-200.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "BMJ Paediatr Open",
    "doi": "10.1136/bmjpo-2026-004903",
    "records": [
     {
      "id": "hb-200",
      "kind": "drug",
      "name": "HB-200",
      "url": "https://onco.cc/drugs/hb-200/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.radonc.2026.111784#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.radonc.2026.111784",
   "title": "Efficacy and safety of omitting the clinical target volume in limited-stage small cell lung cancer: a large-scale multicenter real-world study.",
   "content_text": "Published in Radiother Oncol on 19 September 2026; matched the OnCo record for Limited-stage small-cell lung cancer.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Radiother Oncol",
    "doi": "10.1016/j.radonc.2026.111784",
    "records": [
     {
      "id": "limited-stage-sclc",
      "kind": "cancer",
      "name": "Limited-stage small-cell lung cancer",
      "url": "https://onco.cc/cancers/limited-stage-sclc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00259-026-08191-9#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00259-026-08191-9",
   "title": "Head-to-head comparison of [¹⁸F]F-PSMA-1007 PET/CT and [⁶⁸Ga]Ga-PSMA-11 PET/CT for intraprostatic tumour detection and localisation using histopathology as reference: A prospective single-centre diagnostic accuracy study.",
   "content_text": "Published in Eur J Nucl Med Mol Imaging on 19 September 2026; matched the OnCo record for Gallium-68 gozetotide.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Eur J Nucl Med Mol Imaging",
    "doi": "10.1007/s00259-026-08191-9",
    "records": [
     {
      "id": "ga68-psma-11",
      "kind": "drug",
      "name": "Gallium-68 gozetotide",
      "url": "https://onco.cc/drugs/ga68-psma-11/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1177/10668969261480728#onco-edge-paper",
   "url": "https://doi.org/10.1177/10668969261480728",
   "title": "Hepatocellular Carcinoma With a Grade 3 Neuroendocrine Tumor Component: A Case Report.",
   "content_text": "Published in Int J Surg Pathol on 19 September 2026; matched the OnCo record for Grade 3 well-differentiated neuroendocrine tumour.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Int J Surg Pathol",
    "doi": "10.1177/10668969261480728",
    "records": [
     {
      "id": "grade-3-net",
      "kind": "cancer",
      "name": "Grade 3 well-differentiated neuroendocrine tumour",
      "url": "https://onco.cc/cancers/grade-3-net/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41420-026-03344-z#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41420-026-03344-z",
   "title": "Immunogenic cell death as a mechanism of synergy between sunitinib and <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors.",
   "content_text": "Published in Cell Death Discov on 19 September 2026; matched the OnCo record for Lutetium-177 dotatate.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Cell Death Discov",
    "doi": "10.1038/s41420-026-03344-z",
    "records": [
     {
      "id": "lutathera",
      "kind": "drug",
      "name": "Lutetium-177 dotatate",
      "url": "https://onco.cc/drugs/lutathera/"
     },
     {
      "id": "pancreatic-net",
      "kind": "cancer",
      "name": "Pancreatic neuroendocrine tumours",
      "url": "https://onco.cc/cancers/pancreatic-net/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bcp.2026.118491#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bcp.2026.118491",
   "title": "In vivo CAR‑T cell therapy: mechanisms, clinical advances and optimization strategies.",
   "content_text": "Published in Biochem Pharmacol on 19 September 2026; matched the OnCo record for In vivo CAR-T.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Biochem Pharmacol",
    "doi": "10.1016/j.bcp.2026.118491",
    "records": [
     {
      "id": "in-vivo-car-t",
      "kind": "technology",
      "name": "In vivo CAR-T",
      "url": "https://onco.cc/technologies/in-vivo-car-t/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/19932820.2026.2735579#onco-edge-paper",
   "url": "https://doi.org/10.1080/19932820.2026.2735579",
   "title": "Integrating immunophenotyping and morphology in the diagnosis of acute leukemia at the National Oncology Center, Sana'a, Yemen.",
   "content_text": "Published in Libyan J Med on 19 September 2026; matched the OnCo record for Anal high-grade squamous intraepithelial lesions.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Libyan J Med",
    "doi": "10.1080/19932820.2026.2735579",
    "records": [
     {
      "id": "anal-hsil-precursor",
      "kind": "cancer",
      "name": "Anal high-grade squamous intraepithelial lesions",
      "url": "https://onco.cc/cancers/anal-hsil-precursor/"
     },
     {
      "id": "burkitt-lymphoma",
      "kind": "cancer",
      "name": "Burkitt lymphoma",
      "url": "https://onco.cc/cancers/burkitt-lymphoma/"
     },
     {
      "id": "cd19",
      "kind": "target",
      "name": "CD19",
      "url": "https://onco.cc/targets/cd19/"
     },
     {
      "id": "cd7",
      "kind": "target",
      "name": "CD7",
      "url": "https://onco.cc/targets/cd7/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.oraloncology.2026.108124#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.oraloncology.2026.108124",
   "title": "Investigating the impact of margins on the management of oropharyngeal cancer treated with transoral robotic surgery: a survey of head and neck oncologists' treatment patterns.",
   "content_text": "Published in Oral Oncol on 19 September 2026; matched the OnCo record for Transoral robotic surgery.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Oral Oncol",
    "doi": "10.1016/j.oraloncology.2026.108124",
    "records": [
     {
      "id": "tors",
      "kind": "technology",
      "name": "Transoral robotic surgery",
      "url": "https://onco.cc/technologies/tors/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bcp.2026.118490#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bcp.2026.118490",
   "title": "IRF1-driven chromatin and transcriptional regulation determines the anti-tumor responses to all-trans retinoic acid across cancer types.",
   "content_text": "Published in Biochem Pharmacol on 19 September 2026; matched the OnCo record for Acute promyelocytic leukaemia.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Biochem Pharmacol",
    "doi": "10.1016/j.bcp.2026.118490",
    "records": [
     {
      "id": "apl",
      "kind": "cancer",
      "name": "Acute promyelocytic leukaemia",
      "url": "https://onco.cc/cancers/apl/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s10555-026-10381-8#onco-edge-paper",
   "url": "https://doi.org/10.1007/s10555-026-10381-8",
   "title": "Precision therapeutic strategies for advanced gastrointestinal stromal tumors.",
   "content_text": "Published in Cancer Metastasis Rev on 19 September 2026; matched the OnCo record for Ripretinib.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Cancer Metastasis Rev",
    "doi": "10.1007/s10555-026-10381-8",
    "records": [
     {
      "id": "ripretinib",
      "kind": "drug",
      "name": "Ripretinib",
      "url": "https://onco.cc/drugs/ripretinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jtct.2026.09.008#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jtct.2026.09.008",
   "title": "Prognostic Associations of Molecular MRD and Genomic Features in ZNF384-Rearranged B-ALL Undergoing Allo-HSCT.",
   "content_text": "Published in Transplant Cell Ther on 19 September 2026; matched the OnCo record for CD33.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Transplant Cell Ther",
    "doi": "10.1016/j.jtct.2026.09.008",
    "records": [
     {
      "id": "cd33",
      "kind": "target",
      "name": "CD33",
      "url": "https://onco.cc/targets/cd33/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s40261-026-01592-6#onco-edge-paper",
   "url": "https://doi.org/10.1007/s40261-026-01592-6",
   "title": "Real-World Treatment Patterns, Healthcare Resource Use, and Costs in Patients with Follicular Lymphoma, Waldenström Macroglobulinemia, and Marginal Zone Lymphoma: A Claims-Based Study in the USA.",
   "content_text": "Published in Clin Drug Investig on 19 September 2026; matched the OnCo record for Bendamustine.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Clin Drug Investig",
    "doi": "10.1007/s40261-026-01592-6",
    "records": [
     {
      "id": "bendamustine",
      "kind": "drug",
      "name": "Bendamustine",
      "url": "https://onco.cc/drugs/bendamustine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1177/10668969261479347#onco-edge-paper",
   "url": "https://doi.org/10.1177/10668969261479347",
   "title": "Salivary Duct Carcinoma With Rhabdoid and Signet-Ring Cell Features Mimicking Invasive Lobular Carcinoma of the Breast: A Case Report and Review of the Literature.",
   "content_text": "Published in Int J Surg Pathol on 19 September 2026; matched the OnCo record for Salivary duct carcinoma.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Int J Surg Pathol",
    "doi": "10.1177/10668969261479347",
    "records": [
     {
      "id": "salivary-duct-carcinoma",
      "kind": "cancer",
      "name": "Salivary duct carcinoma",
      "url": "https://onco.cc/cancers/salivary-duct-carcinoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12185-026-04282-3#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12185-026-04282-3",
   "title": "Strategies to prevent post-transplant relapse in acute myeloid leukemia and myelodysplastic syndromes.",
   "content_text": "Published in Int J Hematol on 19 September 2026; matched the OnCo record for Decitabine.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Int J Hematol",
    "doi": "10.1007/s12185-026-04282-3",
    "records": [
     {
      "id": "decitabine",
      "kind": "drug",
      "name": "Decitabine",
      "url": "https://onco.cc/drugs/decitabine/"
     },
     {
      "id": "quizartinib",
      "kind": "drug",
      "name": "Quizartinib",
      "url": "https://onco.cc/drugs/quizartinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11523-026-01245-w#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11523-026-01245-w",
   "title": "Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.",
   "content_text": "Published in Target Oncol on 19 September 2026; matched the OnCo record for Tucatinib.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Target Oncol",
    "doi": "10.1007/s11523-026-01245-w",
    "records": [
     {
      "id": "tucatinib",
      "kind": "drug",
      "name": "Tucatinib",
      "url": "https://onco.cc/drugs/tucatinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s10147-026-03192-y#onco-edge-paper",
   "url": "https://doi.org/10.1007/s10147-026-03192-y",
   "title": "Tarlatamab in small cell lung cancer following platinum-based chemotherapy: subgroup analysis of Japanese patients from the DeLLphi-304 study.",
   "content_text": "Published in Int J Clin Oncol on 19 September 2026; matched the OnCo record for Amrubicin.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "Int J Clin Oncol",
    "doi": "10.1007/s10147-026-03192-y",
    "records": [
     {
      "id": "amrubicin",
      "kind": "drug",
      "name": "Amrubicin",
      "url": "https://onco.cc/drugs/amrubicin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11701-026-03989-z#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11701-026-03989-z",
   "title": "Transoral Robotic Surgery (TORS) versus radical radiotherapy following neoadjuvant therapy for oropharyngeal carcinoma: a multicenter, real-world efficacy and safety analysis.",
   "content_text": "Published in J Robot Surg on 19 September 2026; matched the OnCo record for Transoral robotic surgery.",
   "date_published": "2026-09-19T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-19",
    "precision": "day",
    "venue": "J Robot Surg",
    "doi": "10.1007/s11701-026-03989-z",
    "records": [
     {
      "id": "tors",
      "kind": "technology",
      "name": "Transoral robotic surgery",
      "url": "https://onco.cc/technologies/tors/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1056/nejmoa2610229#onco-edge-paper",
   "url": "https://doi.org/10.1056/nejmoa2610229",
   "title": "Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy.",
   "content_text": "Published in N Engl J Med on 12 September 2026; matched the OnCo record for YL201.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "N Engl J Med",
    "doi": "10.1056/nejmoa2610229",
    "records": [
     {
      "id": "yl201",
      "kind": "drug",
      "name": "YL201",
      "url": "https://onco.cc/drugs/yl201/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3892/or.2026.9195#onco-edge-paper",
   "url": "https://doi.org/10.3892/or.2026.9195",
   "title": "[Corrigendum] The interaction between miR‑148a and DNMT1 suppresses cell migration and invasion by reactivating tumor suppressor genes in pancreatic cancer.",
   "content_text": "Published in Oncol Rep on 18 September 2026; matched the OnCo record for DNMT1.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Oncol Rep",
    "doi": "10.3892/or.2026.9195",
    "records": [
     {
      "id": "dnmt1",
      "kind": "target",
      "name": "DNMT1",
      "url": "https://onco.cc/targets/dnmt1/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00105-026-05778-z#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00105-026-05778-z",
   "title": "[Update on anal dysplasia and anal cancer].",
   "content_text": "Published in Dermatologie (Heidelb) on 18 September 2026; matched the OnCo record for Metastatic and recurrent anal squamous cell carcinoma.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Dermatologie (Heidelb)",
    "doi": "10.1007/s00105-026-05778-z",
    "records": [
     {
      "id": "metastatic-anal-cancer",
      "kind": "cancer",
      "name": "Metastatic and recurrent anal squamous cell carcinoma",
      "url": "https://onco.cc/cancers/metastatic-anal-cancer/"
     },
     {
      "id": "retifanlimab",
      "kind": "drug",
      "name": "Retifanlimab",
      "url": "https://onco.cc/drugs/retifanlimab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41388-026-03984-6#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41388-026-03984-6",
   "title": "A canonical role of SMAD4 in safeguarding 3D genome architecture to suppress lung tumorigenesis.",
   "content_text": "Published in Oncogene on 18 September 2026; matched the OnCo record for Genetically engineered mouse models.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Oncogene",
    "doi": "10.1038/s41388-026-03984-6",
    "records": [
     {
      "id": "genetically-engineered-mouse-models",
      "kind": "technology",
      "name": "Genetically engineered mouse models",
      "url": "https://onco.cc/technologies/genetically-engineered-mouse-models/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3892/mmr.2026.14017#onco-edge-paper",
   "url": "https://doi.org/10.3892/mmr.2026.14017",
   "title": "A four‑gene signature identifies TKI‑induced persister cells and uncovers a ZLN005‑induced pyroptotic vulnerability via the GSDME pathway in EGFR‑mutant lung cancer.",
   "content_text": "Published in Mol Med Rep on 18 September 2026; matched the OnCo record for EGFR-mutated non-small-cell lung cancer.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Mol Med Rep",
    "doi": "10.3892/mmr.2026.14017",
    "records": [
     {
      "id": "egfr-mutant-nsclc",
      "kind": "cancer",
      "name": "EGFR-mutated non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/egfr-mutant-nsclc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1111/bjh.70828#onco-edge-paper",
   "url": "https://doi.org/10.1111/bjh.70828",
   "title": "A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial.",
   "content_text": "Published in Br J Haematol on 18 September 2026; matched the OnCo record for Avelumab.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Br J Haematol",
    "doi": "10.1111/bjh.70828",
    "records": [
     {
      "id": "avelumab",
      "kind": "drug",
      "name": "Avelumab",
      "url": "https://onco.cc/drugs/avelumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.clon.2026.104334#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.clon.2026.104334",
   "title": "Acute Myocardial Infarction in Head and Neck Cancer Patients and Survivors: A Population-Based Cohort Study of Patient, Disease, and Treatment Factors.",
   "content_text": "Published in Clin Oncol (R Coll Radiol) on 18 September 2026; matched the OnCo record for Hypopharyngeal cancer.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Clin Oncol (R Coll Radiol)",
    "doi": "10.1016/j.clon.2026.104334",
    "records": [
     {
      "id": "hypopharyngeal-cancer",
      "kind": "cancer",
      "name": "Hypopharyngeal cancer",
      "url": "https://onco.cc/cancers/hypopharyngeal-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.mcpro.2026.101663#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.mcpro.2026.101663",
   "title": "Anagrelide remodels the PDE3A-SLFN12 interactome to associate with translation initiation machinery in cancer cell lines.",
   "content_text": "Published in Mol Cell Proteomics on 18 September 2026; matched the OnCo record for Anagrelide.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Mol Cell Proteomics",
    "doi": "10.1016/j.mcpro.2026.101663",
    "records": [
     {
      "id": "anagrelide",
      "kind": "drug",
      "name": "Anagrelide",
      "url": "https://onco.cc/drugs/anagrelide/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1136/jcp-2026-210643#onco-edge-paper",
   "url": "https://doi.org/10.1136/jcp-2026-210643",
   "title": "Artificial Intelligence in Digital Pathology for Prostate Cancer Detection: FDA Clearance and Real-World Implementation.",
   "content_text": "Published in J Clin Pathol on 18 September 2026; matched the OnCo record for Paige Prostate Detect.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Clin Pathol",
    "doi": "10.1136/jcp-2026-210643",
    "records": [
     {
      "id": "paige-prostate",
      "kind": "drug",
      "name": "Paige Prostate Detect",
      "url": "https://onco.cc/drugs/paige-prostate/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.spinee.2026.09.009#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.spinee.2026.09.009",
   "title": "Beyond Anatomical Resectability: A Hypermetabolic and Highly Aggressive Subtype of Spinal Chordoma Associated with Cancer-Specific Progression.",
   "content_text": "Published in Spine J on 18 September 2026; matched the OnCo record for Chordoma.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Spine J",
    "doi": "10.1016/j.spinee.2026.09.009",
    "records": [
     {
      "id": "chordoma",
      "kind": "cancer",
      "name": "Chordoma",
      "url": "https://onco.cc/cancers/chordoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1136/bmjopen-2026-119297#onco-edge-paper",
   "url": "https://doi.org/10.1136/bmjopen-2026-119297",
   "title": "Can early <sup>68</sup>Ga-PSMA-11 PET/CT predict 6-month disease control in patients receiving first-line systemic therapy for metastatic clear-cell renal cell carcinoma? Protocol for the multicentre prospective phase II PSMA-RENAL study in Belgium.",
   "content_text": "Published in BMJ Open on 18 September 2026; matched the OnCo record for Gallium-68 gozetotide.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "BMJ Open",
    "doi": "10.1136/bmjopen-2026-119297",
    "records": [
     {
      "id": "ga68-psma-11",
      "kind": "drug",
      "name": "Gallium-68 gozetotide",
      "url": "https://onco.cc/drugs/ga68-psma-11/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/anie.1584222#onco-edge-paper",
   "url": "https://doi.org/10.1002/anie.1584222",
   "title": "Carbohydrate-Directed Labeling Probes for UV-Independent Chemoproteomic Profiling of Carbohydrate-Protein Interactions.",
   "content_text": "Published in Angew Chem Int Ed Engl on 18 September 2026; matched the OnCo record for CD22.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Angew Chem Int Ed Engl",
    "doi": "10.1002/anie.1584222",
    "records": [
     {
      "id": "cd22",
      "kind": "target",
      "name": "CD22",
      "url": "https://onco.cc/targets/cd22/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/ju.0000000000005317#onco-edge-paper",
   "url": "https://doi.org/10.1097/ju.0000000000005317",
   "title": "Chemotherapy Versus Surgery for Stage IIA Nonseminomatous Germ Cell Tumor: A Comparative Cost Utility Analysis.",
   "content_text": "Published in J Urol on 18 September 2026; matched the OnCo record for Testicular germ cell tumours.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Urol",
    "doi": "10.1097/ju.0000000000005317",
    "records": [
     {
      "id": "testicular",
      "kind": "cancer",
      "name": "Testicular germ cell tumours",
      "url": "https://onco.cc/cancers/testicular/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.xcrm.2026.103054#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.xcrm.2026.103054",
   "title": "Class visualizations and activation atlases for computational pathology.",
   "content_text": "Published in Cell Rep Med on 18 September 2026; matched the OnCo record for Pathology & radiology foundation models.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Cell Rep Med",
    "doi": "10.1016/j.xcrm.2026.103054",
    "records": [
     {
      "id": "pathology-foundation-model",
      "kind": "technology",
      "name": "Pathology & radiology foundation models",
      "url": "https://onco.cc/technologies/pathology-foundation-model/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1177/10668969261477760#onco-edge-paper",
   "url": "https://doi.org/10.1177/10668969261477760",
   "title": "Claudin 18.2 Expression and Outcomes in Resected Gallbladder and Biliary Tract Adenocarcinomas: A Pilot Clinicopathologic Study.",
   "content_text": "Published in Int J Surg Pathol on 18 September 2026; matched the OnCo record for VENTANA PD-L1 (SP263) Assay.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Int J Surg Pathol",
    "doi": "10.1177/10668969261477760",
    "records": [
     {
      "id": "ventana-pd-l1-sp263",
      "kind": "drug",
      "name": "VENTANA PD-L1 (SP263) Assay",
      "url": "https://onco.cc/drugs/ventana-pd-l1-sp263/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/coc.0000000000001375#onco-edge-paper",
   "url": "https://doi.org/10.1097/coc.0000000000001375",
   "title": "Combination of Immune Checkpoint Inhibitors With Vascular Endothelial Growth Factor-Targeted Agents in Advanced Gastric and Gastroesophageal Adenocarcinoma: A Systematic Review and Meta-analysis.",
   "content_text": "Published in Am J Clin Oncol on 18 September 2026; matched the OnCo record for Rivoceranib.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Am J Clin Oncol",
    "doi": "10.1097/coc.0000000000001375",
    "records": [
     {
      "id": "rivoceranib",
      "kind": "drug",
      "name": "Rivoceranib",
      "url": "https://onco.cc/drugs/rivoceranib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s40271-026-00840-3#onco-edge-paper",
   "url": "https://doi.org/10.1007/s40271-026-00840-3",
   "title": "Communicating Change on Multi-item Patient-Reported Outcome Measures: What Were the Meaningful Changes in Physical Functioning Experienced by Patients on Vimseltinib in the MOTION Trial.",
   "content_text": "Published in Patient on 18 September 2026; matched the OnCo record for Vimseltinib.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Patient",
    "doi": "10.1007/s40271-026-00840-3",
    "records": [
     {
      "id": "vimseltinib",
      "kind": "drug",
      "name": "Vimseltinib",
      "url": "https://onco.cc/drugs/vimseltinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jaad.2026.09.051#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jaad.2026.09.051",
   "title": "Community-Based Skin Cancer Screening and Follow-up Outcomes from a Statewide Outreach Program.",
   "content_text": "Published in J Am Acad Dermatol on 18 September 2026; matched the OnCo record for Skin cancer screening.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Am Acad Dermatol",
    "doi": "10.1016/j.jaad.2026.09.051",
    "records": [
     {
      "id": "skin-cancer-screening",
      "kind": "technology",
      "name": "Skin cancer screening",
      "url": "https://onco.cc/technologies/skin-cancer-screening/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1158/2767-9764.crc-26-0302#onco-edge-paper",
   "url": "https://doi.org/10.1158/2767-9764.crc-26-0302",
   "title": "Compartment-specific CD8 infiltration and disease-specific survival in resected ampullary adenocarcinoma.",
   "content_text": "Published in Cancer Res Commun on 18 September 2026; matched the OnCo record for Ampullary cancer.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Cancer Res Commun",
    "doi": "10.1158/2767-9764.crc-26-0302",
    "records": [
     {
      "id": "ampullary",
      "kind": "cancer",
      "name": "Ampullary cancer",
      "url": "https://onco.cc/cancers/ampullary/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1136/bcr-2025-271236#onco-edge-paper",
   "url": "https://doi.org/10.1136/bcr-2025-271236",
   "title": "Disseminated <i>Fusarium</i> infection following cladribine chemotherapy for hairy-cell leukaemia.",
   "content_text": "Published in BMJ Case Rep on 18 September 2026; matched the OnCo record for Cladribine.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "BMJ Case Rep",
    "doi": "10.1136/bcr-2025-271236",
    "records": [
     {
      "id": "cladribine",
      "kind": "drug",
      "name": "Cladribine",
      "url": "https://onco.cc/drugs/cladribine/"
     },
     {
      "id": "hairy-cell-leukemia",
      "kind": "cancer",
      "name": "Hairy cell leukaemia",
      "url": "https://onco.cc/cancers/hairy-cell-leukemia/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/07853890.2026.2732274#onco-edge-paper",
   "url": "https://doi.org/10.1080/07853890.2026.2732274",
   "title": "Effect of transcutaneous auricular vagus nerve stimulation on postoperative gastrointestinal dysfunction in patients with gynecological abdominal or pelvic tumors: a study protocol for a prospective, single-center, randomized, controlled clinical trial.",
   "content_text": "Published in Ann Med on 18 September 2026; matched the OnCo record for Stage III melanoma.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Ann Med",
    "doi": "10.1080/07853890.2026.2732274",
    "records": [
     {
      "id": "stage-iii-melanoma",
      "kind": "cancer",
      "name": "Stage III melanoma",
      "url": "https://onco.cc/cancers/stage-iii-melanoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.urolonc.2026.08.015#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.urolonc.2026.08.015",
   "title": "Efficacy and safety analysis of disitamab vedotin combined with immunotherapy as neoadjuvant treatment to promote conversion to bladder preservation in bladder cancer: A retrospective comparative study with the GC combined with immunotherapy regimen.",
   "content_text": "Published in Urol Oncol on 18 September 2026; matched the OnCo record for Gemcitabine + cisplatin.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Urol Oncol",
    "doi": "10.1016/j.urolonc.2026.08.015",
    "records": [
     {
      "id": "gemcitabine-cisplatin",
      "kind": "drug",
      "name": "Gemcitabine + cisplatin",
      "url": "https://onco.cc/drugs/gemcitabine-cisplatin/"
     },
     {
      "id": "toripalimab",
      "kind": "drug",
      "name": "Toripalimab",
      "url": "https://onco.cc/drugs/toripalimab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11060-026-05798-8#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11060-026-05798-8",
   "title": "Efficacy and safety of proton radiotherapy for progressive or surgically unfavorable adult pilocytic astrocytoma: a single-center experience.",
   "content_text": "Published in J Neurooncol on 18 September 2026; matched the OnCo record for Paediatric low-grade glioma.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Neurooncol",
    "doi": "10.1007/s11060-026-05798-8",
    "records": [
     {
      "id": "paediatric-low-grade-glioma",
      "kind": "cancer",
      "name": "Paediatric low-grade glioma",
      "url": "https://onco.cc/cancers/paediatric-low-grade-glioma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/cco.0000000000001279#onco-edge-paper",
   "url": "https://doi.org/10.1097/cco.0000000000001279",
   "title": "Emerging role of targeted therapy in drug-resistant epilepsy in patients with glioma.",
   "content_text": "Published in Curr Opin Oncol on 18 September 2026; matched the OnCo record for Vorasidenib.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Curr Opin Oncol",
    "doi": "10.1097/cco.0000000000001279",
    "records": [
     {
      "id": "vorasidenib",
      "kind": "drug",
      "name": "Vorasidenib",
      "url": "https://onco.cc/drugs/vorasidenib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ad.2026.104739#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ad.2026.104739",
   "title": "Erythematous dorsal plaques in 6 patients with advanced T-cell lymphoma: a clinical variant of mogamulizumab-associated rash.",
   "content_text": "Published in Actas Dermosifiliogr on 18 September 2026; matched the OnCo record for Mogamulizumab.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Actas Dermosifiliogr",
    "doi": "10.1016/j.ad.2026.104739",
    "records": [
     {
      "id": "mogamulizumab",
      "kind": "drug",
      "name": "Mogamulizumab",
      "url": "https://onco.cc/drugs/mogamulizumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1186/s12880-026-02772-8#onco-edge-paper",
   "url": "https://doi.org/10.1186/s12880-026-02772-8",
   "title": "FDG-PET/CT-based treatment response predicts recurrence and overall survival in locally advanced cervical cancer.",
   "content_text": "Published in BMC Med Imaging on 18 September 2026; matched the OnCo record for Locally advanced cervical cancer.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "BMC Med Imaging",
    "doi": "10.1186/s12880-026-02772-8",
    "records": [
     {
      "id": "locally-advanced-cervical-cancer",
      "kind": "cancer",
      "name": "Locally advanced cervical cancer",
      "url": "https://onco.cc/cancers/locally-advanced-cervical-cancer/"
     },
     {
      "id": "recurrent-metastatic-cervical-cancer",
      "kind": "cancer",
      "name": "Recurrent or metastatic cervical cancer",
      "url": "https://onco.cc/cancers/recurrent-metastatic-cervical-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ejmp.2026.107174#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ejmp.2026.107174",
   "title": "Feasibility of prostate offline adaptive radiation therapy using iterative reconstructed CBCT to optimize the ART workflow.",
   "content_text": "Published in Phys Med on 18 September 2026; matched the OnCo record for MR-guided adaptive radiotherapy.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Phys Med",
    "doi": "10.1016/j.ejmp.2026.107174",
    "records": [
     {
      "id": "mr-linac",
      "kind": "technology",
      "name": "MR-guided adaptive radiotherapy",
      "url": "https://onco.cc/technologies/mr-linac/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1136/jitc-2026-015212#onco-edge-paper",
   "url": "https://doi.org/10.1136/jitc-2026-015212",
   "title": "Frailty of older patients is not reflected in the melanoma tumor microenvironment and treatment response to immune checkpoint blockade therapy.",
   "content_text": "Published in J Immunother Cancer on 18 September 2026; matched the OnCo record for Imaging mass cytometry.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Immunother Cancer",
    "doi": "10.1136/jitc-2026-015212",
    "records": [
     {
      "id": "imaging-mass-cytometry",
      "kind": "technology",
      "name": "Imaging mass cytometry",
      "url": "https://onco.cc/technologies/imaging-mass-cytometry/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1136/jitc-2026-016839#onco-edge-paper",
   "url": "https://doi.org/10.1136/jitc-2026-016839",
   "title": "Gene regulatory elements determine efficacy of BCMA-targeted CAR-T cell products.",
   "content_text": "Published in J Immunother Cancer on 18 September 2026; matched the OnCo record for Ciltacabtagene autoleucel.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Immunother Cancer",
    "doi": "10.1136/jitc-2026-016839",
    "records": [
     {
      "id": "ciltacabtagene-autoleucel",
      "kind": "drug",
      "name": "Ciltacabtagene autoleucel",
      "url": "https://onco.cc/drugs/ciltacabtagene-autoleucel/"
     },
     {
      "id": "idecabtagene-vicleucel",
      "kind": "drug",
      "name": "Idecabtagene vicleucel",
      "url": "https://onco.cc/drugs/idecabtagene-vicleucel/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.57264/cer-2026-0138#onco-edge-paper",
   "url": "https://doi.org/10.57264/cer-2026-0138",
   "title": "Indirect treatment comparison of odevixibat and maralixibat for the treatment of cholestatic pruritus in patients with Alagille syndrome.",
   "content_text": "Published in J Comp Eff Res on 18 September 2026; matched the OnCo record for Small intestine cancer.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Comp Eff Res",
    "doi": "10.57264/cer-2026-0138",
    "records": [
     {
      "id": "small-bowel",
      "kind": "cancer",
      "name": "Small intestine cancer",
      "url": "https://onco.cc/cancers/small-bowel/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1182/bloodadvances.2026020742#onco-edge-paper",
   "url": "https://doi.org/10.1182/bloodadvances.2026020742",
   "title": "Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.",
   "content_text": "Published in Blood Adv on 18 September 2026; matched the OnCo record for Allogeneic stem cell transplantation.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Blood Adv",
    "doi": "10.1182/bloodadvances.2026020742",
    "records": [
     {
      "id": "allogeneic-hsct",
      "kind": "technology",
      "name": "Allogeneic stem cell transplantation",
      "url": "https://onco.cc/technologies/allogeneic-hsct/"
     },
     {
      "id": "zynlonta",
      "kind": "drug",
      "name": "Loncastuximab tesirine",
      "url": "https://onco.cc/drugs/zynlonta/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/14796694.2026.2732579#onco-edge-paper",
   "url": "https://doi.org/10.1080/14796694.2026.2732579",
   "title": "MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis.",
   "content_text": "Published in Future Oncol on 18 September 2026; matched the OnCo record for Node-positive and metastatic penile cancer.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Future Oncol",
    "doi": "10.1080/14796694.2026.2732579",
    "records": [
     {
      "id": "node-positive-penile-cancer",
      "kind": "cancer",
      "name": "Node-positive and metastatic penile cancer",
      "url": "https://onco.cc/cancers/node-positive-penile-cancer/"
     },
     {
      "id": "pucotenlimab",
      "kind": "drug",
      "name": "Pucotenlimab",
      "url": "https://onco.cc/drugs/pucotenlimab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.str.2026.08.013#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.str.2026.08.013",
   "title": "Modulating pseudokinase conformation from the ATP-binding site.",
   "content_text": "Published in Structure on 18 September 2026; matched the OnCo record for HER3.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Structure",
    "doi": "10.1016/j.str.2026.08.013",
    "records": [
     {
      "id": "her3",
      "kind": "target",
      "name": "HER3",
      "url": "https://onco.cc/targets/her3/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11899-026-00790-5#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11899-026-00790-5",
   "title": "Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026.",
   "content_text": "Published in Curr Hematol Malig Rep on 18 September 2026; matched the OnCo record for Ropeginterferon alfa-2b.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Curr Hematol Malig Rep",
    "doi": "10.1007/s11899-026-00790-5",
    "records": [
     {
      "id": "ropeginterferon-alfa-2b",
      "kind": "drug",
      "name": "Ropeginterferon alfa-2b",
      "url": "https://onco.cc/drugs/ropeginterferon-alfa-2b/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.anl.2026.09.003#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.anl.2026.09.003",
   "title": "Molecular targeted therapy for thyroid cancer in Japan: Current status and future perspectives.",
   "content_text": "Published in Auris Nasus Larynx on 18 September 2026; matched the OnCo record for Companion diagnostics.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Auris Nasus Larynx",
    "doi": "10.1016/j.anl.2026.09.003",
    "records": [
     {
      "id": "companion-diagnostic",
      "kind": "technology",
      "name": "Companion diagnostics",
      "url": "https://onco.cc/technologies/companion-diagnostic/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/rct.0000000000001928#onco-edge-paper",
   "url": "https://doi.org/10.1097/rct.0000000000001928",
   "title": "Multiparametric Whole-Body MRI Protocols in Contemporary Clinical Practice: Indications, Technical Considerations, and Emerging Applications.",
   "content_text": "Published in J Comput Assist Tomogr on 18 September 2026; matched the OnCo record for Whole-body MRI.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Comput Assist Tomogr",
    "doi": "10.1097/rct.0000000000001928",
    "records": [
     {
      "id": "whole-body-mri",
      "kind": "technology",
      "name": "Whole-body MRI",
      "url": "https://onco.cc/technologies/whole-body-mri/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11033-026-12760-4#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11033-026-12760-4",
   "title": "NHSL3 knockout modulates sorafenib response, growth, and motility in hepatocellular carcinoma cell models.",
   "content_text": "Published in Mol Biol Rep on 18 September 2026; matched the OnCo record for CRAF.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Mol Biol Rep",
    "doi": "10.1007/s11033-026-12760-4",
    "records": [
     {
      "id": "raf1",
      "kind": "target",
      "name": "CRAF",
      "url": "https://onco.cc/targets/raf1/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.drup.2026.101476#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.drup.2026.101476",
   "title": "Nucleolar METTL16 drives ccRCC tumorigenesis and pazopanib resistance via translational activation of JAG1/Notch signaling pathway.",
   "content_text": "Published in Drug Resist Updat on 18 September 2026; matched the OnCo record for Pazopanib.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Drug Resist Updat",
    "doi": "10.1016/j.drup.2026.101476",
    "records": [
     {
      "id": "pazopanib",
      "kind": "drug",
      "name": "Pazopanib",
      "url": "https://onco.cc/drugs/pazopanib/"
     }
    ]
   }
  },
  {
   "id": "https://onco.cc/newsletter/2026-09-18/#onco-edge-issue",
   "url": "https://onco.cc/newsletter/2026-09-18/",
   "title": "OnCo weekly, 2026-09-18",
   "content_text": "303 changelog entries, 1 upcoming date, 11 publications, 8 corrections.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "issue"
   ],
   "_onco": {
    "kind": "issue",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "OnCo weekly issue",
    "records": []
   }
  },
  {
   "id": "https://doi.org/10.4103/aja202635#onco-edge-paper",
   "url": "https://doi.org/10.4103/aja202635",
   "title": "Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis.",
   "content_text": "Published in Asian J Androl on 18 September 2026; matched the OnCo record for Onvansertib.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Asian J Androl",
    "doi": "10.4103/aja202635",
    "records": [
     {
      "id": "onvansertib",
      "kind": "drug",
      "name": "Onvansertib",
      "url": "https://onco.cc/drugs/onvansertib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1021/acssensors.5c04490#onco-edge-paper",
   "url": "https://doi.org/10.1021/acssensors.5c04490",
   "title": "Optimizing the Hinge Length of Chimeric Antigen Receptor with a DdFP-Based Immunological Synapse Biosensor.",
   "content_text": "Published in ACS Sens on 18 September 2026; matched the OnCo record for Mesothelin.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "ACS Sens",
    "doi": "10.1021/acssensors.5c04490",
    "records": [
     {
      "id": "mesothelin",
      "kind": "target",
      "name": "Mesothelin",
      "url": "https://onco.cc/targets/mesothelin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3892/or.2026.9194#onco-edge-paper",
   "url": "https://doi.org/10.3892/or.2026.9194",
   "title": "Pemetrexed increases BRCA1 protein stability and sensitizes TNBC cells to radiotherapy.",
   "content_text": "Published in Oncol Rep on 18 September 2026; matched the OnCo record for Pemetrexed.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Oncol Rep",
    "doi": "10.3892/or.2026.9194",
    "records": [
     {
      "id": "pemetrexed",
      "kind": "drug",
      "name": "Pemetrexed",
      "url": "https://onco.cc/drugs/pemetrexed/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/14756366.2026.2717060#onco-edge-paper",
   "url": "https://doi.org/10.1080/14756366.2026.2717060",
   "title": "Phthalazine as a medically versatile polyheterocyclic core with underexplored anticancer potential.",
   "content_text": "Published in J Enzyme Inhib Med Chem on 18 September 2026; matched the OnCo record for PARP.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Enzyme Inhib Med Chem",
    "doi": "10.1080/14756366.2026.2717060",
    "records": [
     {
      "id": "parp",
      "kind": "target",
      "name": "PARP",
      "url": "https://onco.cc/targets/parp/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.canlet.2026.218853#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.canlet.2026.218853",
   "title": "Plasma cfDNA fragmentomics enables non-invasive detection and preoperative risk stratification of bladder cancer in a multicenter study.",
   "content_text": "Published in Cancer Lett on 18 September 2026; matched the OnCo record for cfDNA fragmentomics.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Cancer Lett",
    "doi": "10.1016/j.canlet.2026.218853",
    "records": [
     {
      "id": "fragmentomics",
      "kind": "technology",
      "name": "cfDNA fragmentomics",
      "url": "https://onco.cc/technologies/fragmentomics/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1515/dx-2026-0114#onco-edge-paper",
   "url": "https://doi.org/10.1515/dx-2026-0114",
   "title": "Plasma signals of lung tumor promotion and the ubiquitous challenge of biomarker specificity.",
   "content_text": "Published in Diagnosis (Berl) on 18 September 2026; matched the OnCo record for CEACAM5.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Diagnosis (Berl)",
    "doi": "10.1515/dx-2026-0114",
    "records": [
     {
      "id": "ceacam5",
      "kind": "target",
      "name": "CEACAM5",
      "url": "https://onco.cc/targets/ceacam5/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.mcpro.2026.101662#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.mcpro.2026.101662",
   "title": "PRC2 loss in MPNST is accompanied by SWI/SNF complex rewiring and sensitization to SMARCA2/4 and BET inhibition in vivo.",
   "content_text": "Published in Mol Cell Proteomics on 18 September 2026; matched the OnCo record for Malignant peripheral nerve sheath tumour.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Mol Cell Proteomics",
    "doi": "10.1016/j.mcpro.2026.101662",
    "records": [
     {
      "id": "malignant-peripheral-nerve-sheath-tumour",
      "kind": "cancer",
      "name": "Malignant peripheral nerve sheath tumour",
      "url": "https://onco.cc/cancers/malignant-peripheral-nerve-sheath-tumour/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jfma.2026.09.025#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jfma.2026.09.025",
   "title": "Pre-operative magnetic resonance imaging for evaluating depth of invasion in oral tongue cancer: Precision and predictive value.",
   "content_text": "Published in J Formos Med Assoc on 18 September 2026; matched the OnCo record for Oral tongue and floor of mouth cancer.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Formos Med Assoc",
    "doi": "10.1016/j.jfma.2026.09.025",
    "records": [
     {
      "id": "oral-tongue-cancer",
      "kind": "cancer",
      "name": "Oral tongue and floor of mouth cancer",
      "url": "https://onco.cc/cancers/oral-tongue-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jgo.2026.104382#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jgo.2026.104382",
   "title": "Prognostic value of the Nice Cancer Ageing Survival (NCAS) score in older adults with cancer: A retrospective single institutional study.",
   "content_text": "Published in J Geriatr Oncol on 18 September 2026; matched the OnCo record for Geriatric assessment.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Geriatr Oncol",
    "doi": "10.1016/j.jgo.2026.104382",
    "records": [
     {
      "id": "geriatric-assessment",
      "kind": "technology",
      "name": "Geriatric assessment",
      "url": "https://onco.cc/technologies/geriatric-assessment/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1245/s10434-026-20537-z#onco-edge-paper",
   "url": "https://doi.org/10.1245/s10434-026-20537-z",
   "title": "Recurrence Patterns of Resected Ampullary Adenocarcinoma and Implications for Multimodal Therapy: A Hidden Genome-Derived Analysis from the Ampullary Cancer Collaborative.",
   "content_text": "Published in Ann Surg Oncol on 18 September 2026; matched the OnCo record for Ampullary cancer.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Ann Surg Oncol",
    "doi": "10.1245/s10434-026-20537-z",
    "records": [
     {
      "id": "ampullary",
      "kind": "cancer",
      "name": "Ampullary cancer",
      "url": "https://onco.cc/cancers/ampullary/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00438-026-02522-z#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00438-026-02522-z",
   "title": "Retraction Note: Buparlisib induces eukaryotic elongation factor-2 expression to cause treatment failure for lung cancer cells.",
   "content_text": "Published in Mol Genet Genomics on 18 September 2026; matched the OnCo record for Elongation factor 2.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Mol Genet Genomics",
    "doi": "10.1007/s00438-026-02522-z",
    "records": [
     {
      "id": "eef2",
      "kind": "target",
      "name": "Elongation factor 2",
      "url": "https://onco.cc/targets/eef2/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bbagen.2026.130998#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bbagen.2026.130998",
   "title": "Retraction notice to \"Smoothened-independent activation of hedgehog signaling by rearranged during transfection promotes neuroblastoma cell proliferation and tumor growth\" [Biochim. Biophys. Acta (BBA) - Gen. Subj. 1860 (2016) 1961-1972].",
   "content_text": "Published in Biochim Biophys Acta Gen Subj on 18 September 2026; matched the OnCo record for Smoothened.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Biochim Biophys Acta Gen Subj",
    "doi": "10.1016/j.bbagen.2026.130998",
    "records": [
     {
      "id": "smoothened",
      "kind": "target",
      "name": "Smoothened",
      "url": "https://onco.cc/targets/smoothened/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.currproblcancer.2026.101343#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.currproblcancer.2026.101343",
   "title": "Salvage outcomes with teclistamab after BCMA-directed therapy failure in relapsed/refractory multiple myeloma: a systematic review and meta-analysis.",
   "content_text": "Published in Curr Probl Cancer on 18 September 2026; matched the OnCo record for Teclistamab.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Curr Probl Cancer",
    "doi": "10.1016/j.currproblcancer.2026.101343",
    "records": [
     {
      "id": "teclistamab",
      "kind": "drug",
      "name": "Teclistamab",
      "url": "https://onco.cc/drugs/teclistamab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1158/1535-7163.mct-26-0264#onco-edge-paper",
   "url": "https://doi.org/10.1158/1535-7163.mct-26-0264",
   "title": "Systematic Evaluation of Combination Strategies with Rezatapopt in p53 Y220C-Mutant Cancer Models.",
   "content_text": "Published in Mol Cancer Ther on 18 September 2026; matched the OnCo record for MDM2 inhibitors.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Mol Cancer Ther",
    "doi": "10.1158/1535-7163.mct-26-0264",
    "records": [
     {
      "id": "mdm2-inhibitors",
      "kind": "technology",
      "name": "MDM2 inhibitors",
      "url": "https://onco.cc/technologies/mdm2-inhibitors/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.6004/jnccn.2026.7038#onco-edge-paper",
   "url": "https://doi.org/10.6004/jnccn.2026.7038",
   "title": "Targeting KRAS-Mutant Lung Cancers.",
   "content_text": "Published in J Natl Compr Canc Netw on 18 September 2026; matched the OnCo record for Adagrasib.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Natl Compr Canc Netw",
    "doi": "10.6004/jnccn.2026.7038",
    "records": [
     {
      "id": "adagrasib",
      "kind": "drug",
      "name": "Adagrasib",
      "url": "https://onco.cc/drugs/adagrasib/"
     },
     {
      "id": "daraxonrasib",
      "kind": "drug",
      "name": "Daraxonrasib",
      "url": "https://onco.cc/drugs/daraxonrasib/"
     },
     {
      "id": "kras-g12c-nsclc",
      "kind": "cancer",
      "name": "KRAS G12C-mutant non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/kras-g12c-nsclc/"
     },
     {
      "id": "sotorasib",
      "kind": "drug",
      "name": "Sotorasib",
      "url": "https://onco.cc/drugs/sotorasib/"
     },
     {
      "id": "zoldonrasib",
      "kind": "drug",
      "name": "Zoldonrasib",
      "url": "https://onco.cc/drugs/zoldonrasib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bioorg.2026.110519#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bioorg.2026.110519",
   "title": "Targeting overexpressed tumor cell receptors with radiolabeled molecules: Biological targets, clinical applications, and translational challenges.",
   "content_text": "Published in Bioorg Chem on 18 September 2026; matched the OnCo record for Somatostatin receptor 2.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Bioorg Chem",
    "doi": "10.1016/j.bioorg.2026.110519",
    "records": [
     {
      "id": "sstr2",
      "kind": "target",
      "name": "Somatostatin receptor 2",
      "url": "https://onco.cc/targets/sstr2/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00432-026-06619-1#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00432-026-06619-1",
   "title": "Upper- versus lower-extremity synovial sarcoma: distinct surgical pathways and postoperative morbidity in a 24-year cohort.",
   "content_text": "Published in J Cancer Res Clin Oncol on 18 September 2026; matched the OnCo record for Synovial sarcoma.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "J Cancer Res Clin Oncol",
    "doi": "10.1007/s00432-026-06619-1",
    "records": [
     {
      "id": "synovial-sarcoma",
      "kind": "cancer",
      "name": "Synovial sarcoma",
      "url": "https://onco.cc/cancers/synovial-sarcoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.brs.2026.103211#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.brs.2026.103211",
   "title": "Vagus Nerve Stimulation Exerts Disease-Modifying Effects in Epileptic Rats by Enhancing Hippocampal Adenosine Signalling.",
   "content_text": "Published in Brain Stimul on 18 September 2026; matched the OnCo record for Pilocarpine.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Brain Stimul",
    "doi": "10.1016/j.brs.2026.103211",
    "records": [
     {
      "id": "pilocarpine",
      "kind": "drug",
      "name": "Pilocarpine",
      "url": "https://onco.cc/drugs/pilocarpine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3892/or.2026.9196#onco-edge-paper",
   "url": "https://doi.org/10.3892/or.2026.9196",
   "title": "Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma.",
   "content_text": "Published in Oncol Rep on 18 September 2026; matched the OnCo record for Interferon alfa-2a/2b.",
   "date_published": "2026-09-18T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-18",
    "precision": "day",
    "venue": "Oncol Rep",
    "doi": "10.3892/or.2026.9196",
    "records": [
     {
      "id": "interferon-alfa",
      "kind": "drug",
      "name": "Interferon alfa-2a/2b",
      "url": "https://onco.cc/drugs/interferon-alfa/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.annonc.2026.09.002#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.annonc.2026.09.002",
   "title": "Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.",
   "content_text": "Published in Ann Oncol on 11 September 2026; matched the OnCo record for Bispecific ADC.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Ann Oncol",
    "doi": "10.1016/j.annonc.2026.09.002",
    "records": [
     {
      "id": "bispecific-adc",
      "kind": "technology",
      "name": "Bispecific ADC",
      "url": "https://onco.cc/technologies/bispecific-adc/"
     },
     {
      "id": "izalontamab-brengitecan",
      "kind": "drug",
      "name": "Izalontamab brengitecan",
      "url": "https://onco.cc/drugs/izalontamab-brengitecan/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1200/jco-26-00602#onco-edge-paper",
   "url": "https://doi.org/10.1200/jco-26-00602",
   "title": "Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial.",
   "content_text": "Published in J Clin Oncol on 11 September 2026; matched the OnCo record for HER2 tyrosine kinase inhibitors.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "J Clin Oncol",
    "doi": "10.1200/jco-26-00602",
    "records": [
     {
      "id": "her2-tyrosine-kinase-inhibitors",
      "kind": "technology",
      "name": "HER2 tyrosine kinase inhibitors",
      "url": "https://onco.cc/technologies/her2-tyrosine-kinase-inhibitors/"
     },
     {
      "id": "trastuzumab-emtansine",
      "kind": "drug",
      "name": "Trastuzumab emtansine",
      "url": "https://onco.cc/drugs/trastuzumab-emtansine/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-new-breast-cancer-treatment#onco-edge-approval",
   "url": "https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-new-breast-cancer-treatment",
   "title": "Approval: Camizestrant (US)",
   "content_text": "Accelerated approval (Etcamah).",
   "date_published": "2026-09-04T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-09-04",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "camizestrant",
      "kind": "drug",
      "name": "Camizestrant",
      "url": "https://onco.cc/drugs/camizestrant/"
     },
     {
      "id": "breast-hr-positive",
      "kind": "cancer",
      "name": "HR-positive / HER2-negative breast cancer",
      "url": "https://onco.cc/cancers/breast-hr-positive/"
     },
     {
      "id": "hr-positive-metastatic-post-cdk46",
      "kind": "cancer",
      "name": "HR-positive metastatic breast cancer after CDK4/6 inhibitors",
      "url": "https://onco.cc/cancers/hr-positive-metastatic-post-cdk46/"
     },
     {
      "id": "estrogen-receptor",
      "kind": "target",
      "name": "Estrogen receptor",
      "url": "https://onco.cc/targets/estrogen-receptor/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-camizestrant-cdk46-inhibitor-esr1-mutated-hr-positive-her2-negative#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-camizestrant-cdk46-inhibitor-esr1-mutated-hr-positive-her2-negative",
   "title": "FDA grants accelerated approval to camizestrant with a CDK4/6 inhibitor for ESR1-Mutated HR-positive, HER2-negative locally advanced or metastatic breast cancer",
   "content_text": "On September 4, 2026, the Food and Drug Administration granted accelerated approval to camizestrant (Etcamah, AstraZeneca), an estrogen receptor antagonist, in combination with a CDK4/6 inhibitor (abemaciclib, palbociclib, or ribociclib) for adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer upon detection of estrogen receptor-1 (ESR1) mutation during aromatase inhibitor and CDK4/6 inhibitor therapy, based on an FDA-authorized test.",
   "date_published": "2026-09-04T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-09-04",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "camizestrant",
      "kind": "drug",
      "name": "Camizestrant",
      "url": "https://onco.cc/drugs/camizestrant/"
     },
     {
      "id": "palbociclib",
      "kind": "drug",
      "name": "Palbociclib",
      "url": "https://onco.cc/drugs/palbociclib/"
     },
     {
      "id": "abemaciclib",
      "kind": "drug",
      "name": "Abemaciclib",
      "url": "https://onco.cc/drugs/abemaciclib/"
     },
     {
      "id": "ribociclib",
      "kind": "drug",
      "name": "Ribociclib",
      "url": "https://onco.cc/drugs/ribociclib/"
     },
     {
      "id": "breast-hr-positive",
      "kind": "cancer",
      "name": "HR-positive / HER2-negative breast cancer",
      "url": "https://onco.cc/cancers/breast-hr-positive/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bulcan.2026.07.012#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bulcan.2026.07.012",
   "title": "[Tenosyovial giant cell tumor (TGCT): From the physiopathology to the emergence of new targeted therapies].",
   "content_text": "Published in Bull Cancer on 17 September 2026; matched the OnCo record for Tenosynovial giant cell tumour.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Bull Cancer",
    "doi": "10.1016/j.bulcan.2026.07.012",
    "records": [
     {
      "id": "tenosynovial-giant-cell-tumour",
      "kind": "cancer",
      "name": "Tenosynovial giant cell tumour",
      "url": "https://onco.cc/cancers/tenosynovial-giant-cell-tumour/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/hem3.70467#onco-edge-paper",
   "url": "https://doi.org/10.1002/hem3.70467",
   "title": "A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax.",
   "content_text": "Published in Hemasphere on 17 September 2026; matched the OnCo record for Functional (ex vivo) drug testing.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Hemasphere",
    "doi": "10.1002/hem3.70467",
    "records": [
     {
      "id": "functional-drug-testing",
      "kind": "technology",
      "name": "Functional (ex vivo) drug testing",
      "url": "https://onco.cc/technologies/functional-drug-testing/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.modpat.2026.101086#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.modpat.2026.101086",
   "title": "Acute Myeloid Leukemia With KMT2A Amplification: A TP53-Alteration-Enriched Subgroup Associated With Chromoanagenesis and Poor Prognosis.",
   "content_text": "Published in Mod Pathol on 17 September 2026; matched the OnCo record for Secondary and therapy-related acute myeloid leukaemia.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Mod Pathol",
    "doi": "10.1016/j.modpat.2026.101086",
    "records": [
     {
      "id": "aml-secondary",
      "kind": "cancer",
      "name": "Secondary and therapy-related acute myeloid leukaemia",
      "url": "https://onco.cc/cancers/aml-secondary/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/07853890.2026.2730555#onco-edge-paper",
   "url": "https://doi.org/10.1080/07853890.2026.2730555",
   "title": "Admission low-density lipoprotein cholesterol and early haematoma expansion after spontaneous intracerebral haemorrhage.",
   "content_text": "Published in Ann Med on 17 September 2026; matched the OnCo record for CT.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Ann Med",
    "doi": "10.1080/07853890.2026.2730555",
    "records": [
     {
      "id": "ct",
      "kind": "technology",
      "name": "CT",
      "url": "https://onco.cc/technologies/ct/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/25310429.2026.2735063#onco-edge-paper",
   "url": "https://doi.org/10.1080/25310429.2026.2735063",
   "title": "ALPHA-1 antitrypsin genotype, sex, and lung cancer: Clinical and molecular characterisation.",
   "content_text": "Published in Pulmonology on 17 September 2026; matched the OnCo record for EGFR.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Pulmonology",
    "doi": "10.1080/25310429.2026.2735063",
    "records": [
     {
      "id": "egfr",
      "kind": "target",
      "name": "EGFR",
      "url": "https://onco.cc/targets/egfr/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41392-026-02927-7#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41392-026-02927-7",
   "title": "An integrated multiomic single-vesicle atlas delineates graft exosome heterogeneity in chronic lung allograft dysfunction.",
   "content_text": "Published in Signal Transduct Target Ther on 17 September 2026; matched the OnCo record for CD73 / adenosine axis.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Signal Transduct Target Ther",
    "doi": "10.1038/s41392-026-02927-7",
    "records": [
     {
      "id": "cd73-adenosine",
      "kind": "target",
      "name": "CD73 / adenosine axis",
      "url": "https://onco.cc/targets/cd73-adenosine/"
     },
     {
      "id": "csf3r",
      "kind": "target",
      "name": "G-CSF receptor",
      "url": "https://onco.cc/targets/csf3r/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1111/os.70429#onco-edge-paper",
   "url": "https://doi.org/10.1111/os.70429",
   "title": "Artificial Intelligence-Driven Precision Bisphosphonate Therapy in Osteoporosis: Mechanisms, Clinical Applications, Risks, and Future Directions.",
   "content_text": "Published in Orthop Surg on 17 September 2026; matched the OnCo record for Zoledronic acid.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Orthop Surg",
    "doi": "10.1111/os.70429",
    "records": [
     {
      "id": "zoledronic-acid",
      "kind": "drug",
      "name": "Zoledronic acid",
      "url": "https://onco.cc/drugs/zoledronic-acid/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/07853890.2026.2731716#onco-edge-paper",
   "url": "https://doi.org/10.1080/07853890.2026.2731716",
   "title": "Association of body mass index with postoperative pulmonary complications and potential explanatory pathways in paediatric scoliosis correction surgery: a multicentre cohort study.",
   "content_text": "Published in Ann Med on 17 September 2026; matched the OnCo record for Neuroblastoma.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Ann Med",
    "doi": "10.1080/07853890.2026.2731716",
    "records": [
     {
      "id": "neuroblastoma",
      "kind": "cancer",
      "name": "Neuroblastoma",
      "url": "https://onco.cc/cancers/neuroblastoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/07853890.2026.2718576#onco-edge-paper",
   "url": "https://doi.org/10.1080/07853890.2026.2718576",
   "title": "Biochemical characteristics associated with spironolactone use in hospitalized patients with hypotonic hyponatraemia.",
   "content_text": "Published in Ann Med on 17 September 2026; matched the OnCo record for EGFR.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Ann Med",
    "doi": "10.1080/07853890.2026.2718576",
    "records": [
     {
      "id": "egfr",
      "kind": "target",
      "name": "EGFR",
      "url": "https://onco.cc/targets/egfr/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.lungcan.2026.109626#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.lungcan.2026.109626",
   "title": "Change in the incidence of medication-related osteonecrosis of the jaw in lung cancer patients receiving bone modifying agents with immune checkpoint inhibitors.",
   "content_text": "Published in Lung Cancer on 17 September 2026; matched the OnCo record for Bone-modifying agents.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Lung Cancer",
    "doi": "10.1016/j.lungcan.2026.109626",
    "records": [
     {
      "id": "bone-modifying-agents",
      "kind": "technology",
      "name": "Bone-modifying agents",
      "url": "https://onco.cc/technologies/bone-modifying-agents/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00280-026-04955-0#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00280-026-04955-0",
   "title": "Characterization of DPYD pharmacogenetic variation in Mexican patients with gastrointestinal malignancies.",
   "content_text": "Published in Cancer Chemother Pharmacol on 17 September 2026; matched the OnCo record for Thymidylate synthase.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Cancer Chemother Pharmacol",
    "doi": "10.1007/s00280-026-04955-0",
    "records": [
     {
      "id": "tyms",
      "kind": "target",
      "name": "Thymidylate synthase",
      "url": "https://onco.cc/targets/tyms/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s10147-026-03196-8#onco-edge-paper",
   "url": "https://doi.org/10.1007/s10147-026-03196-8",
   "title": "Clinical activity of platinum rechallenge with nedaplatin plus irinotecan in recurrent cervical cancer following prior platinum-based systemic chemotherapy: a single-center retrospective study.",
   "content_text": "Published in Int J Clin Oncol on 17 September 2026; matched the OnCo record for Nedaplatin.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Int J Clin Oncol",
    "doi": "10.1007/s10147-026-03196-8",
    "records": [
     {
      "id": "nedaplatin",
      "kind": "drug",
      "name": "Nedaplatin",
      "url": "https://onco.cc/drugs/nedaplatin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.coi.2026.102842#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.coi.2026.102842",
   "title": "Clinical relevance of antiphosphatidylserine/prothrombin antibodies in antiphospholipid syndrome.",
   "content_text": "Published in Curr Opin Immunol on 17 September 2026; matched the OnCo record for Acute promyelocytic leukaemia.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Curr Opin Immunol",
    "doi": "10.1016/j.coi.2026.102842",
    "records": [
     {
      "id": "apl",
      "kind": "cancer",
      "name": "Acute promyelocytic leukaemia",
      "url": "https://onco.cc/cancers/apl/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.modpat.2026.101087#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.modpat.2026.101087",
   "title": "Clinicopathological and Molecular Insights into ERBB2-altered S100/SOX10-positive Uterine Sarcoma: A Report of 6 Cases.",
   "content_text": "Published in Mod Pathol on 17 September 2026; matched the OnCo record for HER3.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Mod Pathol",
    "doi": "10.1016/j.modpat.2026.101087",
    "records": [
     {
      "id": "her3",
      "kind": "target",
      "name": "HER3",
      "url": "https://onco.cc/targets/her3/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00280-026-04950-5#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00280-026-04950-5",
   "title": "CNS distribution and preclinical activity of the PI3K/AKT inhibitors inavolisib and ipatasertib in pediatric-type diffuse high-grade gliomas.",
   "content_text": "Published in Cancer Chemother Pharmacol on 17 September 2026; matched the OnCo record for Inavolisib.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Cancer Chemother Pharmacol",
    "doi": "10.1007/s00280-026-04950-5",
    "records": [
     {
      "id": "inavolisib",
      "kind": "drug",
      "name": "Inavolisib",
      "url": "https://onco.cc/drugs/inavolisib/"
     },
     {
      "id": "ipatasertib",
      "kind": "drug",
      "name": "Ipatasertib",
      "url": "https://onco.cc/drugs/ipatasertib/"
     },
     {
      "id": "paediatric-high-grade-glioma",
      "kind": "cancer",
      "name": "Paediatric high-grade glioma",
      "url": "https://onco.cc/cancers/paediatric-high-grade-glioma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s10072-026-09395-5#onco-edge-paper",
   "url": "https://doi.org/10.1007/s10072-026-09395-5",
   "title": "Do not stop at the variant: a reversible cause of small-fiber neuropathy symptoms in an ATTRv carrier.",
   "content_text": "Published in Neurol Sci on 17 September 2026; matched the OnCo record for TSH receptor.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Neurol Sci",
    "doi": "10.1007/s10072-026-09395-5",
    "records": [
     {
      "id": "tshr",
      "kind": "target",
      "name": "TSH receptor",
      "url": "https://onco.cc/targets/tshr/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jos.2026.08.014#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jos.2026.08.014",
   "title": "Efficacy of prophylactic pegfilgrastim compared with therapeutic filgrastim for preventing febrile neutropenia during chemotherapy for musculoskeletal tumors: A single-center retrospective study.",
   "content_text": "Published in J Orthop Sci on 17 September 2026; matched the OnCo record for Pegfilgrastim.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "J Orthop Sci",
    "doi": "10.1016/j.jos.2026.08.014",
    "records": [
     {
      "id": "pegfilgrastim",
      "kind": "drug",
      "name": "Pegfilgrastim",
      "url": "https://onco.cc/drugs/pegfilgrastim/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1158/1078-0432.ccr-26-0604#onco-edge-paper",
   "url": "https://doi.org/10.1158/1078-0432.ccr-26-0604",
   "title": "Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study.",
   "content_text": "Published in Clin Cancer Res on 17 September 2026; matched the OnCo record for EGFR-mutated non-small-cell lung cancer.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Clin Cancer Res",
    "doi": "10.1158/1078-0432.ccr-26-0604",
    "records": [
     {
      "id": "egfr-mutant-nsclc",
      "kind": "cancer",
      "name": "EGFR-mutated non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/egfr-mutant-nsclc/"
     },
     {
      "id": "savolitinib",
      "kind": "drug",
      "name": "Savolitinib",
      "url": "https://onco.cc/drugs/savolitinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1093/oncolo/oyag368#onco-edge-paper",
   "url": "https://doi.org/10.1093/oncolo/oyag368",
   "title": "Genomic and Transcriptomic Correlates of Deep PSA Response in Patients with Metastatic Androgen Pathway Modulation-Sensitive Prostate Cancer.",
   "content_text": "Published in Oncologist on 17 September 2026; matched the OnCo record for STEAP1.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Oncologist",
    "doi": "10.1093/oncolo/oyag368",
    "records": [
     {
      "id": "steap1",
      "kind": "target",
      "name": "STEAP1",
      "url": "https://onco.cc/targets/steap1/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/pas.0000000000002619#onco-edge-paper",
   "url": "https://doi.org/10.1097/pas.0000000000002619",
   "title": "Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.",
   "content_text": "Published in Am J Surg Pathol on 17 September 2026; matched the OnCo record for FRK kinase.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Am J Surg Pathol",
    "doi": "10.1097/pas.0000000000002619",
    "records": [
     {
      "id": "frk",
      "kind": "target",
      "name": "FRK kinase",
      "url": "https://onco.cc/targets/frk/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s13730-026-01179-2#onco-edge-paper",
   "url": "https://doi.org/10.1007/s13730-026-01179-2",
   "title": "Highly viscous ascites prompting reconsideration of cardiorenal syndrome in a patient with advanced CKD after TAVI.",
   "content_text": "Published in CEN Case Rep on 17 September 2026; matched the OnCo record for Low-grade appendiceal mucinous neoplasm and pseudomyxoma peritonei.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "CEN Case Rep",
    "doi": "10.1007/s13730-026-01179-2",
    "records": [
     {
      "id": "low-grade-appendiceal-mucinous-neoplasm",
      "kind": "cancer",
      "name": "Low-grade appendiceal mucinous neoplasm and pseudomyxoma peritonei",
      "url": "https://onco.cc/cancers/low-grade-appendiceal-mucinous-neoplasm/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s40259-026-00807-8#onco-edge-paper",
   "url": "https://doi.org/10.1007/s40259-026-00807-8",
   "title": "HLX11: A Pertuzumab Biosimilar.",
   "content_text": "Published in BioDrugs on 17 September 2026; matched the OnCo record for HLX11.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "BioDrugs",
    "doi": "10.1007/s40259-026-00807-8",
    "records": [
     {
      "id": "hlx11",
      "kind": "drug",
      "name": "HLX11",
      "url": "https://onco.cc/drugs/hlx11/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1093/stmcls/sxag037#onco-edge-paper",
   "url": "https://doi.org/10.1093/stmcls/sxag037",
   "title": "Human Umbilical Cord Mesenchymal Stem Cells Enhance Folliculogenesis and Fertility in Premature Ovarian Failure Mice via Regulating Steroid synthesis.",
   "content_text": "Published in Stem Cells on 17 September 2026; matched the OnCo record for CYP11A1.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Stem Cells",
    "doi": "10.1093/stmcls/sxag037",
    "records": [
     {
      "id": "cyp11a1",
      "kind": "target",
      "name": "CYP11A1",
      "url": "https://onco.cc/targets/cyp11a1/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/2162402x.2026.2717853#onco-edge-paper",
   "url": "https://doi.org/10.1080/2162402x.2026.2717853",
   "title": "Immune checkpoint knockout screen reveals TIGIT-CD155 interaction as a significant modulator of adapter CAR-T cell function in acute myeloid leukemia.",
   "content_text": "Published in Oncoimmunology on 17 September 2026; matched the OnCo record for CAR-T cell therapy.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Oncoimmunology",
    "doi": "10.1080/2162402x.2026.2717853",
    "records": [
     {
      "id": "car-t",
      "kind": "technology",
      "name": "CAR-T cell therapy",
      "url": "https://onco.cc/technologies/car-t/"
     },
     {
      "id": "checkpoint-inhibitor",
      "kind": "technology",
      "name": "Immune checkpoint inhibitors",
      "url": "https://onco.cc/technologies/checkpoint-inhibitor/"
     },
     {
      "id": "lag3",
      "kind": "target",
      "name": "LAG-3",
      "url": "https://onco.cc/targets/lag3/"
     },
     {
      "id": "tigit-blockade",
      "kind": "technology",
      "name": "TIGIT blockade",
      "url": "https://onco.cc/technologies/tigit-blockade/"
     },
     {
      "id": "tigit",
      "kind": "target",
      "name": "TIGIT",
      "url": "https://onco.cc/targets/tigit/"
     },
     {
      "id": "tim3",
      "kind": "target",
      "name": "TIM-3",
      "url": "https://onco.cc/targets/tim3/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/02656736.2026.2719928#onco-edge-paper",
   "url": "https://doi.org/10.1080/02656736.2026.2719928",
   "title": "Impact of early postoperative human chorionic gonadotropin change direction after high-intensity focused ultrasound on ultrasound-guided dilation and curettage outcomes in cesarean scar pregnancy: a retrospective study.",
   "content_text": "Published in Int J Hyperthermia on 17 September 2026; matched the OnCo record for Focused ultrasound & histotripsy.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Int J Hyperthermia",
    "doi": "10.1080/02656736.2026.2719928",
    "records": [
     {
      "id": "hifu-histotripsy",
      "kind": "technology",
      "name": "Focused ultrasound & histotripsy",
      "url": "https://onco.cc/technologies/hifu-histotripsy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3324/haematol.2026.301244#onco-edge-paper",
   "url": "https://doi.org/10.3324/haematol.2026.301244",
   "title": "Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis.",
   "content_text": "Published in Haematologica on 17 September 2026; matched the OnCo record for Autologous stem cell transplant.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Haematologica",
    "doi": "10.3324/haematol.2026.301244",
    "records": [
     {
      "id": "autologous-stem-cell-transplant",
      "kind": "technology",
      "name": "Autologous stem cell transplant",
      "url": "https://onco.cc/technologies/autologous-stem-cell-transplant/"
     },
     {
      "id": "thalidomide",
      "kind": "drug",
      "name": "Thalidomide",
      "url": "https://onco.cc/drugs/thalidomide/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00066-026-02592-3#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00066-026-02592-3",
   "title": "Intraoperative or postoperative radiotherapy boost in high-risk breast cancer: a matched-pair analysis.",
   "content_text": "Published in Strahlenther Onkol on 17 September 2026; matched the OnCo record for Intraoperative radiotherapy.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Strahlenther Onkol",
    "doi": "10.1007/s00066-026-02592-3",
    "records": [
     {
      "id": "intraoperative-radiotherapy",
      "kind": "technology",
      "name": "Intraoperative radiotherapy",
      "url": "https://onco.cc/technologies/intraoperative-radiotherapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41594-026-01887-4#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41594-026-01887-4",
   "title": "Mechanistic insights into phosphorylation-driven activation and therapeutic inhibition of human ATR-ATRIP.",
   "content_text": "Published in Nat Struct Mol Biol on 17 September 2026; matched the OnCo record for Ceralasertib.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Nat Struct Mol Biol",
    "doi": "10.1038/s41594-026-01887-4",
    "records": [
     {
      "id": "ceralasertib",
      "kind": "drug",
      "name": "Ceralasertib",
      "url": "https://onco.cc/drugs/ceralasertib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/deo2.70433#onco-edge-paper",
   "url": "https://doi.org/10.1002/deo2.70433",
   "title": "Metabolic Improvement and Weight Reduction After Large Endoscopic Submucosal Dissection Including the Papilla for Duodenal Adenoma: A Case Report.",
   "content_text": "Published in DEN Open on 17 September 2026; matched the OnCo record for Iobenguane I-131.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "DEN Open",
    "doi": "10.1002/deo2.70433",
    "records": [
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://onco.cc/newsletter/2026-09-17/#onco-edge-issue",
   "url": "https://onco.cc/newsletter/2026-09-17/",
   "title": "OnCo weekly, 2026-09-17",
   "content_text": "147 changelog entries, 1 upcoming date, 14 publications, 91 corrections.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "issue"
   ],
   "_onco": {
    "kind": "issue",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "OnCo weekly issue",
    "records": []
   }
  },
  {
   "id": "https://doi.org/10.1200/po-26-00661#onco-edge-paper",
   "url": "https://doi.org/10.1200/po-26-00661",
   "title": "Organoids Serve as Viable In Vitro Model for Functional Precision Medicine for Mesonephric-Like Adenocarcinoma of the Ovary.",
   "content_text": "Published in JCO Precis Oncol on 17 September 2026; matched the OnCo record for Functional (ex vivo) drug testing.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "JCO Precis Oncol",
    "doi": "10.1200/po-26-00661",
    "records": [
     {
      "id": "functional-drug-testing",
      "kind": "technology",
      "name": "Functional (ex vivo) drug testing",
      "url": "https://onco.cc/technologies/functional-drug-testing/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1111/ejh.70322#onco-edge-paper",
   "url": "https://doi.org/10.1111/ejh.70322",
   "title": "Post-Hoc Long-Read Sequencing Links Leukemic Mutation Status to Single-Cell Transcriptomes.",
   "content_text": "Published in Eur J Haematol on 17 September 2026; matched the OnCo record for Long-read sequencing.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Eur J Haematol",
    "doi": "10.1111/ejh.70322",
    "records": [
     {
      "id": "long-read-sequencing",
      "kind": "technology",
      "name": "Long-read sequencing",
      "url": "https://onco.cc/technologies/long-read-sequencing/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1093/bjd/ljag409#onco-edge-paper",
   "url": "https://doi.org/10.1093/bjd/ljag409",
   "title": "Precision Medicine for Somatic Mutation-Driven Vascular Anomalies.",
   "content_text": "Published in Br J Dermatol on 17 September 2026; matched the OnCo record for MEK1/2.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Br J Dermatol",
    "doi": "10.1093/bjd/ljag409",
    "records": [
     {
      "id": "mek",
      "kind": "target",
      "name": "MEK1/2",
      "url": "https://onco.cc/targets/mek/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.modpat.2026.101084#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.modpat.2026.101084",
   "title": "Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization.",
   "content_text": "Published in Mod Pathol on 17 September 2026; matched the OnCo record for CD79b.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Mod Pathol",
    "doi": "10.1016/j.modpat.2026.101084",
    "records": [
     {
      "id": "cd79b",
      "kind": "target",
      "name": "CD79b",
      "url": "https://onco.cc/targets/cd79b/"
     }
    ]
   }
  },
  {
   "id": "https://open.fda.gov/apis/drug/label/#onco-edge-proposal",
   "url": "https://open.fda.gov/apis/drug/label/",
   "title": "Proposed approval: Givinostat",
   "content_text": "openFDA has a label for \"Givinostat\".",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "givinostat",
      "kind": "drug",
      "name": "Givinostat",
      "url": "https://onco.cc/drugs/givinostat/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/mabcampath#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/mabcampath",
   "title": "Proposed regional approval row: Alemtuzumab",
   "content_text": "EMA register: MabCampath (alemtuzumab) Withdrawn, 2001-07-06.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "alemtuzumab",
      "kind": "drug",
      "name": "Alemtuzumab",
      "url": "https://onco.cc/drugs/alemtuzumab/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/xagrid#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/xagrid",
   "title": "Proposed regional approval row: Anagrelide",
   "content_text": "EMA register: Xagrid (anagrelide) Authorised, 2004-11-15.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "anagrelide",
      "kind": "drug",
      "name": "Anagrelide",
      "url": "https://onco.cc/drugs/anagrelide/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/emend#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/emend",
   "title": "Proposed regional approval row: Aprepitant",
   "content_text": "EMA register: Emend (aprepitant) Authorised, 2003-11-11.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "aprepitant",
      "kind": "drug",
      "name": "Aprepitant",
      "url": "https://onco.cc/drugs/aprepitant/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/targretin#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/targretin",
   "title": "Proposed regional approval row: Bexarotene",
   "content_text": "EMA register: Targretin (bexarotene) Authorised, 2001-03-29.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "bexarotene",
      "kind": "drug",
      "name": "Bexarotene",
      "url": "https://onco.cc/drugs/bexarotene/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/busilvex#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/busilvex",
   "title": "Proposed regional approval row: Busulfan",
   "content_text": "EMA register: Busilvex (busulfan) Withdrawn, 2003-07-09.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "busulfan",
      "kind": "drug",
      "name": "Busulfan",
      "url": "https://onco.cc/drugs/busulfan/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/xeloda#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/xeloda",
   "title": "Proposed regional approval row: Capecitabine",
   "content_text": "EMA register: Xeloda (capecitabine) Authorised, 2001-02-02.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "capecitabine",
      "kind": "drug",
      "name": "Capecitabine",
      "url": "https://onco.cc/drugs/capecitabine/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/tabrecta#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/tabrecta",
   "title": "Proposed regional approval row: Capmatinib",
   "content_text": "EMA register: Tabrecta (capmatinib) Authorised, 2022-06-20.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "capmatinib",
      "kind": "drug",
      "name": "Capmatinib",
      "url": "https://onco.cc/drugs/capmatinib/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/carmustine-medac#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/carmustine-medac",
   "title": "Proposed regional approval row: Carmustine",
   "content_text": "EMA register: Carmustine medac (previously Carmustine Obvius) (carmustine) Authorised, 2018-07-18.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "carmustine",
      "kind": "drug",
      "name": "Carmustine",
      "url": "https://onco.cc/drugs/carmustine/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/korjuny#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/korjuny",
   "title": "Proposed regional approval row: Catumaxomab",
   "content_text": "EMA register: Korjuny (catumaxomab) Authorised, 2025-02-10.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "catumaxomab",
      "kind": "drug",
      "name": "Catumaxomab",
      "url": "https://onco.cc/drugs/catumaxomab/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/evoltra#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/evoltra",
   "title": "Proposed regional approval row: Clofarabine",
   "content_text": "EMA register: Evoltra (clofarabine) Authorised, 2006-05-29.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "clofarabine",
      "kind": "drug",
      "name": "Clofarabine",
      "url": "https://onco.cc/drugs/clofarabine/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/depocyte#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/depocyte",
   "title": "Proposed regional approval row: Cytarabine",
   "content_text": "EMA register: DepoCyte (cytarabine) Withdrawn, 2001-07-11.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "cytarabine",
      "kind": "drug",
      "name": "Cytarabine",
      "url": "https://onco.cc/drugs/cytarabine/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/tafinlar#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/tafinlar",
   "title": "Proposed regional approval row: Dabrafenib",
   "content_text": "EMA register: Tafinlar (dabrafenib) Authorised, 2013-08-26.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "dabrafenib",
      "kind": "drug",
      "name": "Dabrafenib",
      "url": "https://onco.cc/drugs/dabrafenib/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/aranesp#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/aranesp",
   "title": "Proposed regional approval row: Darbepoetin alfa",
   "content_text": "EMA register: Aranesp (darbepoetin alfa) Authorised, 2001-06-08.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "darbepoetin-alfa",
      "kind": "drug",
      "name": "Darbepoetin alfa",
      "url": "https://onco.cc/drugs/darbepoetin-alfa/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/vyxeos-liposomal#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/vyxeos-liposomal",
   "title": "Proposed regional approval row: Daunorubicin",
   "content_text": "EMA register: Vyxeos liposomal (previously Vyxeos) (daunorubicin;cytarabine) Authorised, 2018-08-23.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "daunorubicin",
      "kind": "drug",
      "name": "Daunorubicin",
      "url": "https://onco.cc/drugs/daunorubicin/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/dacogen#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/dacogen",
   "title": "Proposed regional approval row: Decitabine",
   "content_text": "EMA register: Dacogen (decitabine) Authorised, 2012-09-20.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "decitabine",
      "kind": "drug",
      "name": "Decitabine",
      "url": "https://onco.cc/drugs/decitabine/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/prolia#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/prolia",
   "title": "Proposed regional approval row: Denosumab",
   "content_text": "EMA register: Prolia (denosumab) Authorised, 2010-05-26.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "denosumab",
      "kind": "drug",
      "name": "Denosumab",
      "url": "https://onco.cc/drugs/denosumab/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/neofordex#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/neofordex",
   "title": "Proposed regional approval row: Dexamethasone",
   "content_text": "EMA register: Neofordex (dexamethasone) Authorised, 2016-03-16.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "dexamethasone",
      "kind": "drug",
      "name": "Dexamethasone",
      "url": "https://onco.cc/drugs/dexamethasone/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/zemcelpro#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/zemcelpro",
   "title": "Proposed regional approval row: Dorocubicel",
   "content_text": "EMA register: Zemcelpro (allogeneic umbilical cord-derived CD34- cells, non-expanded;dorocubicel) Authorised (conditional), 2025-08-25.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "dorocubicel",
      "kind": "drug",
      "name": "Dorocubicel",
      "url": "https://onco.cc/drugs/dorocubicel/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/ryzneuta#onco-edge-proposal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/ryzneuta",
   "title": "Proposed regional approval row: Efbemalenograstim alfa",
   "content_text": "EMA register: Ryzneuta (efbemalenograstim alfa) Authorised, 2024-03-21.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "proposal"
   ],
   "_onco": {
    "kind": "proposal",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "EMA",
    "records": [
     {
      "id": "efbemalenograstim-alfa",
      "kind": "drug",
      "name": "Efbemalenograstim alfa",
      "url": "https://onco.cc/drugs/efbemalenograstim-alfa/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.clinme.2026.100644#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.clinme.2026.100644",
   "title": "Redefining Care for IDH-Mutant Low-Grade Gliomas: Clinical Implications of the INDIGO Trial and Updated Guidelines.",
   "content_text": "Published in Clin Med (Lond) on 17 September 2026; matched the OnCo record for Vorasidenib.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Clin Med (Lond)",
    "doi": "10.1016/j.clinme.2026.100644",
    "records": [
     {
      "id": "vorasidenib",
      "kind": "drug",
      "name": "Vorasidenib",
      "url": "https://onco.cc/drugs/vorasidenib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.57264/cer-2026-0141#onco-edge-paper",
   "url": "https://doi.org/10.57264/cer-2026-0141",
   "title": "Rigorous, transparent and inconclusive: what Europe's first joint clinical assessment reveals about a framework trying to serve everyone.",
   "content_text": "Published in J Comp Eff Res on 17 September 2026; matched the OnCo record for Tovorafenib.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "J Comp Eff Res",
    "doi": "10.57264/cer-2026-0141",
    "records": [
     {
      "id": "tovorafenib",
      "kind": "drug",
      "name": "Tovorafenib",
      "url": "https://onco.cc/drugs/tovorafenib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1210/jcemcr/luag287#onco-edge-paper",
   "url": "https://doi.org/10.1210/jcemcr/luag287",
   "title": "Silent pheochromocytoma presenting as refractory hyperglycemia without classic adrenergic symptoms.",
   "content_text": "Published in JCEM Case Rep on 17 September 2026; matched the OnCo record for Pheochromocytoma and paraganglioma.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "JCEM Case Rep",
    "doi": "10.1210/jcemcr/luag287",
    "records": [
     {
      "id": "pheochromocytoma-paraganglioma",
      "kind": "cancer",
      "name": "Pheochromocytoma and paraganglioma",
      "url": "https://onco.cc/cancers/pheochromocytoma-paraganglioma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.celrep.2026.118018#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.celrep.2026.118018",
   "title": "Spontaneous lytic reactivation drives a persistent B cell-vector pathway for epithelial dissemination of the Epstein-Barr virus.",
   "content_text": "Published in Cell Rep on 17 September 2026; matched the OnCo record for EphA2 receptor.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Cell Rep",
    "doi": "10.1016/j.celrep.2026.118018",
    "records": [
     {
      "id": "epha2",
      "kind": "target",
      "name": "EphA2 receptor",
      "url": "https://onco.cc/targets/epha2/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.2460/javma.26.05.0387#onco-edge-paper",
   "url": "https://doi.org/10.2460/javma.26.05.0387",
   "title": "Surgical debulking and electrochemotherapy, including a tetrapolar single-needle electrode, are associated with clinical benefit in dogs with intranasal tumors.",
   "content_text": "Published in J Am Vet Med Assoc on 17 September 2026; matched the OnCo record for Electrochemotherapy.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "J Am Vet Med Assoc",
    "doi": "10.2460/javma.26.05.0387",
    "records": [
     {
      "id": "electrochemotherapy",
      "kind": "technology",
      "name": "Electrochemotherapy",
      "url": "https://onco.cc/technologies/electrochemotherapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12328-026-02451-9#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12328-026-02451-9",
   "title": "Surgical resection of a liver metastasis from an ovarian granulosa cell tumor mimicking a simple hepatic cyst.",
   "content_text": "Published in Clin J Gastroenterol on 17 September 2026; matched the OnCo record for Adult granulosa cell tumour of the ovary.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Clin J Gastroenterol",
    "doi": "10.1007/s12328-026-02451-9",
    "records": [
     {
      "id": "granulosa-cell-tumour",
      "kind": "cancer",
      "name": "Adult granulosa cell tumour of the ovary",
      "url": "https://onco.cc/cancers/granulosa-cell-tumour/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1172/jci200391#onco-edge-paper",
   "url": "https://doi.org/10.1172/jci200391",
   "title": "Targeting tryptophan hydroxylase 1 restricts growth and suppresses plasticity in neuroendocrine prostate cancer.",
   "content_text": "Published in J Clin Invest on 17 September 2026; matched the OnCo record for Neuroendocrine and small-cell prostate cancer.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "J Clin Invest",
    "doi": "10.1172/jci200391",
    "records": [
     {
      "id": "prostate-nepc",
      "kind": "cancer",
      "name": "Neuroendocrine and small-cell prostate cancer",
      "url": "https://onco.cc/cancers/prostate-nepc/"
     },
     {
      "id": "tph1",
      "kind": "target",
      "name": "Tryptophan hydroxylase 1",
      "url": "https://onco.cc/targets/tph1/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1515/jbcpp-2026-0193#onco-edge-paper",
   "url": "https://doi.org/10.1515/jbcpp-2026-0193",
   "title": "To eat, or not to eat… dietary patterns and the clinical recognition of insulinoma: a case report.",
   "content_text": "Published in J Basic Clin Physiol Pharmacol on 17 September 2026; matched the OnCo record for Diazoxide.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "J Basic Clin Physiol Pharmacol",
    "doi": "10.1515/jbcpp-2026-0193",
    "records": [
     {
      "id": "diazoxide",
      "kind": "drug",
      "name": "Diazoxide",
      "url": "https://onco.cc/drugs/diazoxide/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.matbio.2026.102053#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.matbio.2026.102053",
   "title": "Tumor FAK supports fibrillar collagen expression in ovarian cancer ascites.",
   "content_text": "Published in Matrix Biol on 17 September 2026; matched the OnCo record for IN10018.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Matrix Biol",
    "doi": "10.1016/j.matbio.2026.102053",
    "records": [
     {
      "id": "in10018",
      "kind": "drug",
      "name": "IN10018",
      "url": "https://onco.cc/drugs/in10018/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1177/03000605261466854#onco-edge-paper",
   "url": "https://doi.org/10.1177/03000605261466854",
   "title": "Wilms tumor with rare spinal metastasis treated with surgery and chemotherapy: A case report.",
   "content_text": "Published in J Int Med Res on 17 September 2026; matched the OnCo record for Wilms tumour.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "J Int Med Res",
    "doi": "10.1177/03000605261466854",
    "records": [
     {
      "id": "wilms-tumor",
      "kind": "cancer",
      "name": "Wilms tumour",
      "url": "https://onco.cc/cancers/wilms-tumor/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/2162402x.2026.2706271#onco-edge-paper",
   "url": "https://doi.org/10.1080/2162402x.2026.2706271",
   "title": "X‑ray FLASH RT inhibits lung cancer bone metastasis via activating CD4⁺ T-cell‑mediated antitumor immunity with modulation of Th17 cell response.",
   "content_text": "Published in Oncoimmunology on 17 September 2026; matched the OnCo record for FLASH radiotherapy.",
   "date_published": "2026-09-17T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-17",
    "precision": "day",
    "venue": "Oncoimmunology",
    "doi": "10.1080/2162402x.2026.2706271",
    "records": [
     {
      "id": "flash-rt",
      "kind": "technology",
      "name": "FLASH radiotherapy",
      "url": "https://onco.cc/technologies/flash-rt/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41591-026-04703-0#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41591-026-04703-0",
   "title": "A clinically-oriented foundation model for intraoperative pathology.",
   "content_text": "Published in Nat Med on 10 September 2026; matched the OnCo record for Pathology & radiology foundation models.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Nat Med",
    "doi": "10.1038/s41591-026-04703-0",
    "records": [
     {
      "id": "pathology-foundation-model",
      "kind": "technology",
      "name": "Pathology & radiology foundation models",
      "url": "https://onco.cc/technologies/pathology-foundation-model/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1200/jco-26-00545#onco-edge-paper",
   "url": "https://doi.org/10.1200/jco-26-00545",
   "title": "Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.",
   "content_text": "Published in J Clin Oncol on 10 September 2026; matched the OnCo record for Iberdomide.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "J Clin Oncol",
    "doi": "10.1200/jco-26-00545",
    "records": [
     {
      "id": "iberdomide",
      "kind": "drug",
      "name": "Iberdomide",
      "url": "https://onco.cc/drugs/iberdomide/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bulcan.2026.06.004#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bulcan.2026.06.004",
   "title": "[Management of venous thromboembolism in children with acute lymphoblastic leukemia: Recommendations from the harmonization workshops of the Leukemia Committee of the French Society for Childhood Cancer (SFCE)].",
   "content_text": "Published in Bull Cancer on 16 September 2026; matched the OnCo record for Asparaginase.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Bull Cancer",
    "doi": "10.1016/j.bulcan.2026.06.004",
    "records": [
     {
      "id": "asparaginase",
      "kind": "drug",
      "name": "Asparaginase",
      "url": "https://onco.cc/drugs/asparaginase/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1210/jcemcr/luag272#onco-edge-paper",
   "url": "https://doi.org/10.1210/jcemcr/luag272",
   "title": "<i>EML4::RET</i>, a novel transcript fusion in papillary thyroid cancer.",
   "content_text": "Published in JCEM Case Rep on 16 September 2026; matched the OnCo record for Comprehensive genomic profiling.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "JCEM Case Rep",
    "doi": "10.1210/jcemcr/luag272",
    "records": [
     {
      "id": "cgp",
      "kind": "technology",
      "name": "Comprehensive genomic profiling",
      "url": "https://onco.cc/technologies/cgp/"
     },
     {
      "id": "ntrk",
      "kind": "target",
      "name": "NTRK",
      "url": "https://onco.cc/targets/ntrk/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/smll.75785#onco-edge-paper",
   "url": "https://doi.org/10.1002/smll.75785",
   "title": "A Broad-Spectrum Tumor-Penetrating Peptide WKASC: Design, Screening, and Platform Development for Cancer Therapy.",
   "content_text": "Published in Small on 16 September 2026; matched the OnCo record for Methyl aminolevulinate.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Small",
    "doi": "10.1002/smll.75785",
    "records": [
     {
      "id": "methyl-aminolevulinate",
      "kind": "drug",
      "name": "Methyl aminolevulinate",
      "url": "https://onco.cc/drugs/methyl-aminolevulinate/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1210/jcemcr/luag254#onco-edge-paper",
   "url": "https://doi.org/10.1210/jcemcr/luag254",
   "title": "A decade of survival in recurrent nonfunctioning oncocytic adrenocortical carcinoma in a young Filipina.",
   "content_text": "Published in JCEM Case Rep on 16 September 2026; matched the OnCo record for Advanced and metastatic adrenocortical carcinoma.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "JCEM Case Rep",
    "doi": "10.1210/jcemcr/luag254",
    "records": [
     {
      "id": "advanced-adrenocortical-carcinoma",
      "kind": "cancer",
      "name": "Advanced and metastatic adrenocortical carcinoma",
      "url": "https://onco.cc/cancers/advanced-adrenocortical-carcinoma/"
     },
     {
      "id": "mitotane",
      "kind": "drug",
      "name": "Mitotane",
      "url": "https://onco.cc/drugs/mitotane/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s10120-026-01799-8#onco-edge-paper",
   "url": "https://doi.org/10.1007/s10120-026-01799-8",
   "title": "A multicenter phase II trial of ramucirumab plus irinotecan for early recurrence of gastric cancer during or after adjuvant chemotherapy with docetaxel plus S-1 therapy: the RAMIEL trial (OGSG1901).",
   "content_text": "Published in Gastric Cancer on 16 September 2026; matched the OnCo record for Ramucirumab.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Gastric Cancer",
    "doi": "10.1007/s10120-026-01799-8",
    "records": [
     {
      "id": "ramucirumab",
      "kind": "drug",
      "name": "Ramucirumab",
      "url": "https://onco.cc/drugs/ramucirumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1088/2057-1976/aea856#onco-edge-paper",
   "url": "https://doi.org/10.1088/2057-1976/aea856",
   "title": "A Systematic Pipeline for Evaluating Factors Affecting Radar-Based Microwave Breast Imaging Quality.",
   "content_text": "Published in Biomed Phys Eng Express on 16 September 2026; matched the OnCo record for RaDaR.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Biomed Phys Eng Express",
    "doi": "10.1088/2057-1976/aea856",
    "records": [
     {
      "id": "radar-mrd",
      "kind": "drug",
      "name": "RaDaR",
      "url": "https://onco.cc/drugs/radar-mrd/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/1545-5017.70697#onco-edge-paper",
   "url": "https://doi.org/10.1002/1545-5017.70697",
   "title": "Advances in the Targeted Therapy for PIK3CA-Related Overgrowth Spectrum (PROS): From Molecular Mechanisms to Clinical Translation.",
   "content_text": "Published in Pediatr Blood Cancer on 16 September 2026; matched the OnCo record for Alpelisib.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Pediatr Blood Cancer",
    "doi": "10.1002/1545-5017.70697",
    "records": [
     {
      "id": "alpelisib",
      "kind": "drug",
      "name": "Alpelisib",
      "url": "https://onco.cc/drugs/alpelisib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s40200-026-02066-4#onco-edge-paper",
   "url": "https://doi.org/10.1007/s40200-026-02066-4",
   "title": "Analysis of <i>MTHFR</i> C677T polymorphism in elderly Iranian women from Bushehr.",
   "content_text": "Published in J Diabetes Metab Disord on 16 September 2026; matched the OnCo record for DNA methylation profiling.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "J Diabetes Metab Disord",
    "doi": "10.1007/s40200-026-02066-4",
    "records": [
     {
      "id": "methylation-profiling",
      "kind": "technology",
      "name": "DNA methylation profiling",
      "url": "https://onco.cc/technologies/methylation-profiling/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/ags3.70281#onco-edge-paper",
   "url": "https://doi.org/10.1002/ags3.70281",
   "title": "Can Chemoradiotherapy Expand Immune Checkpoint Blockade Responsiveness in Mismatch Repair-Proficient Rectal Cancer?",
   "content_text": "Published in Ann Gastroenterol Surg on 16 September 2026; matched the OnCo record for Mismatch-repair deficient (MSI-high) colorectal cancer.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Ann Gastroenterol Surg",
    "doi": "10.1002/ags3.70281",
    "records": [
     {
      "id": "msi-high-colorectal",
      "kind": "cancer",
      "name": "Mismatch-repair deficient (MSI-high) colorectal cancer",
      "url": "https://onco.cc/cancers/msi-high-colorectal/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s43856-026-01885-z#onco-edge-paper",
   "url": "https://doi.org/10.1038/s43856-026-01885-z",
   "title": "Canakinumab or emavusertib for anemia in lower-risk MDS: results of the CANFIRE and LUCAS phase 2, open-label, multicenter trials.",
   "content_text": "Published in Commun Med (Lond) on 16 September 2026; matched the OnCo record for Emavusertib.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Commun Med (Lond)",
    "doi": "10.1038/s43856-026-01885-z",
    "records": [
     {
      "id": "emavusertib",
      "kind": "drug",
      "name": "Emavusertib",
      "url": "https://onco.cc/drugs/emavusertib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/advs.77691#onco-edge-paper",
   "url": "https://doi.org/10.1002/advs.77691",
   "title": "Collagen-Binding IL-15 Immunocytokine Armed Oncolytic Adenovirus Establishes a Self-Reinforcing Immunostimulatory Milieu to Potentiate Antitumor Immunity.",
   "content_text": "Published in Adv Sci (Weinh) on 16 September 2026; matched the OnCo record for Immunocytokines.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Adv Sci (Weinh)",
    "doi": "10.1002/advs.77691",
    "records": [
     {
      "id": "immunocytokines",
      "kind": "technology",
      "name": "Immunocytokines",
      "url": "https://onco.cc/technologies/immunocytokines/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1210/jcemcr/luag253#onco-edge-paper",
   "url": "https://doi.org/10.1210/jcemcr/luag253",
   "title": "Concomitant parathyroid hormone-secreting oncocytic adrenocortical carcinoma and parathyroid adenoma.",
   "content_text": "Published in JCEM Case Rep on 16 September 2026; matched the OnCo record for Mitotane.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "JCEM Case Rep",
    "doi": "10.1210/jcemcr/luag253",
    "records": [
     {
      "id": "mitotane",
      "kind": "drug",
      "name": "Mitotane",
      "url": "https://onco.cc/drugs/mitotane/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/hc9.0000000000000991#onco-edge-paper",
   "url": "https://doi.org/10.1097/hc9.0000000000000991",
   "title": "Conserved hepatic RNA signatures across multiple cohorts reveal novel mechanistic clues for advanced fibrosis in human MASLD.",
   "content_text": "Published in Hepatol Commun on 16 September 2026; matched the OnCo record for CDH6.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Hepatol Commun",
    "doi": "10.1097/hc9.0000000000000991",
    "records": [
     {
      "id": "cdh6",
      "kind": "target",
      "name": "CDH6",
      "url": "https://onco.cc/targets/cdh6/"
     },
     {
      "id": "pdgfra",
      "kind": "target",
      "name": "PDGFRA",
      "url": "https://onco.cc/targets/pdgfra/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jtct.2026.09.015#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jtct.2026.09.015",
   "title": "Conversion from calcineurin inhibitor to ruxolitinib as GVHD prophylaxis during patients with transplant-associated thrombotic microangiopathy.",
   "content_text": "Published in Transplant Cell Ther on 16 September 2026; matched the OnCo record for Indolent and smouldering systemic mastocytosis.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Transplant Cell Ther",
    "doi": "10.1016/j.jtct.2026.09.015",
    "records": [
     {
      "id": "indolent-systemic-mastocytosis",
      "kind": "cancer",
      "name": "Indolent and smouldering systemic mastocytosis",
      "url": "https://onco.cc/cancers/indolent-systemic-mastocytosis/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.clml.2026.08.006#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.clml.2026.08.006",
   "title": "Corrigendum to \"Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6\"[Clinical Lymphoma Myeloma and Leukemia 26 (2026) 317-327].",
   "content_text": "Published in Clin Lymphoma Myeloma Leuk on 16 September 2026; matched the OnCo record for Epcoritamab.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Clin Lymphoma Myeloma Leuk",
    "doi": "10.1016/j.clml.2026.08.006",
    "records": [
     {
      "id": "epcoritamab",
      "kind": "drug",
      "name": "Epcoritamab",
      "url": "https://onco.cc/drugs/epcoritamab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1177/24741264261486768#onco-edge-paper",
   "url": "https://doi.org/10.1177/24741264261486768",
   "title": "Culture-Proven <i>Haemophilus influenzae</i> Endophthalmitis After Intravitreal Topotecan for Retinoblastoma.",
   "content_text": "Published in J Vitreoretin Dis on 16 September 2026; matched the OnCo record for Melphalan.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "J Vitreoretin Dis",
    "doi": "10.1177/24741264261486768",
    "records": [
     {
      "id": "melphalan",
      "kind": "drug",
      "name": "Melphalan",
      "url": "https://onco.cc/drugs/melphalan/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1111/1346-8138.70497#onco-edge-paper",
   "url": "https://doi.org/10.1111/1346-8138.70497",
   "title": "Cutaneous Toxicities of Anti-GPRC5D Bispecific Antibodies for Multiple Myeloma: Retrospective Study.",
   "content_text": "Published in J Dermatol on 16 September 2026; matched the OnCo record for GPRC5D.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "J Dermatol",
    "doi": "10.1111/1346-8138.70497",
    "records": [
     {
      "id": "gprc5d",
      "kind": "target",
      "name": "GPRC5D",
      "url": "https://onco.cc/targets/gprc5d/"
     },
     {
      "id": "talquetamab",
      "kind": "drug",
      "name": "Talquetamab",
      "url": "https://onco.cc/drugs/talquetamab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/07853890.2026.2732555#onco-edge-paper",
   "url": "https://doi.org/10.1080/07853890.2026.2732555",
   "title": "Effect of phenylephrine versus ephedrine on the incidence of postoperative delirium in elderly patients undergoing non-cardiac and non-neurosurgical procedures: protocol for a multicentre, double-blind, randomized, controlled trial.",
   "content_text": "Published in Ann Med on 16 September 2026; matched the OnCo record for Stage III melanoma.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Ann Med",
    "doi": "10.1080/07853890.2026.2732555",
    "records": [
     {
      "id": "stage-iii-melanoma",
      "kind": "cancer",
      "name": "Stage III melanoma",
      "url": "https://onco.cc/cancers/stage-iii-melanoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s10549-026-08069-2#onco-edge-paper",
   "url": "https://doi.org/10.1007/s10549-026-08069-2",
   "title": "Efficacy, safety and circulating tumor cell dynamics in patients treated with Eribulin for HER2-negative advanced breast cancer - results from the phase II DETECT IVb trial.",
   "content_text": "Published in Breast Cancer Res Treat on 16 September 2026; matched the OnCo record for CellSearch circulating tumour cell count.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Breast Cancer Res Treat",
    "doi": "10.1007/s10549-026-08069-2",
    "records": [
     {
      "id": "cellsearch-ctc-count",
      "kind": "technology",
      "name": "CellSearch circulating tumour cell count",
      "url": "https://onco.cc/technologies/cellsearch-ctc-count/"
     },
     {
      "id": "eribulin",
      "kind": "drug",
      "name": "Eribulin",
      "url": "https://onco.cc/drugs/eribulin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1126/scitranslmed.ady2289#onco-edge-paper",
   "url": "https://doi.org/10.1126/scitranslmed.ady2289",
   "title": "Engineered probiotics for tumor-targeted combination chemoimmunotherapy.",
   "content_text": "Published in Sci Transl Med on 16 September 2026; matched the OnCo record for Cytokines & engineered cytokines.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Sci Transl Med",
    "doi": "10.1126/scitranslmed.ady2289",
    "records": [
     {
      "id": "cytokine-therapy",
      "kind": "technology",
      "name": "Cytokines & engineered cytokines",
      "url": "https://onco.cc/technologies/cytokine-therapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41388-026-03975-7#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41388-026-03975-7",
   "title": "Epithelial tumor suppressor deletion promotes neuroendocrine differentiation in bladder cancer and reveals homoharringtonine as a candidate vulnerability.",
   "content_text": "Published in Oncogene on 16 September 2026; matched the OnCo record for Genetically engineered mouse models.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Oncogene",
    "doi": "10.1038/s41388-026-03975-7",
    "records": [
     {
      "id": "genetically-engineered-mouse-models",
      "kind": "technology",
      "name": "Genetically engineered mouse models",
      "url": "https://onco.cc/technologies/genetically-engineered-mouse-models/"
     },
     {
      "id": "omacetaxine",
      "kind": "drug",
      "name": "Omacetaxine mepesuccinate",
      "url": "https://onco.cc/drugs/omacetaxine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.it.2026.08.014#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.it.2026.08.014",
   "title": "Erythropoietin impacts immune adaptation through myeloid-cell programming.",
   "content_text": "Published in Trends Immunol on 16 September 2026; matched the OnCo record for Erythropoietin receptor.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Trends Immunol",
    "doi": "10.1016/j.it.2026.08.014",
    "records": [
     {
      "id": "epor",
      "kind": "target",
      "name": "Erythropoietin receptor",
      "url": "https://onco.cc/targets/epor/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ijpharm.2026.127429#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ijpharm.2026.127429",
   "title": "Evaluation of a rapid-release mitomycin C-loaded porous microcapsule formulation (MitoCap) in a human urothelium-tumour model.",
   "content_text": "Published in Int J Pharm on 16 September 2026; matched the OnCo record for Mitomycin C.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Int J Pharm",
    "doi": "10.1016/j.ijpharm.2026.127429",
    "records": [
     {
      "id": "mitomycin",
      "kind": "drug",
      "name": "Mitomycin C",
      "url": "https://onco.cc/drugs/mitomycin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.meegid.2026.106019#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.meegid.2026.106019",
   "title": "Evolutionary genomics, tumor dynamics, and mathematical modeling of cancer progression: Implications for precision oncology.",
   "content_text": "Published in Infect Genet Evol on 16 September 2026; matched the OnCo record for Adaptive therapy.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Infect Genet Evol",
    "doi": "10.1016/j.meegid.2026.106019",
    "records": [
     {
      "id": "adaptive-therapy-dynamics",
      "kind": "technology",
      "name": "Adaptive therapy",
      "url": "https://onco.cc/technologies/adaptive-therapy-dynamics/"
     },
     {
      "id": "mathematical-oncology",
      "kind": "technology",
      "name": "Mathematical models of cancer",
      "url": "https://onco.cc/technologies/mathematical-oncology/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ygyno.2026.09.003#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ygyno.2026.09.003",
   "title": "Long-term efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201.",
   "content_text": "Published in Gynecol Oncol on 16 September 2026; matched the OnCo record for Avutometinib + defactinib.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Gynecol Oncol",
    "doi": "10.1016/j.ygyno.2026.09.003",
    "records": [
     {
      "id": "avutometinib-defactinib",
      "kind": "drug",
      "name": "Avutometinib + defactinib",
      "url": "https://onco.cc/drugs/avutometinib-defactinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1210/jcemcr/luag273#onco-edge-paper",
   "url": "https://doi.org/10.1210/jcemcr/luag273",
   "title": "Managing capivasertib-induced hyperglycemia: a report of 3 cases.",
   "content_text": "Published in JCEM Case Rep on 16 September 2026; matched the OnCo record for Alpelisib.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "JCEM Case Rep",
    "doi": "10.1210/jcemcr/luag273",
    "records": [
     {
      "id": "alpelisib",
      "kind": "drug",
      "name": "Alpelisib",
      "url": "https://onco.cc/drugs/alpelisib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1210/jcemcr/luag238#onco-edge-paper",
   "url": "https://doi.org/10.1210/jcemcr/luag238",
   "title": "Medication-related osteonecrosis of the external auditory canal and treatment with teriparatide.",
   "content_text": "Published in JCEM Case Rep on 16 September 2026; matched the OnCo record for Denosumab.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "JCEM Case Rep",
    "doi": "10.1210/jcemcr/luag238",
    "records": [
     {
      "id": "denosumab",
      "kind": "drug",
      "name": "Denosumab",
      "url": "https://onco.cc/drugs/denosumab/"
     }
    ]
   }
  },
  {
   "id": "https://onco.cc/newsletter/2026-09-16/#onco-edge-issue",
   "url": "https://onco.cc/newsletter/2026-09-16/",
   "title": "OnCo weekly, 2026-09-16",
   "content_text": "17 changelog entries, 1 upcoming date, 20 publications, 89 corrections.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "issue"
   ],
   "_onco": {
    "kind": "issue",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "OnCo weekly issue",
    "records": []
   }
  },
  {
   "id": "https://doi.org/10.1007/s11523-026-01253-w#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11523-026-01253-w",
   "title": "Outcomes by Body Mass Index in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin.",
   "content_text": "Published in Target Oncol on 16 September 2026; matched the OnCo record for Inotuzumab ozogamicin.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Target Oncol",
    "doi": "10.1007/s11523-026-01253-w",
    "records": [
     {
      "id": "inotuzumab-ozogamicin",
      "kind": "drug",
      "name": "Inotuzumab ozogamicin",
      "url": "https://onco.cc/drugs/inotuzumab-ozogamicin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/hed.70460#onco-edge-paper",
   "url": "https://doi.org/10.1002/hed.70460",
   "title": "Pattern of Failure in Nasopharyngeal Carcinoma After Radiotherapy in a Low-Incidence Population: A DAHANCA Study.",
   "content_text": "Published in Head Neck on 16 September 2026; matched the OnCo record for Early-stage classical Hodgkin lymphoma.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Head Neck",
    "doi": "10.1002/hed.70460",
    "records": [
     {
      "id": "early-stage-classical-hodgkin-lymphoma",
      "kind": "cancer",
      "name": "Early-stage classical Hodgkin lymphoma",
      "url": "https://onco.cc/cancers/early-stage-classical-hodgkin-lymphoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s10729-026-09754-w#onco-edge-paper",
   "url": "https://doi.org/10.1007/s10729-026-09754-w",
   "title": "Paving the way for more accessible cancer care in low-income countries with optimization.",
   "content_text": "Published in Health Care Manag Sci on 16 September 2026; matched the OnCo record for Mathematical models of cancer.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Health Care Manag Sci",
    "doi": "10.1007/s10729-026-09754-w",
    "records": [
     {
      "id": "mathematical-oncology",
      "kind": "technology",
      "name": "Mathematical models of cancer",
      "url": "https://onco.cc/technologies/mathematical-oncology/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.critrevonc.2026.105598#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.critrevonc.2026.105598",
   "title": "Penpulimab: A next-generation Fc-engineered PD-1 inhibitor in cancer immunotherapy.",
   "content_text": "Published in Crit Rev Oncol Hematol on 16 September 2026; matched the OnCo record for Penpulimab.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Crit Rev Oncol Hematol",
    "doi": "10.1016/j.critrevonc.2026.105598",
    "records": [
     {
      "id": "penpulimab",
      "kind": "drug",
      "name": "Penpulimab",
      "url": "https://onco.cc/drugs/penpulimab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1210/jcemcr/luag278#onco-edge-paper",
   "url": "https://doi.org/10.1210/jcemcr/luag278",
   "title": "Phenotype-driven cascade screening in a Syrian family with clinically consistent multiple endocrine neoplasia type 2A.",
   "content_text": "Published in JCEM Case Rep on 16 September 2026; matched the OnCo record for Medullary thyroid cancer.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "JCEM Case Rep",
    "doi": "10.1210/jcemcr/luag278",
    "records": [
     {
      "id": "medullary-thyroid-cancer",
      "kind": "cancer",
      "name": "Medullary thyroid cancer",
      "url": "https://onco.cc/cancers/medullary-thyroid-cancer/"
     },
     {
      "id": "pheochromocytoma-paraganglioma",
      "kind": "cancer",
      "name": "Pheochromocytoma and paraganglioma",
      "url": "https://onco.cc/cancers/pheochromocytoma-paraganglioma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/14796694.2026.2719409#onco-edge-paper",
   "url": "https://doi.org/10.1080/14796694.2026.2719409",
   "title": "Plain language summary of the KRYSTAL-12 study results: adagrasib for non-small cell lung cancer with KRAS<sup>G12C</sup> mutations.",
   "content_text": "Published in Future Oncol on 16 September 2026; matched the OnCo record for Adagrasib.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Future Oncol",
    "doi": "10.1080/14796694.2026.2719409",
    "records": [
     {
      "id": "adagrasib",
      "kind": "drug",
      "name": "Adagrasib",
      "url": "https://onco.cc/drugs/adagrasib/"
     },
     {
      "id": "krystal-12",
      "kind": "trial",
      "name": "KRYSTAL-12",
      "url": "https://onco.cc/trials/krystal-12/"
     },
     {
      "id": "targeted-therapy-roadmap",
      "kind": "roadmap",
      "name": "Targeted therapy roadmap: imatinib → designed for resistance → the undruggable drivers fall",
      "url": "https://onco.cc/roadmaps/targeted-therapy-roadmap/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/14796694.2026.2719395#onco-edge-paper",
   "url": "https://doi.org/10.1080/14796694.2026.2719395",
   "title": "Plain language summary of the ZUMA-5 study of axicabtagene ciloleucel for people with relapsed or refractory slow-growing non-Hodgkin lymphoma.",
   "content_text": "Published in Future Oncol on 16 September 2026; matched the OnCo record for Axicabtagene ciloleucel.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Future Oncol",
    "doi": "10.1080/14796694.2026.2719395",
    "records": [
     {
      "id": "axicabtagene-ciloleucel",
      "kind": "drug",
      "name": "Axicabtagene ciloleucel",
      "url": "https://onco.cc/drugs/axicabtagene-ciloleucel/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11102-026-01757-8#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11102-026-01757-8",
   "title": "Prolactinoma assessment and management: an international multidisciplinary cross-sectional survey of current practice.",
   "content_text": "Published in Pituitary on 16 September 2026; matched the OnCo record for Cabergoline.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Pituitary",
    "doi": "10.1007/s11102-026-01757-8",
    "records": [
     {
      "id": "cabergoline",
      "kind": "drug",
      "name": "Cabergoline",
      "url": "https://onco.cc/drugs/cabergoline/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.arbres.2026.08.014#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.arbres.2026.08.014",
   "title": "Radiotherapy in Thoracic NUT Carcinoma: A Pooled Analysis of Long-term Survivors and Clinical Outcome Heterogeneity.",
   "content_text": "Published in Arch Bronconeumol on 16 September 2026; matched the OnCo record for NUT carcinoma.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Arch Bronconeumol",
    "doi": "10.1016/j.arbres.2026.08.014",
    "records": [
     {
      "id": "nut-carcinoma",
      "kind": "cancer",
      "name": "NUT carcinoma",
      "url": "https://onco.cc/cancers/nut-carcinoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12035-026-06207-x#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12035-026-06207-x",
   "title": "Repurposing Anticancer Drugs in Parkinson's Treatment: Molecular Pathways Driving Neuroprotection and Therapeutic Advancement.",
   "content_text": "Published in Mol Neurobiol on 16 September 2026; matched the OnCo record for Ixazomib.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Mol Neurobiol",
    "doi": "10.1007/s12035-026-06207-x",
    "records": [
     {
      "id": "ixazomib",
      "kind": "drug",
      "name": "Ixazomib",
      "url": "https://onco.cc/drugs/ixazomib/"
     },
     {
      "id": "nilotinib",
      "kind": "drug",
      "name": "Nilotinib",
      "url": "https://onco.cc/drugs/nilotinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/mph.0000000000003280#onco-edge-paper",
   "url": "https://doi.org/10.1097/mph.0000000000003280",
   "title": "Sex Differences in Complications and Outcomes of Wilms Tumor: Is There a Role for Sex-based Approaches in Nephroblastoma Management?",
   "content_text": "Published in J Pediatr Hematol Oncol on 16 September 2026; matched the OnCo record for Wilms tumour.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "J Pediatr Hematol Oncol",
    "doi": "10.1097/mph.0000000000003280",
    "records": [
     {
      "id": "wilms-tumor",
      "kind": "cancer",
      "name": "Wilms tumour",
      "url": "https://onco.cc/cancers/wilms-tumor/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/1545-5017.70682#onco-edge-paper",
   "url": "https://doi.org/10.1002/1545-5017.70682",
   "title": "Sirolimus Dose Reduction After Belumosudil Initiation in Pediatric and Young Adult Patients With Chronic Graft-Versus-Host-Disease.",
   "content_text": "Published in Pediatr Blood Cancer on 16 September 2026; matched the OnCo record for Belumosudil.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Pediatr Blood Cancer",
    "doi": "10.1002/1545-5017.70682",
    "records": [
     {
      "id": "belumosudil",
      "kind": "drug",
      "name": "Belumosudil",
      "url": "https://onco.cc/drugs/belumosudil/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/advs.77817#onco-edge-paper",
   "url": "https://doi.org/10.1002/advs.77817",
   "title": "Sonogenetics Nanomedicine Activates the cGAS-STING Pathway for Immunotherapy of Triple-Negative Breast Cancer.",
   "content_text": "Published in Adv Sci (Weinh) on 16 September 2026; matched the OnCo record for HER3.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Adv Sci (Weinh)",
    "doi": "10.1002/advs.77817",
    "records": [
     {
      "id": "her3",
      "kind": "target",
      "name": "HER3",
      "url": "https://onco.cc/targets/her3/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/08998280.2026.2718726#onco-edge-paper",
   "url": "https://doi.org/10.1080/08998280.2026.2718726",
   "title": "Surgical considerations in post-programmed cell death-1 therapy for cutaneous squamous cell carcinoma.",
   "content_text": "Published in Proc (Bayl Univ Med Cent) on 16 September 2026; matched the OnCo record for Cemiplimab.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Proc (Bayl Univ Med Cent)",
    "doi": "10.1080/08998280.2026.2718726",
    "records": [
     {
      "id": "cemiplimab",
      "kind": "drug",
      "name": "Cemiplimab",
      "url": "https://onco.cc/drugs/cemiplimab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/resp.70315#onco-edge-paper",
   "url": "https://doi.org/10.1002/resp.70315",
   "title": "Targeting EGFR-Mutant Non-Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination Therapy With EGFR Inhibitors.",
   "content_text": "Published in Respirology on 16 September 2026; matched the OnCo record for EGFR-mutated non-small-cell lung cancer.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "Respirology",
    "doi": "10.1002/resp.70315",
    "records": [
     {
      "id": "egfr-mutant-nsclc",
      "kind": "cancer",
      "name": "EGFR-mutated non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/egfr-mutant-nsclc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jconrel.2026.115360#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jconrel.2026.115360",
   "title": "Tumor-homing peptides in precision oncology.",
   "content_text": "Published in J Control Release on 16 September 2026; matched the OnCo record for Melphalan flufenamide.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "J Control Release",
    "doi": "10.1016/j.jconrel.2026.115360",
    "records": [
     {
      "id": "melflufen",
      "kind": "drug",
      "name": "Melphalan flufenamide",
      "url": "https://onco.cc/drugs/melflufen/"
     },
     {
      "id": "melphalan",
      "kind": "drug",
      "name": "Melphalan",
      "url": "https://onco.cc/drugs/melphalan/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.esmoop.2026.108530#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.esmoop.2026.108530",
   "title": "Zolbetuximab plus chemotherapy versus immune checkpoint inhibitor regimens by programmed death-ligand 1 combined positive score in locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: a Bayesian network meta-analysis.",
   "content_text": "Published in ESMO Open on 16 September 2026; matched the OnCo record for Tislelizumab.",
   "date_published": "2026-09-16T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-16",
    "precision": "day",
    "venue": "ESMO Open",
    "doi": "10.1016/j.esmoop.2026.108530",
    "records": [
     {
      "id": "tislelizumab",
      "kind": "drug",
      "name": "Tislelizumab",
      "url": "https://onco.cc/drugs/tislelizumab/"
     },
     {
      "id": "zolbetuximab",
      "kind": "drug",
      "name": "Zolbetuximab",
      "url": "https://onco.cc/drugs/zolbetuximab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1200/jco-26-00451#onco-edge-paper",
   "url": "https://doi.org/10.1200/jco-26-00451",
   "title": "LymphGen-Sig: Integrating Genetic and Transcriptional States to Predict Therapeutic Response in Diffuse Large B-Cell Lymphoma.",
   "content_text": "Published in J Clin Oncol on 9 September 2026; matched the OnCo record for CD79b.",
   "date_published": "2026-09-09T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-09",
    "precision": "day",
    "venue": "J Clin Oncol",
    "doi": "10.1200/jco-26-00451",
    "records": [
     {
      "id": "cd79b",
      "kind": "target",
      "name": "CD79b",
      "url": "https://onco.cc/targets/cd79b/"
     },
     {
      "id": "polatuzumab-vedotin",
      "kind": "drug",
      "name": "Polatuzumab vedotin",
      "url": "https://onco.cc/drugs/polatuzumab-vedotin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/s2352-3026(26)00224-3#onco-edge-paper",
   "url": "https://doi.org/10.1016/s2352-3026(26)00224-3",
   "title": "Response-adapted inotuzumab ozogamicin in paediatric first-relapse B-cell acute lymphoblastic leukaemia - Authors' reply.",
   "content_text": "Published in Lancet Haematol on 9 September 2026; matched the OnCo record for Inotuzumab ozogamicin.",
   "date_published": "2026-09-09T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-09",
    "precision": "day",
    "venue": "Lancet Haematol",
    "doi": "10.1016/s2352-3026(26)00224-3",
    "records": [
     {
      "id": "inotuzumab-ozogamicin",
      "kind": "drug",
      "name": "Inotuzumab ozogamicin",
      "url": "https://onco.cc/drugs/inotuzumab-ozogamicin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/s2352-3026(26)00221-8#onco-edge-paper",
   "url": "https://doi.org/10.1016/s2352-3026(26)00221-8",
   "title": "Response-adapted inotuzumab ozogamicin in paediatric first-relapse B-cell acute lymphoblastic leukaemia.",
   "content_text": "Published in Lancet Haematol on 9 September 2026; matched the OnCo record for Inotuzumab ozogamicin.",
   "date_published": "2026-09-09T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-09",
    "precision": "day",
    "venue": "Lancet Haematol",
    "doi": "10.1016/s2352-3026(26)00221-8",
    "records": [
     {
      "id": "inotuzumab-ozogamicin",
      "kind": "drug",
      "name": "Inotuzumab ozogamicin",
      "url": "https://onco.cc/drugs/inotuzumab-ozogamicin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41586-026-10998-3#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41586-026-10998-3",
   "title": "TRI-611, a selective, brain-penetrant molecular glue degrader of ALK.",
   "content_text": "Published in Nature on 9 September 2026; matched the OnCo record for TRI-611.",
   "date_published": "2026-09-09T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-09",
    "precision": "day",
    "venue": "Nature",
    "doi": "10.1038/s41586-026-10998-3",
    "records": [
     {
      "id": "tri-611",
      "kind": "drug",
      "name": "TRI-611",
      "url": "https://onco.cc/drugs/tri-611/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3760/cma.j.cn115330-20260328-00183#onco-edge-paper",
   "url": "https://doi.org/10.3760/cma.j.cn115330-20260328-00183",
   "title": "[Development of an artificial intelligence-assisted diagnostic model for malignant head and neck tumors based on endoscopic images].",
   "content_text": "Published in Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi on 15 September 2026; matched the OnCo record for Hypopharyngeal cancer.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi",
    "doi": "10.3760/cma.j.cn115330-20260328-00183",
    "records": [
     {
      "id": "hypopharyngeal-cancer",
      "kind": "cancer",
      "name": "Hypopharyngeal cancer",
      "url": "https://onco.cc/cancers/hypopharyngeal-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/17474086.2026.2732995#onco-edge-paper",
   "url": "https://doi.org/10.1080/17474086.2026.2732995",
   "title": "Adaptations in pacritinib usage for myelofibrosis and thrombocytopenia since FDA approval.",
   "content_text": "Published in Expert Rev Hematol on 15 September 2026; matched the OnCo record for Pacritinib.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Expert Rev Hematol",
    "doi": "10.1080/17474086.2026.2732995",
    "records": [
     {
      "id": "pacritinib",
      "kind": "drug",
      "name": "Pacritinib",
      "url": "https://onco.cc/drugs/pacritinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1158/1078-0432.ccr-26-1372#onco-edge-paper",
   "url": "https://doi.org/10.1158/1078-0432.ccr-26-1372",
   "title": "Amivantamab plus pembrolizumab in previously untreated recurrent/metastatic head and neck squamous cell cancer: Results from the phase 1b/2 OrigAMI-4 study.",
   "content_text": "Published in Clin Cancer Res on 15 September 2026; matched the OnCo record for Amivantamab.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Clin Cancer Res",
    "doi": "10.1158/1078-0432.ccr-26-1372",
    "records": [
     {
      "id": "amivantamab",
      "kind": "drug",
      "name": "Amivantamab",
      "url": "https://onco.cc/drugs/amivantamab/"
     },
     {
      "id": "hpv-positive-oropharyngeal-cancer",
      "kind": "cancer",
      "name": "HPV-positive oropharyngeal cancer",
      "url": "https://onco.cc/cancers/hpv-positive-oropharyngeal-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/13814788.2026.2728342#onco-edge-paper",
   "url": "https://doi.org/10.1080/13814788.2026.2728342",
   "title": "Barriers for general practitioners in post-stroke follow-up within a fragmented healthcare system in Sweden - a focus group study.",
   "content_text": "Published in Eur J Gen Pract on 15 September 2026; matched the OnCo record for Undifferentiated pleomorphic sarcoma.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Eur J Gen Pract",
    "doi": "10.1080/13814788.2026.2728342",
    "records": [
     {
      "id": "undifferentiated-pleomorphic-sarcoma",
      "kind": "cancer",
      "name": "Undifferentiated pleomorphic sarcoma",
      "url": "https://onco.cc/cancers/undifferentiated-pleomorphic-sarcoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.critrevonc.2026.105597#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.critrevonc.2026.105597",
   "title": "Biomarker-guided treatment selection in metastatic colorectal cancer: A critical review of established and emerging therapies.",
   "content_text": "Published in Crit Rev Oncol Hematol on 15 September 2026; matched the OnCo record for Amivantamab.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Crit Rev Oncol Hematol",
    "doi": "10.1016/j.critrevonc.2026.105597",
    "records": [
     {
      "id": "amivantamab",
      "kind": "drug",
      "name": "Amivantamab",
      "url": "https://onco.cc/drugs/amivantamab/"
     },
     {
      "id": "encorafenib",
      "kind": "drug",
      "name": "Encorafenib",
      "url": "https://onco.cc/drugs/encorafenib/"
     },
     {
      "id": "tucatinib",
      "kind": "drug",
      "name": "Tucatinib",
      "url": "https://onco.cc/drugs/tucatinib/"
     },
     {
      "id": "zanzalintinib",
      "kind": "drug",
      "name": "Zanzalintinib",
      "url": "https://onco.cc/drugs/zanzalintinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.4274/tjtcs.2026.2025-12-33#onco-edge-paper",
   "url": "https://doi.org/10.4274/tjtcs.2026.2025-12-33",
   "title": "Bronchial stump re-resection for carcinoid tumor recurrence after left pneumonectomy: Case report.",
   "content_text": "Published in Turk Gogus Kalp Damar Cerrahisi Derg on 15 September 2026; matched the OnCo record for Lung neuroendocrine tumours.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Turk Gogus Kalp Damar Cerrahisi Derg",
    "doi": "10.4274/tjtcs.2026.2025-12-33",
    "records": [
     {
      "id": "lung-net",
      "kind": "cancer",
      "name": "Lung neuroendocrine tumours",
      "url": "https://onco.cc/cancers/lung-net/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/ajum.70063#onco-edge-paper",
   "url": "https://doi.org/10.1002/ajum.70063",
   "title": "Chromophobe Renal Cell Carcinoma With Multimodal Imaging Features: A Case Report.",
   "content_text": "Published in Australas J Ultrasound Med on 15 September 2026; matched the OnCo record for Chromophobe renal cell carcinoma.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Australas J Ultrasound Med",
    "doi": "10.1002/ajum.70063",
    "records": [
     {
      "id": "chromophobe-rcc",
      "kind": "cancer",
      "name": "Chromophobe renal cell carcinoma",
      "url": "https://onco.cc/cancers/chromophobe-rcc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1158/1541-7786.mcr-26-0463#onco-edge-paper",
   "url": "https://doi.org/10.1158/1541-7786.mcr-26-0463",
   "title": "Comparative Transcriptomic and Immune Profiling Reveals a Shared Molecular Identity Between Clear Cell Odontogenic Carcinoma and Hyalinizing Clear Cell Carcinoma.",
   "content_text": "Published in Mol Cancer Res on 15 September 2026; matched the OnCo record for Folate receptor alpha.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Mol Cancer Res",
    "doi": "10.1158/1541-7786.mcr-26-0463",
    "records": [
     {
      "id": "folr1",
      "kind": "target",
      "name": "Folate receptor alpha",
      "url": "https://onco.cc/targets/folr1/"
     },
     {
      "id": "mesothelin",
      "kind": "target",
      "name": "Mesothelin",
      "url": "https://onco.cc/targets/mesothelin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/mco2.70991#onco-edge-paper",
   "url": "https://doi.org/10.1002/mco2.70991",
   "title": "Cooccurrence of Homologous Recombination Deficiency and Mismatch Repair Deficiency in Colorectal Cancer.",
   "content_text": "Published in MedComm (2020) on 15 September 2026; matched the OnCo record for HRD & BRCA testing.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "MedComm (2020)",
    "doi": "10.1002/mco2.70991",
    "records": [
     {
      "id": "hrd-testing",
      "kind": "technology",
      "name": "HRD & BRCA testing",
      "url": "https://onco.cc/technologies/hrd-testing/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1093/nargab/lqag111#onco-edge-paper",
   "url": "https://doi.org/10.1093/nargab/lqag111",
   "title": "Customizable host and viral transcript enrichment using CRISPR-Cas9 long-read sequencing for characterization of low-to-moderate abundance isoforms.",
   "content_text": "Published in NAR Genom Bioinform on 15 September 2026; matched the OnCo record for Long-read sequencing.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "NAR Genom Bioinform",
    "doi": "10.1093/nargab/lqag111",
    "records": [
     {
      "id": "long-read-sequencing",
      "kind": "technology",
      "name": "Long-read sequencing",
      "url": "https://onco.cc/technologies/long-read-sequencing/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.saa.2026.128769#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.saa.2026.128769",
   "title": "Design, calibration, and preliminary testing of an additive-manufactured Raman spectrometer for skin cancer screening.",
   "content_text": "Published in Spectrochim Acta A Mol Biomol Spectrosc on 15 September 2026; matched the OnCo record for Skin cancer screening.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Spectrochim Acta A Mol Biomol Spectrosc",
    "doi": "10.1016/j.saa.2026.128769",
    "records": [
     {
      "id": "skin-cancer-screening",
      "kind": "technology",
      "name": "Skin cancer screening",
      "url": "https://onco.cc/technologies/skin-cancer-screening/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00277-026-07278-5#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00277-026-07278-5",
   "title": "Early deep response to cilta-cel as 2nd CAR T-Cell therapy after CELMoD-based bridging for advanced multiple myeloma.",
   "content_text": "Published in Ann Hematol on 15 September 2026; matched the OnCo record for Ciltacabtagene autoleucel.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Ann Hematol",
    "doi": "10.1007/s00277-026-07278-5",
    "records": [
     {
      "id": "ciltacabtagene-autoleucel",
      "kind": "drug",
      "name": "Ciltacabtagene autoleucel",
      "url": "https://onco.cc/drugs/ciltacabtagene-autoleucel/"
     },
     {
      "id": "idecabtagene-vicleucel",
      "kind": "drug",
      "name": "Idecabtagene vicleucel",
      "url": "https://onco.cc/drugs/idecabtagene-vicleucel/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/mco2.70997#onco-edge-paper",
   "url": "https://doi.org/10.1002/mco2.70997",
   "title": "Efficacy and Safety of Co-Ablation Combined With Aintilimab for Metastatic Melanoma to the Liver (CryoCheck-001): A Phase II Trial.",
   "content_text": "Published in MedComm (2020) on 15 September 2026; matched the OnCo record for Sintilimab.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "MedComm (2020)",
    "doi": "10.1002/mco2.70997",
    "records": [
     {
      "id": "sintilimab",
      "kind": "drug",
      "name": "Sintilimab",
      "url": "https://onco.cc/drugs/sintilimab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/ajh.70441#onco-edge-paper",
   "url": "https://doi.org/10.1002/ajh.70441",
   "title": "Hairy Cell Leukemia: 2026 Update on Diagnosis, Risk-Stratification, and Treatment.",
   "content_text": "Published in Am J Hematol on 15 September 2026; matched the OnCo record for BCL-2 inhibitors.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Am J Hematol",
    "doi": "10.1002/ajh.70441",
    "records": [
     {
      "id": "bcl2-inhibitors",
      "kind": "technology",
      "name": "BCL-2 inhibitors",
      "url": "https://onco.cc/technologies/bcl2-inhibitors/"
     },
     {
      "id": "cd123",
      "kind": "target",
      "name": "CD123",
      "url": "https://onco.cc/targets/cd123/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s44313-026-00175-w#onco-edge-paper",
   "url": "https://doi.org/10.1007/s44313-026-00175-w",
   "title": "High-risk features in adult patients with B-cell acute lymphoblastic leukemia: redefining risk in the era of targeted immunotherapy.",
   "content_text": "Published in Blood Res on 15 September 2026; matched the OnCo record for Ponatinib.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Blood Res",
    "doi": "10.1007/s44313-026-00175-w",
    "records": [
     {
      "id": "ponatinib",
      "kind": "drug",
      "name": "Ponatinib",
      "url": "https://onco.cc/drugs/ponatinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/07853890.2026.2724695#onco-edge-paper",
   "url": "https://doi.org/10.1080/07853890.2026.2724695",
   "title": "Impact of time from diagnosis to endoscopic resection on clinical outcomes in early gastric cancer.",
   "content_text": "Published in Ann Med on 15 September 2026; matched the OnCo record for Endoscopic resection.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Ann Med",
    "doi": "10.1080/07853890.2026.2724695",
    "records": [
     {
      "id": "endoscopic-resection",
      "kind": "technology",
      "name": "Endoscopic resection",
      "url": "https://onco.cc/technologies/endoscopic-resection/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12029-026-01589-6#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12029-026-01589-6",
   "title": "Induction FLOT Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in the Treatment of Lower Esophageal and Proximal Gastric Adenocarcinoma: A Phase II, Single-Arm Clinical Trial.",
   "content_text": "Published in J Gastrointest Cancer on 15 September 2026; matched the OnCo record for FLOT.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "J Gastrointest Cancer",
    "doi": "10.1007/s12029-026-01589-6",
    "records": [
     {
      "id": "flot",
      "kind": "drug",
      "name": "FLOT",
      "url": "https://onco.cc/drugs/flot/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1161/circulationaha.124.072363#onco-edge-paper",
   "url": "https://doi.org/10.1161/circulationaha.124.072363",
   "title": "Intestinal Serotonergic Vagal Signaling as a Mediator of Microbiota-Induced Hypertension.",
   "content_text": "Published on 15 September 2026 after first appearing as a preprint; matched Iobenguane I-131.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "doi": "10.1161/circulationaha.124.072363",
    "records": [
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1177/15578666261485497#onco-edge-paper",
   "url": "https://doi.org/10.1177/15578666261485497",
   "title": "Joint Learning of Drug-Drug Combination and Drug-Drug Interaction via Coupled Tensor-Tensor Factorization with Side Information.",
   "content_text": "Published on 15 September 2026 after first appearing as a preprint; matched Iobenguane I-131.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "doi": "10.1177/15578666261485497",
    "records": [
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.farma.2026.07.002#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.farma.2026.07.002",
   "title": "Multicenter study of cladribine in relapsing-remitting multiple sclerosis in patients over 50 years.",
   "content_text": "Published in Farm Hosp on 15 September 2026; matched the OnCo record for Cladribine.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Farm Hosp",
    "doi": "10.1016/j.farma.2026.07.002",
    "records": [
     {
      "id": "cladribine",
      "kind": "drug",
      "name": "Cladribine",
      "url": "https://onco.cc/drugs/cladribine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/jha2.70390#onco-edge-paper",
   "url": "https://doi.org/10.1002/jha2.70390",
   "title": "Myeloma-Associated Sporadic Late-Onset Nemaline Myopathy, Successfully Treated with Daratumumab Based Induction and Autologous Stem Cell Transplantation: A Case Report.",
   "content_text": "Published in EJHaem on 15 September 2026; matched the OnCo record for Melphalan.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "EJHaem",
    "doi": "10.1002/jha2.70390",
    "records": [
     {
      "id": "melphalan",
      "kind": "drug",
      "name": "Melphalan",
      "url": "https://onco.cc/drugs/melphalan/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jconrel.2026.115355#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jconrel.2026.115355",
   "title": "Nab-paclitaxel fused with the de novo designed receptor binder exhibits enhanced tumor targeting and therapeutic efficacy.",
   "content_text": "Published in J Control Release on 15 September 2026; matched the OnCo record for De novo designed protein binders.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "J Control Release",
    "doi": "10.1016/j.jconrel.2026.115355",
    "records": [
     {
      "id": "de-novo-protein-design",
      "kind": "technology",
      "name": "De novo designed protein binders",
      "url": "https://onco.cc/technologies/de-novo-protein-design/"
     }
    ]
   }
  },
  {
   "id": "https://onco.cc/newsletter/2026-09-15/#onco-edge-issue",
   "url": "https://onco.cc/newsletter/2026-09-15/",
   "title": "OnCo weekly, 2026-09-15",
   "content_text": "14 changelog entries, 1 upcoming date, 20 publications, 89 corrections.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "issue"
   ],
   "_onco": {
    "kind": "issue",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "OnCo weekly issue",
    "records": []
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jormas.2026.102993#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jormas.2026.102993",
   "title": "Oral Manifestations and Management of Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.",
   "content_text": "Published in J Stomatol Oral Maxillofac Surg on 15 September 2026; matched the OnCo record for Tucidinostat.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "J Stomatol Oral Maxillofac Surg",
    "doi": "10.1016/j.jormas.2026.102993",
    "records": [
     {
      "id": "tucidinostat",
      "kind": "drug",
      "name": "Tucidinostat",
      "url": "https://onco.cc/drugs/tucidinostat/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/19490976.2026.2728331#onco-edge-paper",
   "url": "https://doi.org/10.1080/19490976.2026.2728331",
   "title": "Pangenome analysis reveals both niche-specific \"specialists\" and microbial \"side hustlers\" in colorectal cancer microbiomes.",
   "content_text": "Published in Gut Microbes on 15 September 2026; matched the OnCo record for Chemoprevention & risk-reducing surgery.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Gut Microbes",
    "doi": "10.1080/19490976.2026.2728331",
    "records": [
     {
      "id": "chemoprevention",
      "kind": "technology",
      "name": "Chemoprevention & risk-reducing surgery",
      "url": "https://onco.cc/technologies/chemoprevention/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.2169/internalmedicine.7992-26#onco-edge-paper",
   "url": "https://doi.org/10.2169/internalmedicine.7992-26",
   "title": "Paraneoplastic Neurological Syndrome in a Patient with Limited-stage Small-cell Lung Cancer Receiving Durvalumab Maintenance after Concurrent Chemoradiotherapy: A Case Report.",
   "content_text": "Published in Intern Med on 15 September 2026; matched the OnCo record for Limited-stage small-cell lung cancer.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Intern Med",
    "doi": "10.2169/internalmedicine.7992-26",
    "records": [
     {
      "id": "limited-stage-sclc",
      "kind": "cancer",
      "name": "Limited-stage small-cell lung cancer",
      "url": "https://onco.cc/cancers/limited-stage-sclc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.urolonc.2026.08.005#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.urolonc.2026.08.005",
   "title": "Performance of the EORTC and CUETO risk prediction models in contemporary patients undergoing transurethral resection of bladder tumor with blue light cystoscopy.",
   "content_text": "Published in Urol Oncol on 15 September 2026; matched the OnCo record for Hexaminolevulinate.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Urol Oncol",
    "doi": "10.1016/j.urolonc.2026.08.005",
    "records": [
     {
      "id": "hexaminolevulinate",
      "kind": "drug",
      "name": "Hexaminolevulinate",
      "url": "https://onco.cc/drugs/hexaminolevulinate/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1242/jcs.265054#onco-edge-paper",
   "url": "https://doi.org/10.1242/jcs.265054",
   "title": "Phosphoproteomics identifies the DYRK1B protein kinase as a regulator of processing bodies.",
   "content_text": "Published on 15 September 2026 after first appearing as a preprint; matched Proteomics & phosphoproteomics.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "doi": "10.1242/jcs.265054",
    "records": [
     {
      "id": "proteomics",
      "kind": "technology",
      "name": "Proteomics & phosphoproteomics",
      "url": "https://onco.cc/technologies/proteomics/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/mco2.70974#onco-edge-paper",
   "url": "https://doi.org/10.1002/mco2.70974",
   "title": "Post-Tuberculosis Lung Disease: Clinicopathologic Insights, Diagnosis, Prevention, and Management.",
   "content_text": "Published in MedComm (2020) on 15 September 2026; matched the OnCo record for Post-transplant lymphoproliferative disorder.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "MedComm (2020)",
    "doi": "10.1002/mco2.70974",
    "records": [
     {
      "id": "post-transplant-lymphoproliferative-disorder",
      "kind": "cancer",
      "name": "Post-transplant lymphoproliferative disorder",
      "url": "https://onco.cc/cancers/post-transplant-lymphoproliferative-disorder/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ygyno.2026.08.020#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ygyno.2026.08.020",
   "title": "Prognostic implications of HPV and TP53 status in early-stage vulvar squamous cell carcinoma.",
   "content_text": "Published in Gynecol Oncol on 15 September 2026; matched the OnCo record for HPV-independent vulvar squamous cell carcinoma.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Gynecol Oncol",
    "doi": "10.1016/j.ygyno.2026.08.020",
    "records": [
     {
      "id": "hpv-independent-vulvar-cancer",
      "kind": "cancer",
      "name": "HPV-independent vulvar squamous cell carcinoma",
      "url": "https://onco.cc/cancers/hpv-independent-vulvar-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1111/bjh.70835#onco-edge-paper",
   "url": "https://doi.org/10.1111/bjh.70835",
   "title": "Reduced-dose versus standard-dose total body irradiation before allogeneic haematopoietic stem cell transplantation in adults with acute lymphoblastic leukaemia.",
   "content_text": "Published in Br J Haematol on 15 September 2026; matched the OnCo record for Acute lymphoblastic leukaemia.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Br J Haematol",
    "doi": "10.1111/bjh.70835",
    "records": [
     {
      "id": "all-leukemia",
      "kind": "cancer",
      "name": "Acute lymphoblastic leukaemia",
      "url": "https://onco.cc/cancers/all-leukemia/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.kint.2026.07.031#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.kint.2026.07.031",
   "title": "Resident immune cell neighborhoods associate with protein kinase pRIPK3 and fatty acid ligase FACL4 expression during cell injury in ANCA associated vasculitis and lupus nephritis.",
   "content_text": "Published in Kidney Int on 15 September 2026; matched the OnCo record for Imaging mass cytometry.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Kidney Int",
    "doi": "10.1016/j.kint.2026.07.031",
    "records": [
     {
      "id": "imaging-mass-cytometry",
      "kind": "technology",
      "name": "Imaging mass cytometry",
      "url": "https://onco.cc/technologies/imaging-mass-cytometry/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1172/jci207530#onco-edge-paper",
   "url": "https://doi.org/10.1172/jci207530",
   "title": "Reverse genetics in humanized mice reveals CARD8-mediated pyroptosis causing pancytopenia in human DPP9 deficiency.",
   "content_text": "Published on 15 September 2026 after first appearing as a preprint; matched Iobenguane I-131.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "doi": "10.1172/jci207530",
    "records": [
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ijbiomac.2026.154515#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ijbiomac.2026.154515",
   "title": "Synergistic chitosan nanoparticles loaded with baricitinib for the management of persistent chemotherapy-induced alopecia.",
   "content_text": "Published in Int J Biol Macromol on 15 September 2026; matched the OnCo record for Scalp cooling.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Int J Biol Macromol",
    "doi": "10.1016/j.ijbiomac.2026.154515",
    "records": [
     {
      "id": "scalp-cooling",
      "kind": "technology",
      "name": "Scalp cooling",
      "url": "https://onco.cc/technologies/scalp-cooling/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/16078454.2026.2730041#onco-edge-paper",
   "url": "https://doi.org/10.1080/16078454.2026.2730041",
   "title": "Teclistamab-associated adverse events: a disproportionality analysis of the FDA adverse event reporting system.",
   "content_text": "Published in Hematology on 15 September 2026; matched the OnCo record for BCMA.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Hematology",
    "doi": "10.1080/16078454.2026.2730041",
    "records": [
     {
      "id": "bcma",
      "kind": "target",
      "name": "BCMA",
      "url": "https://onco.cc/targets/bcma/"
     },
     {
      "id": "bispecific-antibody",
      "kind": "technology",
      "name": "Bispecific antibodies",
      "url": "https://onco.cc/technologies/bispecific-antibody/"
     },
     {
      "id": "cd3",
      "kind": "target",
      "name": "CD3",
      "url": "https://onco.cc/targets/cd3/"
     },
     {
      "id": "mcla-129",
      "kind": "drug",
      "name": "MCLA-129",
      "url": "https://onco.cc/drugs/mcla-129/"
     },
     {
      "id": "multiple-myeloma",
      "kind": "cancer",
      "name": "Multiple myeloma",
      "url": "https://onco.cc/cancers/multiple-myeloma/"
     },
     {
      "id": "t-cell-engager",
      "kind": "technology",
      "name": "T-cell engagers",
      "url": "https://onco.cc/technologies/t-cell-engager/"
     },
     {
      "id": "teclistamab",
      "kind": "drug",
      "name": "Teclistamab",
      "url": "https://onco.cc/drugs/teclistamab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/puh2.70379#onco-edge-paper",
   "url": "https://doi.org/10.1002/puh2.70379",
   "title": "The Terminator-A Blood Test for Early Detection of 50 Cancers.",
   "content_text": "Published in Public Health Chall on 15 September 2026; matched the OnCo record for Galleri.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Public Health Chall",
    "doi": "10.1002/puh2.70379",
    "records": [
     {
      "id": "galleri",
      "kind": "drug",
      "name": "Galleri",
      "url": "https://onco.cc/drugs/galleri/"
     },
     {
      "id": "mced",
      "kind": "technology",
      "name": "Multi-cancer early detection",
      "url": "https://onco.cc/technologies/mced/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12032-026-03416-1#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12032-026-03416-1",
   "title": "VISTA as a myeloid-centered checkpoint axis in cancer: biology, tumor microenvironment, and therapeutic implications.",
   "content_text": "Published in Med Oncol on 15 September 2026; matched the OnCo record for VISTA.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Med Oncol",
    "doi": "10.1007/s12032-026-03416-1",
    "records": [
     {
      "id": "vista",
      "kind": "target",
      "name": "VISTA",
      "url": "https://onco.cc/targets/vista/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1186/s43556-026-00573-7#onco-edge-paper",
   "url": "https://doi.org/10.1186/s43556-026-00573-7",
   "title": "<sup>177</sup>Lu-trastuzumab radionuclide therapy: a promising strategy for trastuzumab-resistant brain metastases in HER2+ breast cancer.",
   "content_text": "Published in Mol Biomed on 14 September 2026; matched the OnCo record for Immuno-PET.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Mol Biomed",
    "doi": "10.1186/s43556-026-00573-7",
    "records": [
     {
      "id": "immuno-pet",
      "kind": "technology",
      "name": "Immuno-PET",
      "url": "https://onco.cc/technologies/immuno-pet/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41746-026-03254-5#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41746-026-03254-5",
   "title": "A novel multiomics machine learning signature identifies rapid progression in clinically low risk prostate cancer.",
   "content_text": "Published in NPJ Digit Med on 14 September 2026; matched the OnCo record for Localised prostate cancer, very low and low risk.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "NPJ Digit Med",
    "doi": "10.1038/s41746-026-03254-5",
    "records": [
     {
      "id": "prostate-low-risk",
      "kind": "cancer",
      "name": "Localised prostate cancer, very low and low risk",
      "url": "https://onco.cc/cancers/prostate-low-risk/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.71480/nmj.v67i5.1457#onco-edge-paper",
   "url": "https://doi.org/10.71480/nmj.v67i5.1457",
   "title": "Acinar Cell Carcinoma of the Pancreas: A Three Case Series and Literature Review.",
   "content_text": "Published in Niger Med J on 14 September 2026; matched the OnCo record for Pancreatic acinar cell carcinoma.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Niger Med J",
    "doi": "10.71480/nmj.v67i5.1457",
    "records": [
     {
      "id": "pancreatic-acinar-cell-carcinoma",
      "kind": "cancer",
      "name": "Pancreatic acinar cell carcinoma",
      "url": "https://onco.cc/cancers/pancreatic-acinar-cell-carcinoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jtct.2026.08.047#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jtct.2026.08.047",
   "title": "Belumosudil Demonstrates Steroid-Sparing, Safety, and Efficacy in Pediatric Chronic Graft-Versus-Host Disease.",
   "content_text": "Published in Transplant Cell Ther on 14 September 2026; matched the OnCo record for Belumosudil.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Transplant Cell Ther",
    "doi": "10.1016/j.jtct.2026.08.047",
    "records": [
     {
      "id": "belumosudil",
      "kind": "drug",
      "name": "Belumosudil",
      "url": "https://onco.cc/drugs/belumosudil/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11060-026-05801-2#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11060-026-05801-2",
   "title": "Brain dose burden is associated with treatment-related lymphopenia in IDH-wildtype glioblastoma: dosimetric determinants and prognostic impact.",
   "content_text": "Published on 14 September 2026 after first appearing as a preprint; matched Temozolomide.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "doi": "10.1007/s11060-026-05801-2",
    "records": [
     {
      "id": "temozolomide",
      "kind": "drug",
      "name": "Temozolomide",
      "url": "https://onco.cc/drugs/temozolomide/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/cji.0000000000000618#onco-edge-paper",
   "url": "https://doi.org/10.1097/cji.0000000000000618",
   "title": "Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing.",
   "content_text": "Published in J Immunother on 14 September 2026; matched the OnCo record for Bomedemstat.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "J Immunother",
    "doi": "10.1097/cji.0000000000000618",
    "records": [
     {
      "id": "bomedemstat",
      "kind": "drug",
      "name": "Bomedemstat",
      "url": "https://onco.cc/drugs/bomedemstat/"
     },
     {
      "id": "lsd1-inhibitors",
      "kind": "technology",
      "name": "LSD1 inhibitors",
      "url": "https://onco.cc/technologies/lsd1-inhibitors/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11060-026-05786-y#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11060-026-05786-y",
   "title": "CD73 and PD-L1 expression in WHO grade 1 and grade 2 meningiomas: an exploratory analysis of purinergic and immune-related profiles.",
   "content_text": "Published in J Neurooncol on 14 September 2026; matched the OnCo record for CD73 / adenosine axis.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "J Neurooncol",
    "doi": "10.1007/s11060-026-05786-y",
    "records": [
     {
      "id": "cd73-adenosine",
      "kind": "target",
      "name": "CD73 / adenosine axis",
      "url": "https://onco.cc/targets/cd73-adenosine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1186/s43046-026-00414-2#onco-edge-paper",
   "url": "https://doi.org/10.1186/s43046-026-00414-2",
   "title": "Comparative efficacy and safety of first, second, and third-generation EGFR tyrosine kinase inhibitors in treatment-naïve EGFR-mutant advanced non-small cell lung cancer: a systematic review and network meta-analysis of randomized controlled trials.",
   "content_text": "Published in J Egypt Natl Canc Inst on 14 September 2026; matched the OnCo record for Befotertinib.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "J Egypt Natl Canc Inst",
    "doi": "10.1186/s43046-026-00414-2",
    "records": [
     {
      "id": "befotertinib",
      "kind": "drug",
      "name": "Befotertinib",
      "url": "https://onco.cc/drugs/befotertinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.4143/crt.2026.0614#onco-edge-paper",
   "url": "https://doi.org/10.4143/crt.2026.0614",
   "title": "Comparative Prognostic Value of Pre- and Post-Induction Chemotherapy Tumor Volumes in Locoregionally Advanced Nasopharyngeal Carcinoma.",
   "content_text": "Published in Cancer Res Treat on 14 September 2026; matched the OnCo record for Locoregionally advanced nasopharyngeal carcinoma.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Cancer Res Treat",
    "doi": "10.4143/crt.2026.0614",
    "records": [
     {
      "id": "locoregionally-advanced-nasopharyngeal-carcinoma",
      "kind": "cancer",
      "name": "Locoregionally advanced nasopharyngeal carcinoma",
      "url": "https://onco.cc/cancers/locoregionally-advanced-nasopharyngeal-carcinoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00259-026-08110-y#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00259-026-08110-y",
   "title": "Correlation of <sup>68</sup>Ga-PSMA-11 PET/CT biodistribution with PSMA expression by immunohistochemistry in patients with HCC: A pilot prospective monocentric study.",
   "content_text": "Published in Eur J Nucl Med Mol Imaging on 14 September 2026; matched the OnCo record for Gallium-68 gozetotide.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Eur J Nucl Med Mol Imaging",
    "doi": "10.1007/s00259-026-08110-y",
    "records": [
     {
      "id": "ga68-psma-11",
      "kind": "drug",
      "name": "Gallium-68 gozetotide",
      "url": "https://onco.cc/drugs/ga68-psma-11/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/02656736.2026.2716351#onco-edge-paper",
   "url": "https://doi.org/10.1080/02656736.2026.2716351",
   "title": "Effect of neoadjuvant androgen deprivation therapy on prostate and tumor morphology prior to MRI-guided transurethral ultrasound ablation of prostate cancer.",
   "content_text": "Published in Int J Hyperthermia on 14 September 2026; matched the OnCo record for Androgen deprivation & AR pathway inhibitors.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Int J Hyperthermia",
    "doi": "10.1080/02656736.2026.2716351",
    "records": [
     {
      "id": "androgen-deprivation",
      "kind": "technology",
      "name": "Androgen deprivation & AR pathway inhibitors",
      "url": "https://onco.cc/technologies/androgen-deprivation/"
     },
     {
      "id": "degarelix",
      "kind": "drug",
      "name": "Degarelix",
      "url": "https://onco.cc/drugs/degarelix/"
     },
     {
      "id": "mp-mri",
      "kind": "technology",
      "name": "Multiparametric prostate MRI",
      "url": "https://onco.cc/technologies/mp-mri/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1186/s11671-026-04895-x#onco-edge-paper",
   "url": "https://doi.org/10.1186/s11671-026-04895-x",
   "title": "eGFP tagged ZnO nanoparticles from glioblastoma targeting ferroptosis and MRP1 in head and neck squamous cell carcinoma.",
   "content_text": "Published in Discov Nano on 14 September 2026; matched the OnCo record for Hypopharyngeal cancer.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Discov Nano",
    "doi": "10.1186/s11671-026-04895-x",
    "records": [
     {
      "id": "hypopharyngeal-cancer",
      "kind": "cancer",
      "name": "Hypopharyngeal cancer",
      "url": "https://onco.cc/cancers/hypopharyngeal-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12149-026-02282-1#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12149-026-02282-1",
   "title": "From sensitivity gain to clinical decisions: total-body and long-axial-field-of-view PET/CT for diagnosis and image-based management in oncology and systemic disease.",
   "content_text": "Published in Ann Nucl Med on 14 September 2026; matched the OnCo record for Immuno-PET.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Ann Nucl Med",
    "doi": "10.1007/s12149-026-02282-1",
    "records": [
     {
      "id": "immuno-pet",
      "kind": "technology",
      "name": "Immuno-PET",
      "url": "https://onco.cc/technologies/immuno-pet/"
     },
     {
      "id": "radioembolisation-tare",
      "kind": "technology",
      "name": "Radioembolisation",
      "url": "https://onco.cc/technologies/radioembolisation-tare/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/lgt.0000000000000981#onco-edge-paper",
   "url": "https://doi.org/10.1097/lgt.0000000000000981",
   "title": "HPV-associated Cancer Diagnoses and Mortality in People With HIV in South Carolina During the Antiretroviral Therapy Era.",
   "content_text": "Published in J Low Genit Tract Dis on 14 September 2026; matched the OnCo record for Vulvar cancer.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "J Low Genit Tract Dis",
    "doi": "10.1097/lgt.0000000000000981",
    "records": [
     {
      "id": "vulvar",
      "kind": "cancer",
      "name": "Vulvar cancer",
      "url": "https://onco.cc/cancers/vulvar/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.5644/ama2006-124.516#onco-edge-paper",
   "url": "https://doi.org/10.5644/ama2006-124.516",
   "title": "Hypersensitivity to PEG-Asparaginase and Desensitization Strategies in Pediatric Acute Lymphoblastic Leukemia: A Narrative Review.",
   "content_text": "Published in Acta Med Acad on 14 September 2026; matched the OnCo record for Asparaginase.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Acta Med Acad",
    "doi": "10.5644/ama2006-124.516",
    "records": [
     {
      "id": "asparaginase",
      "kind": "drug",
      "name": "Asparaginase",
      "url": "https://onco.cc/drugs/asparaginase/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00066-026-02589-y#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00066-026-02589-y",
   "title": "Image-guided high-dose-rate brachytherapy after short-course external beam radiotherapy for elderly/frail rectal cancer patients.",
   "content_text": "Published in Strahlenther Onkol on 14 September 2026; matched the OnCo record for High-dose-rate brachytherapy.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Strahlenther Onkol",
    "doi": "10.1007/s00066-026-02589-y",
    "records": [
     {
      "id": "hdr-brachytherapy",
      "kind": "technology",
      "name": "High-dose-rate brachytherapy",
      "url": "https://onco.cc/technologies/hdr-brachytherapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00520-026-11217-5#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00520-026-11217-5",
   "title": "Integrative oncology consultation and patient referral to complementary therapies: results from the prospective study THERAC.",
   "content_text": "Published in Support Care Cancer on 14 September 2026; matched the OnCo record for Aromatherapy.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Support Care Cancer",
    "doi": "10.1007/s00520-026-11217-5",
    "records": [
     {
      "id": "aromatherapy-cancer",
      "kind": "technology",
      "name": "Aromatherapy",
      "url": "https://onco.cc/technologies/aromatherapy-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ejso.2026.112134#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ejso.2026.112134",
   "title": "Long-term quality of life and physical functioning after curative local treatment of colorectal metastases in older patients.",
   "content_text": "Published in Eur J Surg Oncol on 14 September 2026; matched the OnCo record for G8 geriatric screening tool.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Eur J Surg Oncol",
    "doi": "10.1016/j.ejso.2026.112134",
    "records": [
     {
      "id": "g8-geriatric-screening",
      "kind": "technology",
      "name": "G8 geriatric screening tool",
      "url": "https://onco.cc/technologies/g8-geriatric-screening/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.lungcan.2026.109588#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.lungcan.2026.109588",
   "title": "Long-term safety of first-line osimertinib plus platinum-pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2.",
   "content_text": "Published in Lung Cancer on 14 September 2026; found by the roadmap watch for FLAURA2.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Lung Cancer",
    "doi": "10.1016/j.lungcan.2026.109588",
    "records": [
     {
      "id": "flaura2",
      "kind": "trial",
      "name": "FLAURA2",
      "url": "https://onco.cc/trials/flaura2/"
     },
     {
      "id": "targeted-therapy-roadmap",
      "kind": "roadmap",
      "name": "Targeted therapy roadmap: imatinib → designed for resistance → the undruggable drivers fall",
      "url": "https://onco.cc/roadmaps/targeted-therapy-roadmap/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/pas.0000000000002618#onco-edge-paper",
   "url": "https://doi.org/10.1097/pas.0000000000002618",
   "title": "Molecular Subtyping of Biliary Tract Neuroendocrine Carcinomas: Clinicopathological Features and Prognostic Implications.",
   "content_text": "Published in Am J Surg Pathol on 14 September 2026; matched the OnCo record for Ampullary cancer.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Am J Surg Pathol",
    "doi": "10.1097/pas.0000000000002618",
    "records": [
     {
      "id": "ampullary",
      "kind": "cancer",
      "name": "Ampullary cancer",
      "url": "https://onco.cc/cancers/ampullary/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1200/op-26-00570#onco-edge-paper",
   "url": "https://doi.org/10.1200/op-26-00570",
   "title": "Multicancer Detection Tests for Population-Wide Screening of Asymptomatic Individuals: A Systematic Review.",
   "content_text": "Published in JCO Oncol Pract on 14 September 2026; matched the OnCo record for Early-stage classical Hodgkin lymphoma.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "JCO Oncol Pract",
    "doi": "10.1200/op-26-00570",
    "records": [
     {
      "id": "early-stage-classical-hodgkin-lymphoma",
      "kind": "cancer",
      "name": "Early-stage classical Hodgkin lymphoma",
      "url": "https://onco.cc/cancers/early-stage-classical-hodgkin-lymphoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1111/cup.70209#onco-edge-paper",
   "url": "https://doi.org/10.1111/cup.70209",
   "title": "New Annular, Indurated Plaques During Mogamulizumab Therapy in Cutaneous T-Cell Lymphoma: A Clinicopathologic Pitfall.",
   "content_text": "Published in J Cutan Pathol on 14 September 2026; matched the OnCo record for Mogamulizumab.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "J Cutan Pathol",
    "doi": "10.1111/cup.70209",
    "records": [
     {
      "id": "mogamulizumab",
      "kind": "drug",
      "name": "Mogamulizumab",
      "url": "https://onco.cc/drugs/mogamulizumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/20008066.2026.2726597#onco-edge-paper",
   "url": "https://doi.org/10.1080/20008066.2026.2726597",
   "title": "Occupational trauma and probable PTSD among sworn and civilian police employees.",
   "content_text": "Published in Eur J Psychotraumatol on 14 September 2026; matched the OnCo record for Plasma cell leukaemia.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Eur J Psychotraumatol",
    "doi": "10.1080/20008066.2026.2726597",
    "records": [
     {
      "id": "plasma-cell-leukaemia",
      "kind": "cancer",
      "name": "Plasma cell leukaemia",
      "url": "https://onco.cc/cancers/plasma-cell-leukaemia/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.71480/nmj.v67i5.1498#onco-edge-paper",
   "url": "https://doi.org/10.71480/nmj.v67i5.1498",
   "title": "Paediatric Primary Intracranial Tumours: A 14-year Clinicopathologic Study in North-Central Nigeria.",
   "content_text": "Published in Niger Med J on 14 September 2026; matched the OnCo record for Paediatric low-grade glioma.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Niger Med J",
    "doi": "10.71480/nmj.v67i5.1498",
    "records": [
     {
      "id": "paediatric-low-grade-glioma",
      "kind": "cancer",
      "name": "Paediatric low-grade glioma",
      "url": "https://onco.cc/cancers/paediatric-low-grade-glioma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1128/spectrum.01550-26#onco-edge-paper",
   "url": "https://doi.org/10.1128/spectrum.01550-26",
   "title": "Paired oral clinical specimens reveal the underlying ecology supporting the emergence of inflammophilic microbiome communities.",
   "content_text": "Published on 14 September 2026 after first appearing as a preprint; matched Azacitidine, Decitabine + cedazuridine and Iobenguane I-131.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "doi": "10.1128/spectrum.01550-26",
    "records": [
     {
      "id": "azacitidine",
      "kind": "drug",
      "name": "Azacitidine",
      "url": "https://onco.cc/drugs/azacitidine/"
     },
     {
      "id": "decitabine-cedazuridine",
      "kind": "drug",
      "name": "Decitabine + cedazuridine",
      "url": "https://onco.cc/drugs/decitabine-cedazuridine/"
     },
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1242/dmm.052907#onco-edge-paper",
   "url": "https://doi.org/10.1242/dmm.052907",
   "title": "Pharmacokinetics and efficacy of tank water-administered BRAF-inhibitor dabrafenib in a zebrafish melanoma model.",
   "content_text": "Published in Dis Model Mech on 14 September 2026; matched the OnCo record for BRAF V600-mutant melanoma.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Dis Model Mech",
    "doi": "10.1242/dmm.052907",
    "records": [
     {
      "id": "braf-v600-melanoma",
      "kind": "cancer",
      "name": "BRAF V600-mutant melanoma",
      "url": "https://onco.cc/cancers/braf-v600-melanoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/15592294.2026.2726624#onco-edge-paper",
   "url": "https://doi.org/10.1080/15592294.2026.2726624",
   "title": "PSMA1, PSMA5, and PSMB2 serve as prognostic biomarkers and are correlated with tumor-infiltrating leukocytes in HCC.",
   "content_text": "Published in Epigenetics on 14 September 2026; matched the OnCo record for Atlas.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Epigenetics",
    "doi": "10.1080/15592294.2026.2726624",
    "records": [
     {
      "id": "atlas-aignostics",
      "kind": "technology",
      "name": "Atlas",
      "url": "https://onco.cc/technologies/atlas-aignostics/"
     },
     {
      "id": "methylation-profiling",
      "kind": "technology",
      "name": "DNA methylation profiling",
      "url": "https://onco.cc/technologies/methylation-profiling/"
     },
     {
      "id": "proteasome",
      "kind": "target",
      "name": "Proteasome",
      "url": "https://onco.cc/targets/proteasome/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/17474086.2026.2732994#onco-edge-paper",
   "url": "https://doi.org/10.1080/17474086.2026.2732994",
   "title": "Resistance mechanisms and therapeutic strategies after menin inhibitor failure in acute myeloid leukemia.",
   "content_text": "Published in Expert Rev Hematol on 14 September 2026; matched the OnCo record for Revumenib.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Expert Rev Hematol",
    "doi": "10.1080/17474086.2026.2732994",
    "records": [
     {
      "id": "revumenib",
      "kind": "drug",
      "name": "Revumenib",
      "url": "https://onco.cc/drugs/revumenib/"
     },
     {
      "id": "ziftomenib",
      "kind": "drug",
      "name": "Ziftomenib",
      "url": "https://onco.cc/drugs/ziftomenib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3390/cancers18182964#onco-edge-paper",
   "url": "https://doi.org/10.3390/cancers18182964",
   "title": "RETRACTED: Salem et al. Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model. <i>Cancers</i> 2020, <i>12</i>, 2854.",
   "content_text": "Published in Cancers (Basel) on 14 September 2026; matched the OnCo record for EphA2 receptor.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Cancers (Basel)",
    "doi": "10.3390/cancers18182964",
    "records": [
     {
      "id": "epha2",
      "kind": "target",
      "name": "EphA2 receptor",
      "url": "https://onco.cc/targets/epha2/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.tranon.2026.102891#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.tranon.2026.102891",
   "title": "Reversing sarcopenia with megestrol acetate ameliorates systemic inflammation and improves survival in NSCLC.",
   "content_text": "Published in Transl Oncol on 14 September 2026; matched the OnCo record for Progestins.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Transl Oncol",
    "doi": "10.1016/j.tranon.2026.102891",
    "records": [
     {
      "id": "megestrol-progestins",
      "kind": "drug",
      "name": "Progestins",
      "url": "https://onco.cc/drugs/megestrol-progestins/"
     },
     {
      "id": "megestrol",
      "kind": "drug",
      "name": "Megestrol acetate",
      "url": "https://onco.cc/drugs/megestrol/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1177/10966218261488240#onco-edge-paper",
   "url": "https://doi.org/10.1177/10966218261488240",
   "title": "Songwriting in Medical Music Therapy in Pediatric Palliative Care: Case-Based Clinical Insight from Music Therapy Practice.",
   "content_text": "Published in J Palliat Med on 14 September 2026; matched the OnCo record for Burkitt lymphoma.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "J Palliat Med",
    "doi": "10.1177/10966218261488240",
    "records": [
     {
      "id": "burkitt-lymphoma",
      "kind": "cancer",
      "name": "Burkitt lymphoma",
      "url": "https://onco.cc/cancers/burkitt-lymphoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jviscsurg.2026.07.015#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jviscsurg.2026.07.015",
   "title": "Syndromic primary hyperparathyroidism.",
   "content_text": "Published in J Visc Surg on 14 September 2026; matched the OnCo record for Parathyroid carcinoma.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "J Visc Surg",
    "doi": "10.1016/j.jviscsurg.2026.07.015",
    "records": [
     {
      "id": "parathyroid-carcinoma",
      "kind": "cancer",
      "name": "Parathyroid carcinoma",
      "url": "https://onco.cc/cancers/parathyroid-carcinoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jphotobiol.2026.113566#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jphotobiol.2026.113566",
   "title": "Synergistic effects of hypericin-mediated photodynamic therapy and low-dose cisplatin on cervical cancer cells.",
   "content_text": "Published in J Photochem Photobiol B on 14 September 2026; matched the OnCo record for Synthetic hypericin.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "J Photochem Photobiol B",
    "doi": "10.1016/j.jphotobiol.2026.113566",
    "records": [
     {
      "id": "hypericin-sgx301",
      "kind": "drug",
      "name": "Synthetic hypericin",
      "url": "https://onco.cc/drugs/hypericin-sgx301/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41375-026-03130-x#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41375-026-03130-x",
   "title": "Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.",
   "content_text": "Published in Leukemia on 14 September 2026; matched the OnCo record for CD7.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Leukemia",
    "doi": "10.1038/s41375-026-03130-x",
    "records": [
     {
      "id": "cd7",
      "kind": "target",
      "name": "CD7",
      "url": "https://onco.cc/targets/cd7/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/hem3.70475#onco-edge-paper",
   "url": "https://doi.org/10.1002/hem3.70475",
   "title": "The machine-learning classifier ALLCatchR2 identifies 20 T-ALL subtypes across cohorts and age groups.",
   "content_text": "Published on 14 September 2026 after first appearing as a preprint; matched IDH1 / IDH2 and DNA methyltransferase 3A.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "doi": "10.1002/hem3.70475",
    "records": [
     {
      "id": "idh",
      "kind": "target",
      "name": "IDH1 / IDH2",
      "url": "https://onco.cc/targets/idh/"
     },
     {
      "id": "dnmt3a",
      "kind": "target",
      "name": "DNA methyltransferase 3A",
      "url": "https://onco.cc/targets/dnmt3a/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/20008066.2026.2721729#onco-edge-paper",
   "url": "https://doi.org/10.1080/20008066.2026.2721729",
   "title": "The Nova Protocol: a comprehensive multimodal longitudinal study among civilian survivors of a mass trauma event.",
   "content_text": "Published in Eur J Psychotraumatol on 14 September 2026; matched the OnCo record for Plasma cell leukaemia.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Eur J Psychotraumatol",
    "doi": "10.1080/20008066.2026.2721729",
    "records": [
     {
      "id": "plasma-cell-leukaemia",
      "kind": "cancer",
      "name": "Plasma cell leukaemia",
      "url": "https://onco.cc/cancers/plasma-cell-leukaemia/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1111/ddg.70608#onco-edge-paper",
   "url": "https://doi.org/10.1111/ddg.70608",
   "title": "Two Blastic Plasmacytoid Dendritic Cell Neoplasms treated with the CD123-targeted agent Tagraxofusp presenting divergent outcomes.",
   "content_text": "Published in J Dtsch Dermatol Ges on 14 September 2026; matched the OnCo record for CD123.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "J Dtsch Dermatol Ges",
    "doi": "10.1111/ddg.70608",
    "records": [
     {
      "id": "cd123",
      "kind": "target",
      "name": "CD123",
      "url": "https://onco.cc/targets/cd123/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.neo.2026.101359#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.neo.2026.101359",
   "title": "Understanding tumor adaptations and resistance to MET inhibitors in MET-altered non-small cell lung cancer.",
   "content_text": "Published in Neoplasia on 14 September 2026; matched the OnCo record for Capmatinib.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Neoplasia",
    "doi": "10.1016/j.neo.2026.101359",
    "records": [
     {
      "id": "capmatinib",
      "kind": "drug",
      "name": "Capmatinib",
      "url": "https://onco.cc/drugs/capmatinib/"
     },
     {
      "id": "tepotinib",
      "kind": "drug",
      "name": "Tepotinib",
      "url": "https://onco.cc/drugs/tepotinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/pgp.0000000000001214#onco-edge-paper",
   "url": "https://doi.org/10.1097/pgp.0000000000001214",
   "title": "Uterine Carcinosarcoma: Mutational Profiling of p53-Abnormal Tumors and Its Association with Histologic Subtypes and Survival in an Underserved Population.",
   "content_text": "Published in Int J Gynecol Pathol on 14 September 2026; matched the OnCo record for Uterine carcinosarcoma.",
   "date_published": "2026-09-14T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-14",
    "precision": "day",
    "venue": "Int J Gynecol Pathol",
    "doi": "10.1097/pgp.0000000000001214",
    "records": [
     {
      "id": "uterine-carcinosarcoma",
      "kind": "cancer",
      "name": "Uterine carcinosarcoma",
      "url": "https://onco.cc/cancers/uterine-carcinosarcoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/164_2026_852#onco-edge-paper",
   "url": "https://doi.org/10.1007/164_2026_852",
   "title": "Biological and Medicinal Aspects of Peptides and Sugar-Based Boron-Containing Compounds.",
   "content_text": "Published in Handb Exp Pharmacol on 13 September 2026; matched the OnCo record for Ixazomib.",
   "date_published": "2026-09-13T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-13",
    "precision": "day",
    "venue": "Handb Exp Pharmacol",
    "doi": "10.1007/164_2026_852",
    "records": [
     {
      "id": "ixazomib",
      "kind": "drug",
      "name": "Ixazomib",
      "url": "https://onco.cc/drugs/ixazomib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12308-026-00731-4#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12308-026-00731-4",
   "title": "Chromosome 17p deletion in aplastic anaemia with paroxysmal nocturnal haemoglobinuria clone: a diagnostic challenge.",
   "content_text": "Published in J Hematop on 13 September 2026; matched the OnCo record for Romiplostim.",
   "date_published": "2026-09-13T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-13",
    "precision": "day",
    "venue": "J Hematop",
    "doi": "10.1007/s12308-026-00731-4",
    "records": [
     {
      "id": "romiplostim",
      "kind": "drug",
      "name": "Romiplostim",
      "url": "https://onco.cc/drugs/romiplostim/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.7759/cureus.116164#onco-edge-paper",
   "url": "https://doi.org/10.7759/cureus.116164",
   "title": "Comparative Outcomes of Transoral Robotic Surgery Versus Open Surgery in Head and Neck Cancer: A Systematic Review and Meta-Analysis.",
   "content_text": "Published in Cureus on 13 September 2026; matched the OnCo record for Transoral robotic surgery.",
   "date_published": "2026-09-13T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-13",
    "precision": "day",
    "venue": "Cureus",
    "doi": "10.7759/cureus.116164",
    "records": [
     {
      "id": "tors",
      "kind": "technology",
      "name": "Transoral robotic surgery",
      "url": "https://onco.cc/technologies/tors/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00415-026-14096-2#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00415-026-14096-2",
   "title": "Longitudinal plasma neurofilament light chain and patient-reported outcomes as complementary markers of vincristine-associated peripheral neuropathy in adults with lymphoma: a cohort study.",
   "content_text": "Published on 13 September 2026 after first appearing as a preprint; matched Cytotoxic chemotherapy and Vincristine.",
   "date_published": "2026-09-13T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-13",
    "precision": "day",
    "doi": "10.1007/s00415-026-14096-2",
    "records": [
     {
      "id": "cytotoxic-chemotherapy",
      "kind": "technology",
      "name": "Cytotoxic chemotherapy",
      "url": "https://onco.cc/technologies/cytotoxic-chemotherapy/"
     },
     {
      "id": "vincristine",
      "kind": "drug",
      "name": "Vincristine",
      "url": "https://onco.cc/drugs/vincristine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41598-026-71512-3#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41598-026-71512-3",
   "title": "Patient-derived 3D organotypic co-cultures as a long-term ex vivo model for pleomorphic adenoma of the parotid gland.",
   "content_text": "Published in Sci Rep on 13 September 2026; matched the OnCo record for Somatostatin receptor 2.",
   "date_published": "2026-09-13T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-13",
    "precision": "day",
    "venue": "Sci Rep",
    "doi": "10.1038/s41598-026-71512-3",
    "records": [
     {
      "id": "sstr2",
      "kind": "target",
      "name": "Somatostatin receptor 2",
      "url": "https://onco.cc/targets/sstr2/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ctrv.2026.103213#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ctrv.2026.103213",
   "title": "Selective estrogen receptor degraders in premenopausal breast cancer: Biological activity and endpoint relevance in window of opportunity trials.",
   "content_text": "Published in Cancer Treat Rev on 13 September 2026; matched the OnCo record for Goserelin / leuprolide.",
   "date_published": "2026-09-13T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-13",
    "precision": "day",
    "venue": "Cancer Treat Rev",
    "doi": "10.1016/j.ctrv.2026.103213",
    "records": [
     {
      "id": "goserelin",
      "kind": "drug",
      "name": "Goserelin / leuprolide",
      "url": "https://onco.cc/drugs/goserelin/"
     },
     {
      "id": "oral-serds",
      "kind": "technology",
      "name": "Oral SERDs",
      "url": "https://onco.cc/technologies/oral-serds/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.lana.2026.101632#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.lana.2026.101632",
   "title": "Assessing methodological differences in estimating exposure to intimate-partner violence against women in Brazil: a multi-source observational analysis.",
   "content_text": "Published in Lancet Reg Health Am on 12 September 2026; matched the OnCo record for Logic-gated therapeutics.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Lancet Reg Health Am",
    "doi": "10.1016/j.lana.2026.101632",
    "records": [
     {
      "id": "logic-gated-therapeutics",
      "kind": "technology",
      "name": "Logic-gated therapeutics",
      "url": "https://onco.cc/technologies/logic-gated-therapeutics/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/pro6.70095#onco-edge-paper",
   "url": "https://doi.org/10.1002/pro6.70095",
   "title": "C-X-C Motif Chemokine Receptor 4 (CXCR4)-Targeted Biologically Guided Proton Spatially Fractionated Radiotherapy for Bulky Limited-Stage Small Cell Lung Cancer.",
   "content_text": "Published in Precis Radiat Oncol on 12 September 2026; matched the OnCo record for Limited-stage small-cell lung cancer.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Precis Radiat Oncol",
    "doi": "10.1002/pro6.70095",
    "records": [
     {
      "id": "limited-stage-sclc",
      "kind": "cancer",
      "name": "Limited-stage small-cell lung cancer",
      "url": "https://onco.cc/cancers/limited-stage-sclc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/07853890.2026.2726636#onco-edge-paper",
   "url": "https://doi.org/10.1080/07853890.2026.2726636",
   "title": "Development and internal validation of a prediction model for early anastomotic leak after minimally invasive esophagectomy: a prospective cohort study.",
   "content_text": "Published in Ann Med on 12 September 2026; matched the OnCo record for Cytarabine + anthracycline.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Ann Med",
    "doi": "10.1080/07853890.2026.2726636",
    "records": [
     {
      "id": "cytarabine-7-3",
      "kind": "drug",
      "name": "Cytarabine + anthracycline",
      "url": "https://onco.cc/drugs/cytarabine-7-3/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/19420862.2026.2731282#onco-edge-paper",
   "url": "https://doi.org/10.1080/19420862.2026.2731282",
   "title": "Discovery and engineering of bispecific TCR-mimic antibodies targeting peptide-HLA complex.",
   "content_text": "Published in MAbs on 12 September 2026; matched the OnCo record for Bispecific antibodies.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "MAbs",
    "doi": "10.1080/19420862.2026.2731282",
    "records": [
     {
      "id": "bispecific-antibody",
      "kind": "technology",
      "name": "Bispecific antibodies",
      "url": "https://onco.cc/technologies/bispecific-antibody/"
     },
     {
      "id": "mcla-129",
      "kind": "drug",
      "name": "MCLA-129",
      "url": "https://onco.cc/drugs/mcla-129/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12022-026-09935-x#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12022-026-09935-x",
   "title": "Divergent c-MYC Expression Patterns in NET and NEC: Insights from a Multicentre Cohort of 1380 Neuroendocrine Neoplasms.",
   "content_text": "Published in Endocr Pathol on 12 September 2026; matched the OnCo record for Grade 3 well-differentiated neuroendocrine tumour.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Endocr Pathol",
    "doi": "10.1007/s12022-026-09935-x",
    "records": [
     {
      "id": "grade-3-net",
      "kind": "cancer",
      "name": "Grade 3 well-differentiated neuroendocrine tumour",
      "url": "https://onco.cc/cancers/grade-3-net/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1136/jitc-2026-015228#onco-edge-paper",
   "url": "https://doi.org/10.1136/jitc-2026-015228",
   "title": "Epigenetic plus cytokine therapy induces stem-like CD8<sup>+</sup> T-cell reservoirs and intratumoral immune niches to overcome anti-PD-1 resistance.",
   "content_text": "Published in J Immunother Cancer on 12 September 2026; matched the OnCo record for Cytokines & engineered cytokines.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "J Immunother Cancer",
    "doi": "10.1136/jitc-2026-015228",
    "records": [
     {
      "id": "cytokine-therapy",
      "kind": "technology",
      "name": "Cytokines & engineered cytokines",
      "url": "https://onco.cc/technologies/cytokine-therapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.afjem.2026.101011#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.afjem.2026.101011",
   "title": "Factors affecting time-to-disposition at a district hospital emergency centre in Cape Town, South Africa.",
   "content_text": "Published in Afr J Emerg Med on 12 September 2026; matched the OnCo record for Neuroblastoma.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Afr J Emerg Med",
    "doi": "10.1016/j.afjem.2026.101011",
    "records": [
     {
      "id": "neuroblastoma",
      "kind": "cancer",
      "name": "Neuroblastoma",
      "url": "https://onco.cc/cancers/neuroblastoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11033-026-12715-9#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11033-026-12715-9",
   "title": "Hepatic stellate cells promote structural and functional remodeling of three-dimensional hepatocellular carcinoma coculture spheroids.",
   "content_text": "Published on 12 September 2026 after first appearing as a preprint; matched Sorafenib and Iobenguane I-131.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "doi": "10.1007/s11033-026-12715-9",
    "records": [
     {
      "id": "sorafenib",
      "kind": "drug",
      "name": "Sorafenib",
      "url": "https://onco.cc/drugs/sorafenib/"
     },
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.4103/mgr.medgasres-d-25-00365#onco-edge-paper",
   "url": "https://doi.org/10.4103/mgr.medgasres-d-25-00365",
   "title": "High levels of nitric oxide and peroxynitrite with protein nitration: a new therapeutic target for gliomas.",
   "content_text": "Published in Med Gas Res on 12 September 2026; matched the OnCo record for Immune checkpoint inhibitors.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Med Gas Res",
    "doi": "10.4103/mgr.medgasres-d-25-00365",
    "records": [
     {
      "id": "checkpoint-inhibitor",
      "kind": "technology",
      "name": "Immune checkpoint inhibitors",
      "url": "https://onco.cc/technologies/checkpoint-inhibitor/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.clindermatol.2026.09.009#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.clindermatol.2026.09.009",
   "title": "Immune Checkpoint Inhibition in Locally Advanced, Recurrent, and Metastatic Cutaneous Squamous Cell Carcinoma.",
   "content_text": "Published in Clin Dermatol on 12 September 2026; matched the OnCo record for Cemiplimab.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Clin Dermatol",
    "doi": "10.1016/j.clindermatol.2026.09.009",
    "records": [
     {
      "id": "cemiplimab",
      "kind": "drug",
      "name": "Cemiplimab",
      "url": "https://onco.cc/drugs/cemiplimab/"
     },
     {
      "id": "cosibelimab",
      "kind": "drug",
      "name": "Cosibelimab",
      "url": "https://onco.cc/drugs/cosibelimab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1186/s12866-026-05648-7#onco-edge-paper",
   "url": "https://doi.org/10.1186/s12866-026-05648-7",
   "title": "Inferred functional microbiome features are associated with clinical trajectories of low-grade cervical lesions.",
   "content_text": "Published on 12 September 2026 after first appearing as a preprint; matched State.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "doi": "10.1186/s12866-026-05648-7",
    "records": [
     {
      "id": "state-arc",
      "kind": "technology",
      "name": "State",
      "url": "https://onco.cc/technologies/state-arc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.adro.2026.102154#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.adro.2026.102154",
   "title": "International Western Radiation Therapy Guidelines Applicability in Low- and Middle-Income Countries for Cervical Cancer Management: A Comparative Survey Example from South and North Border of the Mediterranean Area Countries.",
   "content_text": "Published in Adv Radiat Oncol on 12 September 2026; matched the OnCo record for Brachytherapy.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Adv Radiat Oncol",
    "doi": "10.1016/j.adro.2026.102154",
    "records": [
     {
      "id": "brachytherapy",
      "kind": "technology",
      "name": "Brachytherapy",
      "url": "https://onco.cc/technologies/brachytherapy/"
     },
     {
      "id": "cervical",
      "kind": "cancer",
      "name": "Cervical cancer",
      "url": "https://onco.cc/cancers/cervical/"
     },
     {
      "id": "ct",
      "kind": "technology",
      "name": "CT",
      "url": "https://onco.cc/technologies/ct/"
     },
     {
      "id": "mri",
      "kind": "technology",
      "name": "MRI",
      "url": "https://onco.cc/technologies/mri/"
     },
     {
      "id": "pet",
      "kind": "technology",
      "name": "PET",
      "url": "https://onco.cc/technologies/pet/"
     },
     {
      "id": "vmat",
      "kind": "technology",
      "name": "Volumetric modulated arc therapy",
      "url": "https://onco.cc/technologies/vmat/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11523-026-01242-z#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11523-026-01242-z",
   "title": "Management of Adverse Events Associated with MET TKIs in Patients with Advanced NSCLC: A Podcast Discussion.",
   "content_text": "Published in Target Oncol on 12 September 2026; matched the OnCo record for Capmatinib.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Target Oncol",
    "doi": "10.1007/s11523-026-01242-z",
    "records": [
     {
      "id": "capmatinib",
      "kind": "drug",
      "name": "Capmatinib",
      "url": "https://onco.cc/drugs/capmatinib/"
     },
     {
      "id": "tepotinib",
      "kind": "drug",
      "name": "Tepotinib",
      "url": "https://onco.cc/drugs/tepotinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jep.2026.122369#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jep.2026.122369",
   "title": "Mechanism of Qilu Buxue granules in alleviating chemotherapy-induced leukopenia: Insights from network pharmacology, integrated omics, and experimental validation.",
   "content_text": "Published in J Ethnopharmacol on 12 September 2026; matched the OnCo record for PI3K delta.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "J Ethnopharmacol",
    "doi": "10.1016/j.jep.2026.122369",
    "records": [
     {
      "id": "pik3cd",
      "kind": "target",
      "name": "PI3K delta",
      "url": "https://onco.cc/targets/pik3cd/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ejro.2026.100818#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ejro.2026.100818",
   "title": "MRI-based radiomics analysis and machine learning in the differentiation of endometriomas from hemorrhagic ovarian cysts.",
   "content_text": "Published in Eur J Radiol Open on 12 September 2026; matched the OnCo record for Radiomics.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Eur J Radiol Open",
    "doi": "10.1016/j.ejro.2026.100818",
    "records": [
     {
      "id": "radiomics",
      "kind": "technology",
      "name": "Radiomics",
      "url": "https://onco.cc/technologies/radiomics/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1111/1754-9485.70185#onco-edge-paper",
   "url": "https://doi.org/10.1111/1754-9485.70185",
   "title": "MRI-Guided SBRT Boost for Patients With Locally Advanced Cervical Cancer Who Are Unsuitable for Standard of Care Image-Guided Brachytherapy.",
   "content_text": "Published in J Med Imaging Radiat Oncol on 12 September 2026; matched the OnCo record for Locally advanced cervical cancer.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "J Med Imaging Radiat Oncol",
    "doi": "10.1111/1754-9485.70185",
    "records": [
     {
      "id": "locally-advanced-cervical-cancer",
      "kind": "cancer",
      "name": "Locally advanced cervical cancer",
      "url": "https://onco.cc/cancers/locally-advanced-cervical-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.radcr.2026.08.067#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.radcr.2026.08.067",
   "title": "Multimodality imaging localization of a giant functional parathyroid adenoma in a young fitness trainer with delayed recognition of hypercalcemia: A case report.",
   "content_text": "Published in Radiol Case Rep on 12 September 2026; matched the OnCo record for FDG PET.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Radiol Case Rep",
    "doi": "10.1016/j.radcr.2026.08.067",
    "records": [
     {
      "id": "fdg-pet",
      "kind": "technology",
      "name": "FDG PET",
      "url": "https://onco.cc/technologies/fdg-pet/"
     },
     {
      "id": "fludeoxyglucose-f18",
      "kind": "drug",
      "name": "Fludeoxyglucose F-18",
      "url": "https://onco.cc/drugs/fludeoxyglucose-f18/"
     },
     {
      "id": "pet-ct",
      "kind": "technology",
      "name": "PET/CT",
      "url": "https://onco.cc/technologies/pet-ct/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00520-026-11204-w#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00520-026-11204-w",
   "title": "Navigating rural challenges and promoting posttraumatic growth via expressive writing: a qualitative study among rural breast cancer survivors.",
   "content_text": "Published on 12 September 2026 after first appearing as a preprint; matched Iobenguane I-131.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "doi": "10.1007/s00520-026-11204-w",
    "records": [
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1021/acssensors.6c02987#onco-edge-paper",
   "url": "https://doi.org/10.1021/acssensors.6c02987",
   "title": "Nucleic Acid Turnover and Lipid Remodeling Distinguish T Cell Activation and Exhaustion States via Label-Free Raman Spectroscopy.",
   "content_text": "Published on 12 September 2026 after first appearing as a preprint; matched State.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "doi": "10.1021/acssensors.6c02987",
    "records": [
     {
      "id": "state-arc",
      "kind": "technology",
      "name": "State",
      "url": "https://onco.cc/technologies/state-arc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/19420862.2026.2731283#onco-edge-paper",
   "url": "https://doi.org/10.1080/19420862.2026.2731283",
   "title": "Preclinical development of ABL206, a novel bispecific antibody-drug conjugate targeting B7-H3 and ROR1.",
   "content_text": "Published in MAbs on 12 September 2026; matched the OnCo record for Antibody-drug conjugate.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "MAbs",
    "doi": "10.1080/19420862.2026.2731283",
    "records": [
     {
      "id": "adc",
      "kind": "technology",
      "name": "Antibody-drug conjugate",
      "url": "https://onco.cc/technologies/adc/"
     },
     {
      "id": "bispecific-adc",
      "kind": "technology",
      "name": "Bispecific ADC",
      "url": "https://onco.cc/technologies/bispecific-adc/"
     },
     {
      "id": "bispecific-antibody",
      "kind": "technology",
      "name": "Bispecific antibodies",
      "url": "https://onco.cc/technologies/bispecific-antibody/"
     },
     {
      "id": "ifinatamab-deruxtecan",
      "kind": "drug",
      "name": "Ifinatamab deruxtecan",
      "url": "https://onco.cc/drugs/ifinatamab-deruxtecan/"
     },
     {
      "id": "mcla-129",
      "kind": "drug",
      "name": "MCLA-129",
      "url": "https://onco.cc/drugs/mcla-129/"
     },
     {
      "id": "pdx-models",
      "kind": "technology",
      "name": "Patient-derived xenografts",
      "url": "https://onco.cc/technologies/pdx-models/"
     },
     {
      "id": "topoisomerase-inhibitors",
      "kind": "technology",
      "name": "Topoisomerase-I inhibitors",
      "url": "https://onco.cc/technologies/topoisomerase-inhibitors/"
     },
     {
      "id": "zilovertamab-vedotin",
      "kind": "drug",
      "name": "Zilovertamab vedotin",
      "url": "https://onco.cc/drugs/zilovertamab-vedotin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ejmp.2026.107179#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ejmp.2026.107179",
   "title": "Pulse-resolved spatial dosimetry of ultra-high dose rate electron FLASH beams using optical imaging.",
   "content_text": "Published in Phys Med on 12 September 2026; matched the OnCo record for FLASH radiotherapy.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Phys Med",
    "doi": "10.1016/j.ejmp.2026.107179",
    "records": [
     {
      "id": "flash-rt",
      "kind": "technology",
      "name": "FLASH radiotherapy",
      "url": "https://onco.cc/technologies/flash-rt/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/20450923.2026.2731867#onco-edge-paper",
   "url": "https://doi.org/10.1080/20450923.2026.2731867",
   "title": "Racial and ethnic survival disparities in primary liver cancer in the United States: a National Cancer Database propensity score-matched study.",
   "content_text": "Published in Hepat Oncol on 12 September 2026; matched the OnCo record for Cytotoxic chemotherapy.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Hepat Oncol",
    "doi": "10.1080/20450923.2026.2731867",
    "records": [
     {
      "id": "cytotoxic-chemotherapy",
      "kind": "technology",
      "name": "Cytotoxic chemotherapy",
      "url": "https://onco.cc/technologies/cytotoxic-chemotherapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11701-026-03942-0#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11701-026-03942-0",
   "title": "Robotic versus laparoscopic gastrectomy with splenic hilar lymph node dissection: short-term outcomes from a propensity score-matched study.",
   "content_text": "Published on 12 September 2026 after first appearing as a preprint; matched Robotic & minimally invasive surgery and Cytotoxic chemotherapy.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "doi": "10.1007/s11701-026-03942-0",
    "records": [
     {
      "id": "robotic-surgery",
      "kind": "technology",
      "name": "Robotic & minimally invasive surgery",
      "url": "https://onco.cc/technologies/robotic-surgery/"
     },
     {
      "id": "cytotoxic-chemotherapy",
      "kind": "technology",
      "name": "Cytotoxic chemotherapy",
      "url": "https://onco.cc/technologies/cytotoxic-chemotherapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.isci.2026.117510#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.isci.2026.117510",
   "title": "Single-cell transcriptomic atlas of the human fetal uveal tract reveals heterogeneity in melanocyte populations.",
   "content_text": "Published in iScience on 12 September 2026; matched the OnCo record for Multiplex immunofluorescence.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "iScience",
    "doi": "10.1016/j.isci.2026.117510",
    "records": [
     {
      "id": "multiplex-immunofluorescence",
      "kind": "technology",
      "name": "Multiplex immunofluorescence",
      "url": "https://onco.cc/technologies/multiplex-immunofluorescence/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s44321-026-00520-7#onco-edge-paper",
   "url": "https://doi.org/10.1038/s44321-026-00520-7",
   "title": "Targeted AAV gene therapy for neuroblastoma via direct capsid-antibody coupling.",
   "content_text": "Published in EMBO Mol Med on 12 September 2026; matched the OnCo record for GD2.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "EMBO Mol Med",
    "doi": "10.1038/s44321-026-00520-7",
    "records": [
     {
      "id": "gd2",
      "kind": "target",
      "name": "GD2",
      "url": "https://onco.cc/targets/gd2/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1507/endocrj.ej26-0396#onco-edge-paper",
   "url": "https://doi.org/10.1507/endocrj.ej26-0396",
   "title": "Tirzepatide for pasireotide-induced hyperglycemia in a GH/TSH-producing pituitary adenoma/PitNET: a case report and literature review.",
   "content_text": "Published in Endocr J on 12 September 2026; matched the OnCo record for Pasireotide.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Endocr J",
    "doi": "10.1507/endocrj.ej26-0396",
    "records": [
     {
      "id": "pasireotide",
      "kind": "drug",
      "name": "Pasireotide",
      "url": "https://onco.cc/drugs/pasireotide/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.exer.2026.111217#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.exer.2026.111217",
   "title": "Using patient iPSC-derived retinal pigment epithelium to evaluate differential susceptibility to MEK inhibitor-associated retinopathy.",
   "content_text": "Published in Exp Eye Res on 12 September 2026; matched the OnCo record for Selumetinib.",
   "date_published": "2026-09-12T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-12",
    "precision": "day",
    "venue": "Exp Eye Res",
    "doi": "10.1016/j.exer.2026.111217",
    "records": [
     {
      "id": "selumetinib",
      "kind": "drug",
      "name": "Selumetinib",
      "url": "https://onco.cc/drugs/selumetinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/02656736.2026.2723463#onco-edge-paper",
   "url": "https://doi.org/10.1080/02656736.2026.2723463",
   "title": "'Methodological considerations regarding propensity score matching and interpretation of oncologic outcomes in ultrasound-guided versus CT-guided microwave ablation for liver metastases'.",
   "content_text": "Published in Int J Hyperthermia on 11 September 2026; matched the OnCo record for Thermal ablation.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Int J Hyperthermia",
    "doi": "10.1080/02656736.2026.2723463",
    "records": [
     {
      "id": "thermal-ablation",
      "kind": "technology",
      "name": "Thermal ablation",
      "url": "https://onco.cc/technologies/thermal-ablation/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bioactmat.2026.07.001#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bioactmat.2026.07.001",
   "title": "3D-printed PCL scaffold coated with chitosan-hyaluronic acid hydrogel loaded with NGF-overexpressing UiPSC-derived neural crest cells restores erectile function via cavernous nerve regeneration.",
   "content_text": "Published in Bioact Mater on 11 September 2026; matched the OnCo record for Plasma cell leukaemia.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Bioact Mater",
    "doi": "10.1016/j.bioactmat.2026.07.001",
    "records": [
     {
      "id": "plasma-cell-leukaemia",
      "kind": "cancer",
      "name": "Plasma cell leukaemia",
      "url": "https://onco.cc/cancers/plasma-cell-leukaemia/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jbc.2026.113548#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jbc.2026.113548",
   "title": "5-Iodotubercidin inhibits Epithelial to Mesenchymal Transition by inhibiting IKK/NFκB-dependent gene expression.",
   "content_text": "Published on 11 September 2026 after first appearing as a preprint; matched Small-molecule kinase inhibitors.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "doi": "10.1016/j.jbc.2026.113548",
    "records": [
     {
      "id": "kinase-inhibitors",
      "kind": "technology",
      "name": "Small-molecule kinase inhibitors",
      "url": "https://onco.cc/technologies/kinase-inhibitors/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ejca.2026.117044#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ejca.2026.117044",
   "title": "70-gene signature MammaPrint for early-stage HR-positive, HER2-negative breast cancer: Outcome in the MINDACT trial for key clinical-pathological high-risk subgroups.",
   "content_text": "Published in Eur J Cancer on 11 September 2026; matched the OnCo record for MammaPrint.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Eur J Cancer",
    "doi": "10.1016/j.ejca.2026.117044",
    "records": [
     {
      "id": "mammaprint",
      "kind": "drug",
      "name": "MammaPrint",
      "url": "https://onco.cc/drugs/mammaprint/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/15592294.2026.2714582#onco-edge-paper",
   "url": "https://doi.org/10.1080/15592294.2026.2714582",
   "title": "A breast tissue-specific epigenetic clock provides accurate chronological age predictions and reveals de-correlation of age and DNA methylation in tumor-adjacent and tumor samples.",
   "content_text": "Published in Epigenetics on 11 September 2026; matched the OnCo record for HER2.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Epigenetics",
    "doi": "10.1080/15592294.2026.2714582",
    "records": [
     {
      "id": "her2",
      "kind": "target",
      "name": "HER2",
      "url": "https://onco.cc/targets/her2/"
     },
     {
      "id": "pdgfra",
      "kind": "target",
      "name": "PDGFRA",
      "url": "https://onco.cc/targets/pdgfra/"
     },
     {
      "id": "tnbc",
      "kind": "cancer",
      "name": "Triple-negative breast cancer",
      "url": "https://onco.cc/cancers/tnbc/"
     },
     {
      "id": "methylation-profiling",
      "kind": "technology",
      "name": "DNA methylation profiling",
      "url": "https://onco.cc/technologies/methylation-profiling/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1227/ons.0000000000002200#onco-edge-paper",
   "url": "https://doi.org/10.1227/ons.0000000000002200",
   "title": "A Novel Intraoperative Peripheral Nerve Surgery Navigation Technique Using Radar Reflector Localization: Case Series.",
   "content_text": "Published in Oper Neurosurg on 11 September 2026; matched the OnCo record for RaDaR.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Oper Neurosurg",
    "doi": "10.1227/ons.0000000000002200",
    "records": [
     {
      "id": "radar-mrd",
      "kind": "drug",
      "name": "RaDaR",
      "url": "https://onco.cc/drugs/radar-mrd/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bcp.2026.118465#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bcp.2026.118465",
   "title": "A novel pipeline for the validation of manganese chelators for the treatment of manganese overload.",
   "content_text": "Published on 11 September 2026 after first appearing as a preprint; matched Azacitidine and Decitabine + cedazuridine.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "doi": "10.1016/j.bcp.2026.118465",
    "records": [
     {
      "id": "azacitidine",
      "kind": "drug",
      "name": "Azacitidine",
      "url": "https://onco.cc/drugs/azacitidine/"
     },
     {
      "id": "decitabine-cedazuridine",
      "kind": "drug",
      "name": "Decitabine + cedazuridine",
      "url": "https://onco.cc/drugs/decitabine-cedazuridine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s13555-026-01919-3#onco-edge-paper",
   "url": "https://doi.org/10.1007/s13555-026-01919-3",
   "title": "A Review of Modern Therapies and New Innovations in the Treatment of Cutaneous Graft-versus-Host Disease.",
   "content_text": "Published in Dermatol Ther (Heidelb) on 11 September 2026; matched the OnCo record for Belumosudil.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Dermatol Ther (Heidelb)",
    "doi": "10.1007/s13555-026-01919-3",
    "records": [
     {
      "id": "belumosudil",
      "kind": "drug",
      "name": "Belumosudil",
      "url": "https://onco.cc/drugs/belumosudil/"
     },
     {
      "id": "methoxsalen-ecp",
      "kind": "drug",
      "name": "Methoxsalen",
      "url": "https://onco.cc/drugs/methoxsalen-ecp/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bbcan.2026.189709#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bbcan.2026.189709",
   "title": "Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment.",
   "content_text": "Published in Biochim Biophys Acta Rev Cancer on 11 September 2026; matched the OnCo record for Necitumumab.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Biochim Biophys Acta Rev Cancer",
    "doi": "10.1016/j.bbcan.2026.189709",
    "records": [
     {
      "id": "necitumumab",
      "kind": "drug",
      "name": "Necitumumab",
      "url": "https://onco.cc/drugs/necitumumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12072-026-11146-9#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12072-026-11146-9",
   "title": "Antiviral therapies are associated with reduced mortality but under-utilized in patients with viral hepatocellular carcinoma: a multinational REAL-HCC study.",
   "content_text": "Published in Hepatol Int on 11 September 2026; matched the OnCo record for Early hepatocellular carcinoma.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Hepatol Int",
    "doi": "10.1007/s12072-026-11146-9",
    "records": [
     {
      "id": "hcc-early",
      "kind": "cancer",
      "name": "Early hepatocellular carcinoma",
      "url": "https://onco.cc/cancers/hcc-early/"
     },
     {
      "id": "hcc-intermediate",
      "kind": "cancer",
      "name": "Intermediate hepatocellular carcinoma",
      "url": "https://onco.cc/cancers/hcc-intermediate/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.euf.2026.07.003#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.euf.2026.07.003",
   "title": "Association Between Castration-resistant Prostate Cancer Progression Patterns and Survival Outcomes in Metastatic Castration-sensitive Prostate Cancer: A Post Hoc Analysis of the TITAN Trial.",
   "content_text": "Published in Eur Urol Focus on 11 September 2026; matched the OnCo record for Apalutamide.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Eur Urol Focus",
    "doi": "10.1016/j.euf.2026.07.003",
    "records": [
     {
      "id": "apalutamide",
      "kind": "drug",
      "name": "Apalutamide",
      "url": "https://onco.cc/drugs/apalutamide/"
     },
     {
      "id": "titan",
      "kind": "technology",
      "name": "TITAN",
      "url": "https://onco.cc/technologies/titan/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1182/bloodadvances.2026020405#onco-edge-paper",
   "url": "https://doi.org/10.1182/bloodadvances.2026020405",
   "title": "Association between patient-reported symptoms and clinical outcomes in R/R CLL.",
   "content_text": "Published in Blood Adv on 11 September 2026; matched the OnCo record for Zanubrutinib.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Blood Adv",
    "doi": "10.1182/bloodadvances.2026020405",
    "records": [
     {
      "id": "zanubrutinib",
      "kind": "drug",
      "name": "Zanubrutinib",
      "url": "https://onco.cc/drugs/zanubrutinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41588-026-02738-0#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41588-026-02738-0",
   "title": "Cancer treatment alters mutant selection in normal esophagus.",
   "content_text": "Published in Nat Genet on 11 September 2026; matched the OnCo record for FLOT.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Nat Genet",
    "doi": "10.1038/s41588-026-02738-0",
    "records": [
     {
      "id": "flot",
      "kind": "drug",
      "name": "FLOT",
      "url": "https://onco.cc/drugs/flot/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3802/jgo.2027.38.e30#onco-edge-paper",
   "url": "https://doi.org/10.3802/jgo.2027.38.e30",
   "title": "Changes and clinical impact of HER3 and <i>ERBB3</i> expression in primary and recurrent ovarian cancer.",
   "content_text": "Published in J Gynecol Oncol on 11 September 2026; matched the OnCo record for HER3.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "J Gynecol Oncol",
    "doi": "10.3802/jgo.2027.38.e30",
    "records": [
     {
      "id": "her3",
      "kind": "target",
      "name": "HER3",
      "url": "https://onco.cc/targets/her3/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.2174/0115734056486226260826150258#onco-edge-paper",
   "url": "https://doi.org/10.2174/0115734056486226260826150258",
   "title": "Clinical Insights and Therapeutic Strategies for Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Case Report with Literature Review.",
   "content_text": "Published in Curr Med Imaging on 11 September 2026; matched the OnCo record for Tislelizumab.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Curr Med Imaging",
    "doi": "10.2174/0115734056486226260826150258",
    "records": [
     {
      "id": "tislelizumab",
      "kind": "drug",
      "name": "Tislelizumab",
      "url": "https://onco.cc/drugs/tislelizumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.biopha.2026.119925#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.biopha.2026.119925",
   "title": "Comparative analysis of platinum nanoparticles interactions with Mitomycin C and its activated metabolite.",
   "content_text": "Published in Biomed Pharmacother on 11 September 2026; matched the OnCo record for Mitomycin C.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Biomed Pharmacother",
    "doi": "10.1016/j.biopha.2026.119925",
    "records": [
     {
      "id": "mitomycin",
      "kind": "drug",
      "name": "Mitomycin C",
      "url": "https://onco.cc/drugs/mitomycin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.pscia.2026.100150#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.pscia.2026.100150",
   "title": "Corrigendum to \"Computational screening of <i>Sophora flavescens</i> phytochemicals as potential aromatase inhibitors: Molecular docking, ADMET, Network pharmacology, Molecular dynamics simulation, and DFT studies\" [Pharmaceutic. Sci. Adv. 4 (2026) 100108].",
   "content_text": "Published in Pharm Sci Adv on 11 September 2026; matched the OnCo record for Aromatase.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Pharm Sci Adv",
    "doi": "10.1016/j.pscia.2026.100150",
    "records": [
     {
      "id": "aromatase",
      "kind": "target",
      "name": "Aromatase",
      "url": "https://onco.cc/targets/aromatase/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jval.2026.08.004#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jval.2026.08.004",
   "title": "Cost-Effectiveness of Cilta-cel in Lenalidomide-Refractory Multiple Myeloma: An Analysis of the CARTITUDE-4 Trial.",
   "content_text": "Published in Value Health on 11 September 2026; matched the OnCo record for Ciltacabtagene autoleucel.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Value Health",
    "doi": "10.1016/j.jval.2026.08.004",
    "records": [
     {
      "id": "ciltacabtagene-autoleucel",
      "kind": "drug",
      "name": "Ciltacabtagene autoleucel",
      "url": "https://onco.cc/drugs/ciltacabtagene-autoleucel/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jhin.2026.09.002#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jhin.2026.09.002",
   "title": "Creating reference data for early hospital outbreak detection algorithms from experts' ratings.",
   "content_text": "Published in J Hosp Infect on 11 September 2026; matched the OnCo record for Altretamine.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "J Hosp Infect",
    "doi": "10.1016/j.jhin.2026.09.002",
    "records": [
     {
      "id": "altretamine",
      "kind": "drug",
      "name": "Altretamine",
      "url": "https://onco.cc/drugs/altretamine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.esmoop.2026.108538#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.esmoop.2026.108538",
   "title": "Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer: results from the TROPION-Breast01 China cohort.",
   "content_text": "Published in ESMO Open on 11 September 2026; matched the OnCo record for Eribulin.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "ESMO Open",
    "doi": "10.1016/j.esmoop.2026.108538",
    "records": [
     {
      "id": "eribulin",
      "kind": "drug",
      "name": "Eribulin",
      "url": "https://onco.cc/drugs/eribulin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1039/d6ra07332h#onco-edge-paper",
   "url": "https://doi.org/10.1039/d6ra07332h",
   "title": "Design, synthesis, molecular docking and anticancer activity of novel <i>N</i>-(4-(chlorodifluoromethoxy)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-5-carboxamide derivatives.",
   "content_text": "Published in RSC Adv on 11 September 2026; matched the OnCo record for Asciminib.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "RSC Adv",
    "doi": "10.1039/d6ra07332h",
    "records": [
     {
      "id": "asciminib",
      "kind": "drug",
      "name": "Asciminib",
      "url": "https://onco.cc/drugs/asciminib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.humpath.2026.106260#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.humpath.2026.106260",
   "title": "Detection of androgen receptor (AR) splice variants across diverse prostatic and non-prostatic tumor types using the TruSight Oncology 500 (TSO500) assay.",
   "content_text": "Published in Hum Pathol on 11 September 2026; matched the OnCo record for Adult granulosa cell tumour of the ovary.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Hum Pathol",
    "doi": "10.1016/j.humpath.2026.106260",
    "records": [
     {
      "id": "granulosa-cell-tumour",
      "kind": "cancer",
      "name": "Adult granulosa cell tumour of the ovary",
      "url": "https://onco.cc/cancers/granulosa-cell-tumour/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.radcr.2026.08.041#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.radcr.2026.08.041",
   "title": "Diffuse midline glioma, H3 K27-altered, forming a suprasellar mass: A case report.",
   "content_text": "Published in Radiol Case Rep on 11 September 2026; matched the OnCo record for Diffuse midline glioma, H3 K27-altered.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Radiol Case Rep",
    "doi": "10.1016/j.radcr.2026.08.041",
    "records": [
     {
      "id": "dipg-dmg",
      "kind": "cancer",
      "name": "Diffuse midline glioma, H3 K27-altered",
      "url": "https://onco.cc/cancers/dipg-dmg/"
     },
     {
      "id": "mri",
      "kind": "technology",
      "name": "MRI",
      "url": "https://onco.cc/technologies/mri/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1088/1361-6560/aea1bb#onco-edge-paper",
   "url": "https://doi.org/10.1088/1361-6560/aea1bb",
   "title": "Dynamic proton arc therapy sequencing optimization algorithm for brain stereotactic radiosurgery.",
   "content_text": "Published in Phys Med Biol on 11 September 2026; matched the OnCo record for Proton arc therapy.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Phys Med Biol",
    "doi": "10.1088/1361-6560/aea1bb",
    "records": [
     {
      "id": "proton-arc-therapy",
      "kind": "technology",
      "name": "Proton arc therapy",
      "url": "https://onco.cc/technologies/proton-arc-therapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/pan.70312#onco-edge-paper",
   "url": "https://doi.org/10.1002/pan.70312",
   "title": "Effect of Thermal Softening of Endotracheal Tubes on Perioperative Respiratory Adverse Events in Children Undergoing Adenotonsillectomy: A Randomized Controlled Trial.",
   "content_text": "Published in Paediatr Anaesth on 11 September 2026; matched the OnCo record for Placental-site trophoblastic tumour and epithelioid trophoblastic tumour.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Paediatr Anaesth",
    "doi": "10.1002/pan.70312",
    "records": [
     {
      "id": "placental-site-trophoblastic-tumour",
      "kind": "cancer",
      "name": "Placental-site trophoblastic tumour and epithelioid trophoblastic tumour",
      "url": "https://onco.cc/cancers/placental-site-trophoblastic-tumour/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1128/aac.01765-25#onco-edge-paper",
   "url": "https://doi.org/10.1128/aac.01765-25",
   "title": "Effectiveness and safety of cefazolin vs antistaphylococcal penicillins for methicillin-susceptible <i>Staphylococcus aureus</i> bacteremia: a multicenter real-world evaluation using the international TriNetX database.",
   "content_text": "Published in Antimicrob Agents Chemother on 11 September 2026; matched the OnCo record for Alveolar soft part sarcoma.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Antimicrob Agents Chemother",
    "doi": "10.1128/aac.01765-25",
    "records": [
     {
      "id": "alveolar-soft-part-sarcoma",
      "kind": "cancer",
      "name": "Alveolar soft part sarcoma",
      "url": "https://onco.cc/cancers/alveolar-soft-part-sarcoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.adro.2026.102159#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.adro.2026.102159",
   "title": "Endobronchial High-Dose-Rate Brachytherapy for Posttransplant-Associated Bronchial Stenosis: Extended Follow-up of Pulmonary Function and Subsequent Procedures.",
   "content_text": "Published in Adv Radiat Oncol on 11 September 2026; matched the OnCo record for High-dose-rate brachytherapy.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Adv Radiat Oncol",
    "doi": "10.1016/j.adro.2026.102159",
    "records": [
     {
      "id": "hdr-brachytherapy",
      "kind": "technology",
      "name": "High-dose-rate brachytherapy",
      "url": "https://onco.cc/technologies/hdr-brachytherapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1200/po-26-00114#onco-edge-paper",
   "url": "https://doi.org/10.1200/po-26-00114",
   "title": "Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without Atezolizumab.",
   "content_text": "Published in JCO Precis Oncol on 11 September 2026; matched the OnCo record for Early triple-negative breast cancer.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "JCO Precis Oncol",
    "doi": "10.1200/po-26-00114",
    "records": [
     {
      "id": "tnbc-early",
      "kind": "cancer",
      "name": "Early triple-negative breast cancer",
      "url": "https://onco.cc/cancers/tnbc-early/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.radcr.2026.08.028#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.radcr.2026.08.028",
   "title": "Giant retroperitoneal dedifferentiated liposarcoma with intraperitoneal extension: A case report.",
   "content_text": "Published in Radiol Case Rep on 11 September 2026; matched the OnCo record for Liposarcoma.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Radiol Case Rep",
    "doi": "10.1016/j.radcr.2026.08.028",
    "records": [
     {
      "id": "liposarcoma",
      "kind": "cancer",
      "name": "Liposarcoma",
      "url": "https://onco.cc/cancers/liposarcoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/rlu.0000000000006691#onco-edge-paper",
   "url": "https://doi.org/10.1097/rlu.0000000000006691",
   "title": "Incidental Thyroid Uptake on 18F-FES PET/CT Revealing Papillary Thyroid Carcinoma.",
   "content_text": "Published in Clin Nucl Med on 11 September 2026; matched the OnCo record for FES PET.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Clin Nucl Med",
    "doi": "10.1097/rlu.0000000000006691",
    "records": [
     {
      "id": "fes-pet",
      "kind": "technology",
      "name": "FES PET",
      "url": "https://onco.cc/technologies/fes-pet/"
     },
     {
      "id": "fluoroestradiol-f18",
      "kind": "drug",
      "name": "Fluoroestradiol F-18",
      "url": "https://onco.cc/drugs/fluoroestradiol-f18/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/deo2.70419#onco-edge-paper",
   "url": "https://doi.org/10.1002/deo2.70419",
   "title": "Intensive Endoscopic Resection for Downstaging of Superficial Non-ampullary Duodenal Epithelial Tumor Burden in Familial Adenomatous Polyposis: A Single-center Retrospective Study on Long-term Clinical Outcome.",
   "content_text": "Published in DEN Open on 11 September 2026; matched the OnCo record for Endoscopic resection.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "DEN Open",
    "doi": "10.1002/deo2.70419",
    "records": [
     {
      "id": "endoscopic-resection",
      "kind": "technology",
      "name": "Endoscopic resection",
      "url": "https://onco.cc/technologies/endoscopic-resection/"
     },
     {
      "id": "fap",
      "kind": "target",
      "name": "FAP",
      "url": "https://onco.cc/targets/fap/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.adro.2026.102132#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.adro.2026.102132",
   "title": "Interobserver Study on HDR Prostate-Human-Selected Versus AI-Selected Plans.",
   "content_text": "Published in Adv Radiat Oncol on 11 September 2026; matched the OnCo record for High-dose-rate brachytherapy.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Adv Radiat Oncol",
    "doi": "10.1016/j.adro.2026.102132",
    "records": [
     {
      "id": "hdr-brachytherapy",
      "kind": "technology",
      "name": "High-dose-rate brachytherapy",
      "url": "https://onco.cc/technologies/hdr-brachytherapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1200/go-26-00265#onco-edge-paper",
   "url": "https://doi.org/10.1200/go-26-00265",
   "title": "Latin American Consensus for the Diagnosis, Staging, and Treatment of Peripheral T-Cell Lymphoma Not Otherwise Specified.",
   "content_text": "Published in JCO Glob Oncol on 11 September 2026; matched the OnCo record for Brentuximab vedotin.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "JCO Glob Oncol",
    "doi": "10.1200/go-26-00265",
    "records": [
     {
      "id": "brentuximab-vedotin",
      "kind": "drug",
      "name": "Brentuximab vedotin",
      "url": "https://onco.cc/drugs/brentuximab-vedotin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/01443615.2026.2719764#onco-edge-paper",
   "url": "https://doi.org/10.1080/01443615.2026.2719764",
   "title": "Lymphocyte markers with CA125 and HE4 for diagnosing early endometrial cancer in postmenopausal women: case-control study.",
   "content_text": "Published in J Obstet Gynaecol on 11 September 2026; matched the OnCo record for Endometrial cancer.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "J Obstet Gynaecol",
    "doi": "10.1080/01443615.2026.2719764",
    "records": [
     {
      "id": "endometrial",
      "kind": "cancer",
      "name": "Endometrial cancer",
      "url": "https://onco.cc/cancers/endometrial/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12105-026-01966-4#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12105-026-01966-4",
   "title": "Melanotic Oncocytic Metaplasia of the Nasopharynx: A Benign Mimic of Mucosal Melanoma.",
   "content_text": "Published in Head Neck Pathol on 11 September 2026; matched the OnCo record for Mucosal melanoma.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Head Neck Pathol",
    "doi": "10.1007/s12105-026-01966-4",
    "records": [
     {
      "id": "mucosal-melanoma",
      "kind": "cancer",
      "name": "Mucosal melanoma",
      "url": "https://onco.cc/cancers/mucosal-melanoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1126/sciadv.aef3957#onco-edge-paper",
   "url": "https://doi.org/10.1126/sciadv.aef3957",
   "title": "Microglia stabilize sleep homeostasis via adenosine A<sub>3</sub> receptor signaling.",
   "content_text": "Published on 11 September 2026 after first appearing as a preprint; matched State.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "doi": "10.1126/sciadv.aef3957",
    "records": [
     {
      "id": "state-arc",
      "kind": "technology",
      "name": "State",
      "url": "https://onco.cc/technologies/state-arc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.2174/0115734056482743260824063132#onco-edge-paper",
   "url": "https://doi.org/10.2174/0115734056482743260824063132",
   "title": "MRI Features of Diffuse Glioneuronal Tumor with Oligodendroglioma-like features and Nuclear Clusters: A Case Report and Literature Review.",
   "content_text": "Published in Curr Med Imaging on 11 September 2026; matched the OnCo record for Oligodendroglioma, IDH-mutant and 1p/19q-codeleted.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Curr Med Imaging",
    "doi": "10.2174/0115734056482743260824063132",
    "records": [
     {
      "id": "oligodendroglioma",
      "kind": "cancer",
      "name": "Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",
      "url": "https://onco.cc/cancers/oligodendroglioma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bioactmat.2026.08.026#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bioactmat.2026.08.026",
   "title": "Nanoadjuvant-based membrane poration boosts antitumor immunity via modulating mitochondrial metabolism to downregulate PD-L1 and upregulate STING.",
   "content_text": "Published in Bioact Mater on 11 September 2026; matched the OnCo record for STING & innate immune agonists.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Bioact Mater",
    "doi": "10.1016/j.bioactmat.2026.08.026",
    "records": [
     {
      "id": "sting-agonist",
      "kind": "technology",
      "name": "STING & innate immune agonists",
      "url": "https://onco.cc/technologies/sting-agonist/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.7554/elife.110919#onco-edge-paper",
   "url": "https://doi.org/10.7554/elife.110919",
   "title": "Nerve injury-induced protein 2 preserves lysosomal membrane integrity to suppress ferroptosis.",
   "content_text": "Published on 11 September 2026 after first appearing as a preprint; matched Iobenguane I-131.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "doi": "10.7554/elife.110919",
    "records": [
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jgo.2026.104122#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jgo.2026.104122",
   "title": "Non-surgical therapies for localized non-melanoma skin cancer in older adults: A review.",
   "content_text": "Published in J Geriatr Oncol on 11 September 2026; matched the OnCo record for Hedgehog pathway inhibitors.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "J Geriatr Oncol",
    "doi": "10.1016/j.jgo.2026.104122",
    "records": [
     {
      "id": "hedgehog-inhibitors",
      "kind": "technology",
      "name": "Hedgehog pathway inhibitors",
      "url": "https://onco.cc/technologies/hedgehog-inhibitors/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/10428194.2026.2721768#onco-edge-paper",
   "url": "https://doi.org/10.1080/10428194.2026.2721768",
   "title": "Optimized dosing of momelotinib in myelofibrosis through quantitative medicine: a clinical commentary.",
   "content_text": "Published in Leuk Lymphoma on 11 September 2026; matched the OnCo record for Momelotinib.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Leuk Lymphoma",
    "doi": "10.1080/10428194.2026.2721768",
    "records": [
     {
      "id": "momelotinib",
      "kind": "drug",
      "name": "Momelotinib",
      "url": "https://onco.cc/drugs/momelotinib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ctrv.2026.103212#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ctrv.2026.103212",
   "title": "p53 Co-mutations in EGFR-mutant NSCLC: biological insight and therapeutic implications.",
   "content_text": "Published in Cancer Treat Rev on 11 September 2026; matched the OnCo record for EGFR-mutated non-small-cell lung cancer.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Cancer Treat Rev",
    "doi": "10.1016/j.ctrv.2026.103212",
    "records": [
     {
      "id": "egfr-mutant-nsclc",
      "kind": "cancer",
      "name": "EGFR-mutated non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/egfr-mutant-nsclc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1210/jcemcr/luag264#onco-edge-paper",
   "url": "https://doi.org/10.1210/jcemcr/luag264",
   "title": "Papillary craniopharyngioma following an initial diagnosis of Rathke cleft cyst: a case report and narrative review.",
   "content_text": "Published in JCEM Case Rep on 11 September 2026; matched the OnCo record for Craniopharyngioma.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "JCEM Case Rep",
    "doi": "10.1210/jcemcr/luag264",
    "records": [
     {
      "id": "craniopharyngioma",
      "kind": "cancer",
      "name": "Craniopharyngioma",
      "url": "https://onco.cc/cancers/craniopharyngioma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ijrobp.2026.08.069#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ijrobp.2026.08.069",
   "title": "Phase 1a clinical trial of XRD-0394, a first-in-class dual ATM/DNA-PK inhibitor, in combination with palliative radiotherapy.",
   "content_text": "Published in Int J Radiat Oncol Biol Phys on 11 September 2026; matched the OnCo record for Palliative radiotherapy.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Int J Radiat Oncol Biol Phys",
    "doi": "10.1016/j.ijrobp.2026.08.069",
    "records": [
     {
      "id": "palliative-radiotherapy",
      "kind": "technology",
      "name": "Palliative radiotherapy",
      "url": "https://onco.cc/technologies/palliative-radiotherapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1158/2326-6066.cir-26-0293#onco-edge-paper",
   "url": "https://doi.org/10.1158/2326-6066.cir-26-0293",
   "title": "Phenotypic and functional characterization of tumor-reactive T cells in malignant pleural effusions.",
   "content_text": "Published on 11 September 2026 after first appearing as a preprint; matched Single-cell & spatial profiling, TIL therapy and CD3.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "doi": "10.1158/2326-6066.cir-26-0293",
    "records": [
     {
      "id": "single-cell-spatial",
      "kind": "technology",
      "name": "Single-cell & spatial profiling",
      "url": "https://onco.cc/technologies/single-cell-spatial/"
     },
     {
      "id": "til-therapy",
      "kind": "technology",
      "name": "TIL therapy",
      "url": "https://onco.cc/technologies/til-therapy/"
     },
     {
      "id": "cd3",
      "kind": "target",
      "name": "CD3",
      "url": "https://onco.cc/targets/cd3/"
     },
     {
      "id": "aldesleukin",
      "kind": "drug",
      "name": "Aldesleukin",
      "url": "https://onco.cc/drugs/aldesleukin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ejca.2026.117045#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ejca.2026.117045",
   "title": "Quality of life in patients with RAS wild-type metastatic colorectal cancer treated mFOLFOXIRI + panitumumab versus FOLFOXIRI: A prespecified secondary analysis of the phase II VOLFI AIO-KRK 0109 trial.",
   "content_text": "Published in Eur J Cancer on 11 September 2026; matched the OnCo record for Panitumumab.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Eur J Cancer",
    "doi": "10.1016/j.ejca.2026.117045",
    "records": [
     {
      "id": "panitumumab",
      "kind": "drug",
      "name": "Panitumumab",
      "url": "https://onco.cc/drugs/panitumumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00261-026-05787-5#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00261-026-05787-5",
   "title": "Quantitative dual-layer spectral CT parameters associated with a continuous improvement response pattern to CAPTEM in advanced gastroenteropancreatic neuroendocrine neoplasms.",
   "content_text": "Published in Abdom Radiol (NY) on 11 September 2026; matched the OnCo record for Capecitabine + temozolomide.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Abdom Radiol (NY)",
    "doi": "10.1007/s00261-026-05787-5",
    "records": [
     {
      "id": "capecitabine-temozolomide",
      "kind": "drug",
      "name": "Capecitabine + temozolomide",
      "url": "https://onco.cc/drugs/capecitabine-temozolomide/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1093/jnci/djag311#onco-edge-paper",
   "url": "https://doi.org/10.1093/jnci/djag311",
   "title": "RE: Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or gemcitabine-nab-paclitaxel: a multinational analysis.",
   "content_text": "Published in J Natl Cancer Inst on 11 September 2026; matched the OnCo record for Gemcitabine + nab-paclitaxel.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "J Natl Cancer Inst",
    "doi": "10.1093/jnci/djag311",
    "records": [
     {
      "id": "gemcitabine-nab-paclitaxel",
      "kind": "drug",
      "name": "Gemcitabine + nab-paclitaxel",
      "url": "https://onco.cc/drugs/gemcitabine-nab-paclitaxel/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1093/jnci/djag312#onco-edge-paper",
   "url": "https://doi.org/10.1093/jnci/djag312",
   "title": "RE: Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis.",
   "content_text": "Published in J Natl Cancer Inst on 11 September 2026; matched the OnCo record for Gemcitabine + nab-paclitaxel.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "J Natl Cancer Inst",
    "doi": "10.1093/jnci/djag312",
    "records": [
     {
      "id": "gemcitabine-nab-paclitaxel",
      "kind": "drug",
      "name": "Gemcitabine + nab-paclitaxel",
      "url": "https://onco.cc/drugs/gemcitabine-nab-paclitaxel/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11864-026-01413-0#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11864-026-01413-0",
   "title": "Recent Advances in Tumor-Infiltrating Lymphocyte Therapy for Melanoma.",
   "content_text": "Published in Curr Treat Options Oncol on 11 September 2026; matched the OnCo record for GC101 TIL.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Curr Treat Options Oncol",
    "doi": "10.1007/s11864-026-01413-0",
    "records": [
     {
      "id": "gc101-til",
      "kind": "drug",
      "name": "GC101 TIL",
      "url": "https://onco.cc/drugs/gc101-til/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.4103/sjg.sjg_325_26#onco-edge-paper",
   "url": "https://doi.org/10.4103/sjg.sjg_325_26",
   "title": "Response to meeting STRIDE-II targets in routine practice: Assessment, access, and service design.",
   "content_text": "Published in Saudi J Gastroenterol on 11 September 2026; matched the OnCo record for STRIDE DNA break detection.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Saudi J Gastroenterol",
    "doi": "10.4103/sjg.sjg_325_26",
    "records": [
     {
      "id": "stride-dna-break-detection",
      "kind": "technology",
      "name": "STRIDE DNA break detection",
      "url": "https://onco.cc/technologies/stride-dna-break-detection/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s13304-026-02839-9#onco-edge-paper",
   "url": "https://doi.org/10.1007/s13304-026-02839-9",
   "title": "Risk factors for complications after cytoreductive surgery (CRS) and HIPEC in 290 peritoneal malignancies of primary and secondary origins.",
   "content_text": "Published in Updates Surg on 11 September 2026; matched the OnCo record for Sodium thiosulfate.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Updates Surg",
    "doi": "10.1007/s13304-026-02839-9",
    "records": [
     {
      "id": "sodium-thiosulfate",
      "kind": "drug",
      "name": "Sodium thiosulfate",
      "url": "https://onco.cc/drugs/sodium-thiosulfate/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.radcr.2026.08.068#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.radcr.2026.08.068",
   "title": "Sacral benign notochordal cell tumor with atypical imaging features and 16-year spontaneous partial regression: A case report.",
   "content_text": "Published in Radiol Case Rep on 11 September 2026; matched the OnCo record for Chordoma.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Radiol Case Rep",
    "doi": "10.1016/j.radcr.2026.08.068",
    "records": [
     {
      "id": "chordoma",
      "kind": "cancer",
      "name": "Chordoma",
      "url": "https://onco.cc/cancers/chordoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1371/journal.ppat.1013914#onco-edge-paper",
   "url": "https://doi.org/10.1371/journal.ppat.1013914",
   "title": "Small molecule inhibition of the mitochondrial lipid transfer protein STARD7 attenuates influenza viral replication.",
   "content_text": "Published on 11 September 2026 after first appearing as a preprint; matched Iobenguane I-131.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "doi": "10.1371/journal.ppat.1013914",
    "records": [
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11302-026-10186-y#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11302-026-10186-y",
   "title": "Soluble P2X7 receptor (sP2X7R) as a marker of inflammation in pregnancy.",
   "content_text": "Published on 11 September 2026 after first appearing as a preprint; matched State.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "doi": "10.1007/s11302-026-10186-y",
    "records": [
     {
      "id": "state-arc",
      "kind": "technology",
      "name": "State",
      "url": "https://onco.cc/technologies/state-arc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.drudis.2026.104803#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.drudis.2026.104803",
   "title": "Synthetic lethality and context-selective DNA-damage response dependencies: from genetic vulnerability to pharmacological translation.",
   "content_text": "Published in Drug Discov Today on 11 September 2026; matched the OnCo record for WRN helicase.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Drug Discov Today",
    "doi": "10.1016/j.drudis.2026.104803",
    "records": [
     {
      "id": "wrn",
      "kind": "target",
      "name": "WRN helicase",
      "url": "https://onco.cc/targets/wrn/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41388-026-03976-6#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41388-026-03976-6",
   "title": "Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis.",
   "content_text": "Published on 11 September 2026 after first appearing as a preprint; matched SRC family kinases, Iobenguane I-131 and RANK ligand.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "doi": "10.1038/s41388-026-03976-6",
    "records": [
     {
      "id": "src",
      "kind": "target",
      "name": "SRC family kinases",
      "url": "https://onco.cc/targets/src/"
     },
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     },
     {
      "id": "rankl",
      "kind": "target",
      "name": "RANK ligand",
      "url": "https://onco.cc/targets/rankl/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1021/acschembio.6c00605#onco-edge-paper",
   "url": "https://doi.org/10.1021/acschembio.6c00605",
   "title": "Ultramutagenesis through Combined Msh2 Depletion and Proofreading-Deficient DNA Polymerase ε Expression Enhances Small-Molecule Target Identification in Forward Genetic Screens.",
   "content_text": "Published on 11 September 2026 after first appearing as a preprint; matched Lurbinectedin, Bortezomib and Whole-exome & whole-genome sequencing.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "doi": "10.1021/acschembio.6c00605",
    "records": [
     {
      "id": "lurbinectedin",
      "kind": "drug",
      "name": "Lurbinectedin",
      "url": "https://onco.cc/drugs/lurbinectedin/"
     },
     {
      "id": "bortezomib",
      "kind": "drug",
      "name": "Bortezomib",
      "url": "https://onco.cc/drugs/bortezomib/"
     },
     {
      "id": "wes-wgs",
      "kind": "technology",
      "name": "Whole-exome & whole-genome sequencing",
      "url": "https://onco.cc/technologies/wes-wgs/"
     },
     {
      "id": "proteasome",
      "kind": "target",
      "name": "Proteasome",
      "url": "https://onco.cc/targets/proteasome/"
     },
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.2174/0115734056485227260724115008#onco-edge-paper",
   "url": "https://doi.org/10.2174/0115734056485227260724115008",
   "title": "Ultrasound Features of Female Adnexal Tumor of Probable Wolffian Origin (FATWO): A Case Series and Literature Review.",
   "content_text": "Published in Curr Med Imaging on 11 September 2026; matched the OnCo record for Adult granulosa cell tumour of the ovary.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Curr Med Imaging",
    "doi": "10.2174/0115734056485227260724115008",
    "records": [
     {
      "id": "granulosa-cell-tumour",
      "kind": "cancer",
      "name": "Adult granulosa cell tumour of the ovary",
      "url": "https://onco.cc/cancers/granulosa-cell-tumour/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s10620-026-10244-w#onco-edge-paper",
   "url": "https://doi.org/10.1007/s10620-026-10244-w",
   "title": "Vorasidenib-Induced Acute Liver Injury.",
   "content_text": "Published in Dig Dis Sci on 11 September 2026; matched the OnCo record for Vorasidenib.",
   "date_published": "2026-09-11T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-11",
    "precision": "day",
    "venue": "Dig Dis Sci",
    "doi": "10.1007/s10620-026-10244-w",
    "records": [
     {
      "id": "vorasidenib",
      "kind": "drug",
      "name": "Vorasidenib",
      "url": "https://onco.cc/drugs/vorasidenib/"
     },
     {
      "id": "met",
      "kind": "target",
      "name": "MET",
      "url": "https://onco.cc/targets/met/"
     },
     {
      "id": "prednisone",
      "kind": "drug",
      "name": "Prednisone",
      "url": "https://onco.cc/drugs/prednisone/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3324/haematol.2026.300962#onco-edge-paper",
   "url": "https://doi.org/10.3324/haematol.2026.300962",
   "title": "\"Bendamustine monotherapy induces high response rates and STAT3 inhibition in high burden T-cell large granular lymphocytic leukemia\".",
   "content_text": "Published in Haematologica on 10 September 2026; matched the OnCo record for Bendamustine.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Haematologica",
    "doi": "10.3324/haematol.2026.300962",
    "records": [
     {
      "id": "bendamustine",
      "kind": "drug",
      "name": "Bendamustine",
      "url": "https://onco.cc/drugs/bendamustine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/rlu.0000000000006681#onco-edge-paper",
   "url": "https://doi.org/10.1097/rlu.0000000000006681",
   "title": "177Lu-FAPI-2286 Radioligand Therapy in Refractory Scalp Melanoma.",
   "content_text": "Published in Clin Nucl Med on 10 September 2026; matched the OnCo record for Lutetium-177 dotatate.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Clin Nucl Med",
    "doi": "10.1097/rlu.0000000000006681",
    "records": [
     {
      "id": "lutathera",
      "kind": "drug",
      "name": "Lutetium-177 dotatate",
      "url": "https://onco.cc/drugs/lutathera/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1186/s12911-026-03633-8#onco-edge-paper",
   "url": "https://doi.org/10.1186/s12911-026-03633-8",
   "title": "A framework for extraction of clinical information from radiological mammography reports using large language models and retrieval augmented generation.",
   "content_text": "Published on 10 September 2026 after first appearing as a preprint; matched Mammography & tomosynthesis.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "doi": "10.1186/s12911-026-03633-8",
    "records": [
     {
      "id": "mammography",
      "kind": "technology",
      "name": "Mammography & tomosynthesis",
      "url": "https://onco.cc/technologies/mammography/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jhsg.2026.101052#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jhsg.2026.101052",
   "title": "Aneurysmal Bone Cyst of the Distal Phalanx: A Case Report.",
   "content_text": "Published in J Hand Surg Glob Online on 10 September 2026; matched the OnCo record for MRI.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "J Hand Surg Glob Online",
    "doi": "10.1016/j.jhsg.2026.101052",
    "records": [
     {
      "id": "mri",
      "kind": "technology",
      "name": "MRI",
      "url": "https://onco.cc/technologies/mri/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ejso.2026.112122#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ejso.2026.112122",
   "title": "Assessing the efficacy of adjuvant chemotherapy in patients with T3N0 gastric cancer.",
   "content_text": "Published in Eur J Surg Oncol on 10 September 2026; matched the OnCo record for CAPOX.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Eur J Surg Oncol",
    "doi": "10.1016/j.ejso.2026.112122",
    "records": [
     {
      "id": "capox",
      "kind": "drug",
      "name": "CAPOX",
      "url": "https://onco.cc/drugs/capox/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s12032-026-03392-6#onco-edge-paper",
   "url": "https://doi.org/10.1007/s12032-026-03392-6",
   "title": "Beyond KRASG12C: emerging therapeutic strategies, patent landscape, and clinical progress in targeting KRAS-mutant cancers.",
   "content_text": "Published in Med Oncol on 10 September 2026; matched the OnCo record for MRTX1133.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Med Oncol",
    "doi": "10.1007/s12032-026-03392-6",
    "records": [
     {
      "id": "mrtx1133",
      "kind": "drug",
      "name": "MRTX1133",
      "url": "https://onco.cc/drugs/mrtx1133/"
     },
     {
      "id": "setidegrasib",
      "kind": "drug",
      "name": "Setidegrasib",
      "url": "https://onco.cc/drugs/setidegrasib/"
     },
     {
      "id": "zoldonrasib",
      "kind": "drug",
      "name": "Zoldonrasib",
      "url": "https://onco.cc/drugs/zoldonrasib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.mtbio.2026.103662#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.mtbio.2026.103662",
   "title": "Bioinspired liquid metal-spidroin (LMS) stripe microneedle actuators.",
   "content_text": "Published in Mater Today Bio on 10 September 2026; matched the OnCo record for Leiomyosarcoma.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Mater Today Bio",
    "doi": "10.1016/j.mtbio.2026.103662",
    "records": [
     {
      "id": "leiomyosarcoma",
      "kind": "cancer",
      "name": "Leiomyosarcoma",
      "url": "https://onco.cc/cancers/leiomyosarcoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3324/haematol.2026.301865#onco-edge-paper",
   "url": "https://doi.org/10.3324/haematol.2026.301865",
   "title": "Central nervous system management remains an evidence gap in first-line tagraxofusp therapy for blastic plasmacytoid dendritic cell neoplasm. Comment on: \"First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level\".",
   "content_text": "Published in Haematologica on 10 September 2026; matched the OnCo record for Blastic plasmacytoid dendritic cell neoplasm.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Haematologica",
    "doi": "10.3324/haematol.2026.301865",
    "records": [
     {
      "id": "bpdcn",
      "kind": "cancer",
      "name": "Blastic plasmacytoid dendritic cell neoplasm",
      "url": "https://onco.cc/cancers/bpdcn/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.suronc.2026.102566#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.suronc.2026.102566",
   "title": "Clinicopathological characteristics and surgical outcomes of primary hepatic perivascular epithelioid cell tumor (PEComa): A single-center cohort study.",
   "content_text": "Published in Surg Oncol on 10 September 2026; matched the OnCo record for Perivascular epithelioid cell tumour.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Surg Oncol",
    "doi": "10.1016/j.suronc.2026.102566",
    "records": [
     {
      "id": "pecoma",
      "kind": "cancer",
      "name": "Perivascular epithelioid cell tumour",
      "url": "https://onco.cc/cancers/pecoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/cyto.b.70071#onco-edge-paper",
   "url": "https://doi.org/10.1002/cyto.b.70071",
   "title": "Coexistence of immunophenotypically normal and aberrant mast cells in patients with clonal mast cell diseases associates with more indolent subtypes and less severe disease characteristics.",
   "content_text": "Published in Cytometry B Clin Cytom on 10 September 2026; matched the OnCo record for Systemic mastocytosis.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Cytometry B Clin Cytom",
    "doi": "10.1002/cyto.b.70071",
    "records": [
     {
      "id": "systemic-mastocytosis",
      "kind": "cancer",
      "name": "Systemic mastocytosis",
      "url": "https://onco.cc/cancers/systemic-mastocytosis/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s11701-026-03945-x#onco-edge-paper",
   "url": "https://doi.org/10.1007/s11701-026-03945-x",
   "title": "Comparative analysis of robotic- and endoscopic-assisted minimally invasive nipple-areola complex-sparing mastectomy for breast cancer: a meta-analysis with subgroup analyses.",
   "content_text": "Published on 10 September 2026 after first appearing as a preprint; matched Robotic & minimally invasive surgery.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "doi": "10.1007/s11701-026-03945-x",
    "records": [
     {
      "id": "robotic-surgery",
      "kind": "technology",
      "name": "Robotic & minimally invasive surgery",
      "url": "https://onco.cc/technologies/robotic-surgery/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41409-026-03016-7#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41409-026-03016-7",
   "title": "Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.",
   "content_text": "Published in Bone Marrow Transplant on 10 September 2026; matched the OnCo record for Alemtuzumab.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Bone Marrow Transplant",
    "doi": "10.1038/s41409-026-03016-7",
    "records": [
     {
      "id": "alemtuzumab",
      "kind": "drug",
      "name": "Alemtuzumab",
      "url": "https://onco.cc/drugs/alemtuzumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ijrobp.2026.09.005#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ijrobp.2026.09.005",
   "title": "Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiotherapy for Locally Advanced Pancreatic Cancer.",
   "content_text": "Published in Int J Radiat Oncol Biol Phys on 10 September 2026; matched the OnCo record for Carbon-ion therapy.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Int J Radiat Oncol Biol Phys",
    "doi": "10.1016/j.ijrobp.2026.09.005",
    "records": [
     {
      "id": "carbon-ion",
      "kind": "technology",
      "name": "Carbon-ion therapy",
      "url": "https://onco.cc/technologies/carbon-ion/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1186/s40959-026-00555-2#onco-edge-paper",
   "url": "https://doi.org/10.1186/s40959-026-00555-2",
   "title": "Coronary artery calcification score as a prognostic factor in patients undergoing allogeneic stem cell transplantation - a retrospective analysis.",
   "content_text": "Published in Cardiooncology on 10 September 2026; matched the OnCo record for Allogeneic stem cell transplantation.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Cardiooncology",
    "doi": "10.1186/s40959-026-00555-2",
    "records": [
     {
      "id": "allogeneic-hsct",
      "kind": "technology",
      "name": "Allogeneic stem cell transplantation",
      "url": "https://onco.cc/technologies/allogeneic-hsct/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/deo2.70430#onco-edge-paper",
   "url": "https://doi.org/10.1002/deo2.70430",
   "title": "Current Status and Unmet Needs of EUS Education in Japan: A Nationwide Survey Focusing on Screening EUS, EUS-Guided Sampling, and Interventional EUS.",
   "content_text": "Published in DEN Open on 10 September 2026; matched the OnCo record for Iobenguane I-131.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "DEN Open",
    "doi": "10.1002/deo2.70430",
    "records": [
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     },
     {
      "id": "ultrasound",
      "kind": "technology",
      "name": "Ultrasound",
      "url": "https://onco.cc/technologies/ultrasound/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.colsurfb.2026.116154#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.colsurfb.2026.116154",
   "title": "CXCR4-directed liposomal co-delivery of cytarabine and AMD3100 for redox-associated chemosensitization in acute myeloid leukemia.",
   "content_text": "Published in Colloids Surf B Biointerfaces on 10 September 2026; matched the OnCo record for Plerixafor.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Colloids Surf B Biointerfaces",
    "doi": "10.1016/j.colsurfb.2026.116154",
    "records": [
     {
      "id": "plerixafor",
      "kind": "drug",
      "name": "Plerixafor",
      "url": "https://onco.cc/drugs/plerixafor/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1182/bloodadvances.2026021463#onco-edge-paper",
   "url": "https://doi.org/10.1182/bloodadvances.2026021463",
   "title": "Cytokine concentrations in pediatric primary mediastinal large B cell lymphoma correlate with disease extent and outcome.",
   "content_text": "Published in Blood Adv on 10 September 2026; matched the OnCo record for Primary mediastinal (thymic) large B-cell lymphoma.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Blood Adv",
    "doi": "10.1182/bloodadvances.2026021463",
    "records": [
     {
      "id": "primary-mediastinal-b-cell-lymphoma",
      "kind": "cancer",
      "name": "Primary mediastinal (thymic) large B-cell lymphoma",
      "url": "https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.jaccas.2026.110281#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.jaccas.2026.110281",
   "title": "Disseminated HIV-Associated Burkitt Lymphoma With Cardiac and Presumed Central Nervous System Involvement.",
   "content_text": "Published in JACC Case Rep on 10 September 2026; matched the OnCo record for Burkitt lymphoma.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "JACC Case Rep",
    "doi": "10.1016/j.jaccas.2026.110281",
    "records": [
     {
      "id": "burkitt-lymphoma",
      "kind": "cancer",
      "name": "Burkitt lymphoma",
      "url": "https://onco.cc/cancers/burkitt-lymphoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/07853890.2026.2721850#onco-edge-paper",
   "url": "https://doi.org/10.1080/07853890.2026.2721850",
   "title": "Dose-Registered CT assessment of radiation-induced lung injury after chemoradiotherapy for stage III NSCLC.",
   "content_text": "Published in Ann Med on 10 September 2026; matched the OnCo record for Durvalumab.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Ann Med",
    "doi": "10.1080/07853890.2026.2721850",
    "records": [
     {
      "id": "durvalumab",
      "kind": "drug",
      "name": "Durvalumab",
      "url": "https://onco.cc/drugs/durvalumab/"
     },
     {
      "id": "vmat",
      "kind": "technology",
      "name": "Volumetric modulated arc therapy",
      "url": "https://onco.cc/technologies/vmat/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1093/jeb/voag070#onco-edge-paper",
   "url": "https://doi.org/10.1093/jeb/voag070",
   "title": "Enabling Evolutionary Therapy in metastatic cancer lacking serum biomarkers.",
   "content_text": "Published in J Evol Biol on 10 September 2026; matched the OnCo record for Platinum-sensitive ovarian cancer.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "J Evol Biol",
    "doi": "10.1093/jeb/voag070",
    "records": [
     {
      "id": "platinum-sensitive-ovarian-cancer",
      "kind": "cancer",
      "name": "Platinum-sensitive ovarian cancer",
      "url": "https://onco.cc/cancers/platinum-sensitive-ovarian-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/1545-5017.70662#onco-edge-paper",
   "url": "https://doi.org/10.1002/1545-5017.70662",
   "title": "ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma.",
   "content_text": "Published in Pediatr Blood Cancer on 10 September 2026; matched the OnCo record for Nelarabine.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Pediatr Blood Cancer",
    "doi": "10.1002/1545-5017.70662",
    "records": [
     {
      "id": "nelarabine",
      "kind": "drug",
      "name": "Nelarabine",
      "url": "https://onco.cc/drugs/nelarabine/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.ejso.2026.112123#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.ejso.2026.112123",
   "title": "Epithelioid sarcoma: A retrospective review from a single centre tertiary orthopaedic sarcoma unit.",
   "content_text": "Published in Eur J Surg Oncol on 10 September 2026; matched the OnCo record for Epithelioid sarcoma.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Eur J Surg Oncol",
    "doi": "10.1016/j.ejso.2026.112123",
    "records": [
     {
      "id": "epithelioid-sarcoma",
      "kind": "cancer",
      "name": "Epithelioid sarcoma",
      "url": "https://onco.cc/cancers/epithelioid-sarcoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1177/19373341261486719#onco-edge-paper",
   "url": "https://doi.org/10.1177/19373341261486719",
   "title": "Fibrotic Substrate Stiffness Enhances Endometriotic Epithelial Cell Motility.",
   "content_text": "Published on 10 September 2026 after first appearing as a preprint; matched Single-cell & spatial profiling and State.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "doi": "10.1177/19373341261486719",
    "records": [
     {
      "id": "single-cell-spatial",
      "kind": "technology",
      "name": "Single-cell & spatial profiling",
      "url": "https://onco.cc/technologies/single-cell-spatial/"
     },
     {
      "id": "state-arc",
      "kind": "technology",
      "name": "State",
      "url": "https://onco.cc/technologies/state-arc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3324/haematol.2026.301753#onco-edge-paper",
   "url": "https://doi.org/10.3324/haematol.2026.301753",
   "title": "First line asciminib in chronic myeloid leukemia: a quest for the \"Holy Grail\" of tolerability.",
   "content_text": "Published in Haematologica on 10 September 2026; matched the OnCo record for Asciminib.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Haematologica",
    "doi": "10.3324/haematol.2026.301753",
    "records": [
     {
      "id": "asciminib",
      "kind": "drug",
      "name": "Asciminib",
      "url": "https://onco.cc/drugs/asciminib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1152/physiolgenomics.00135.2026#onco-edge-paper",
   "url": "https://doi.org/10.1152/physiolgenomics.00135.2026",
   "title": "Genetic Basis of Pancreatic Steatosis: A Systematic Review of Comparison between African and Non-African Populations.",
   "content_text": "Published in Physiol Genomics on 10 September 2026; matched the OnCo record for PLUTO.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Physiol Genomics",
    "doi": "10.1152/physiolgenomics.00135.2026",
    "records": [
     {
      "id": "pluto",
      "kind": "technology",
      "name": "PLUTO",
      "url": "https://onco.cc/technologies/pluto/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.isci.2026.117478#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.isci.2026.117478",
   "title": "Gypenosides ameliorate polycystic ovary syndrome via gut microbiota modulation: An integrated gut microbiome and ovarian transcriptome study.",
   "content_text": "Published in iScience on 10 September 2026; matched the OnCo record for Letrozole.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "iScience",
    "doi": "10.1016/j.isci.2026.117478",
    "records": [
     {
      "id": "letrozole",
      "kind": "drug",
      "name": "Letrozole",
      "url": "https://onco.cc/drugs/letrozole/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00247-026-06781-1#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00247-026-06781-1",
   "title": "Image-guided ablation for pediatric malignant solid tumors: a review of modalities, evidence, and clinical applications.",
   "content_text": "Published in Pediatr Radiol on 10 September 2026; matched the OnCo record for Electrochemotherapy.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Pediatr Radiol",
    "doi": "10.1007/s00247-026-06781-1",
    "records": [
     {
      "id": "electrochemotherapy",
      "kind": "technology",
      "name": "Electrochemotherapy",
      "url": "https://onco.cc/technologies/electrochemotherapy/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/16078454.2026.2721241#onco-edge-paper",
   "url": "https://doi.org/10.1080/16078454.2026.2721241",
   "title": "Impact of defibrotide on survival in sinusoidal obstruction syndrome / veno-occlusive disease: a retrospective cohort study comparing two sequential treatment eras.",
   "content_text": "Published in Hematology on 10 September 2026; matched the OnCo record for Defibrotide.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Hematology",
    "doi": "10.1080/16078454.2026.2721241",
    "records": [
     {
      "id": "defibrotide",
      "kind": "drug",
      "name": "Defibrotide",
      "url": "https://onco.cc/drugs/defibrotide/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s00520-026-11154-3#onco-edge-paper",
   "url": "https://doi.org/10.1007/s00520-026-11154-3",
   "title": "Improved quality of life and prolonged survival with add-on homeopathic treatment in patients with non-small cell lung cancer: a prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study.",
   "content_text": "Published in Support Care Cancer on 10 September 2026; matched the OnCo record for Homeopathy.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Support Care Cancer",
    "doi": "10.1007/s00520-026-11154-3",
    "records": [
     {
      "id": "homeopathy-cancer",
      "kind": "technology",
      "name": "Homeopathy",
      "url": "https://onco.cc/technologies/homeopathy-cancer/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s43630-026-00952-7#onco-edge-paper",
   "url": "https://doi.org/10.1007/s43630-026-00952-7",
   "title": "Inhibiting glioma cell invasion by sequential photo-sonodynamic therapy.",
   "content_text": "Published on 10 September 2026 after first appearing as a preprint; matched Focused ultrasound & histotripsy, Photoimmunotherapy & photodynamic therapy and Sonodynamic therapy.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "doi": "10.1007/s43630-026-00952-7",
    "records": [
     {
      "id": "hifu-histotripsy",
      "kind": "technology",
      "name": "Focused ultrasound & histotripsy",
      "url": "https://onco.cc/technologies/hifu-histotripsy/"
     },
     {
      "id": "photoimmunotherapy",
      "kind": "technology",
      "name": "Photoimmunotherapy & photodynamic therapy",
      "url": "https://onco.cc/technologies/photoimmunotherapy/"
     },
     {
      "id": "sonodynamic-therapy",
      "kind": "technology",
      "name": "Sonodynamic therapy",
      "url": "https://onco.cc/technologies/sonodynamic-therapy/"
     },
     {
      "id": "aminolevulinic-acid-gleolan",
      "kind": "drug",
      "name": "5-Aminolevulinic acid",
      "url": "https://onco.cc/drugs/aminolevulinic-acid-gleolan/"
     },
     {
      "id": "aminolevulinic-acid",
      "kind": "drug",
      "name": "Aminolevulinic acid",
      "url": "https://onco.cc/drugs/aminolevulinic-acid/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1080/07853890.2026.2729596#onco-edge-paper",
   "url": "https://doi.org/10.1080/07853890.2026.2729596",
   "title": "Interpretable four-class machine learning prediction of initial I-131 therapy responses in differentiated thyroid cancer.",
   "content_text": "Published in Ann Med on 10 September 2026; matched the OnCo record for Radioactive iodine.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Ann Med",
    "doi": "10.1080/07853890.2026.2729596",
    "records": [
     {
      "id": "radioactive-iodine",
      "kind": "drug",
      "name": "Radioactive iodine",
      "url": "https://onco.cc/drugs/radioactive-iodine/"
     },
     {
      "id": "thyroid-cancer-markers",
      "kind": "technology",
      "name": "Thyroglobulin, calcitonin and CEA in thyroid cancer follow-up",
      "url": "https://onco.cc/technologies/thyroid-cancer-markers/"
     },
     {
      "id": "thyroid",
      "kind": "cancer",
      "name": "Thyroid cancer",
      "url": "https://onco.cc/cancers/thyroid/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.esmogo.2026.100412#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.esmogo.2026.100412",
   "title": "Intra- and intertumoral discordance of Claudin-18.2: a systematic review and meta-analysis.",
   "content_text": "Published in ESMO Gastrointest Oncol on 10 September 2026; matched the OnCo record for Claudin 18.2.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "ESMO Gastrointest Oncol",
    "doi": "10.1016/j.esmogo.2026.100412",
    "records": [
     {
      "id": "cldn18-2",
      "kind": "target",
      "name": "Claudin 18.2",
      "url": "https://onco.cc/targets/cldn18-2/"
     },
     {
      "id": "histopathology-ihc",
      "kind": "technology",
      "name": "Histopathology & immunohistochemistry",
      "url": "https://onco.cc/technologies/histopathology-ihc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.3324/haematol.2026.301067#onco-edge-paper",
   "url": "https://doi.org/10.3324/haematol.2026.301067",
   "title": "Ixazomib, pomalidomide and dexamethasone in triple-class exposed multiple myeloma patients - a phase II study.",
   "content_text": "Published in Haematologica on 10 September 2026; matched the OnCo record for Ixazomib.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Haematologica",
    "doi": "10.3324/haematol.2026.301067",
    "records": [
     {
      "id": "ixazomib",
      "kind": "drug",
      "name": "Ixazomib",
      "url": "https://onco.cc/drugs/ixazomib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1007/s10555-026-10378-3#onco-edge-paper",
   "url": "https://doi.org/10.1007/s10555-026-10378-3",
   "title": "Langerhans cell histiocytosis: molecular mechanisms underlying pathogenesis and emerging targeted therapeutics.",
   "content_text": "Published in Cancer Metastasis Rev on 10 September 2026; matched the OnCo record for Cobimetinib.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Cancer Metastasis Rev",
    "doi": "10.1007/s10555-026-10378-3",
    "records": [
     {
      "id": "cobimetinib",
      "kind": "drug",
      "name": "Cobimetinib",
      "url": "https://onco.cc/drugs/cobimetinib/"
     },
     {
      "id": "mek",
      "kind": "target",
      "name": "MEK1/2",
      "url": "https://onco.cc/targets/mek/"
     },
     {
      "id": "raf1",
      "kind": "target",
      "name": "CRAF",
      "url": "https://onco.cc/targets/raf1/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1093/jamiaopen/ooag173#onco-edge-paper",
   "url": "https://doi.org/10.1093/jamiaopen/ooag173",
   "title": "Large language model-based evaluation of the impact of gender in medical research.",
   "content_text": "Published on 10 September 2026 after first appearing as a preprint; matched AI trial matching & clinical decision support.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "doi": "10.1093/jamiaopen/ooag173",
    "records": [
     {
      "id": "ai-trial-matching",
      "kind": "technology",
      "name": "AI trial matching & clinical decision support",
      "url": "https://onco.cc/technologies/ai-trial-matching/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1002/1545-5017.70652#onco-edge-paper",
   "url": "https://doi.org/10.1002/1545-5017.70652",
   "title": "Late Endocrine and Organ Toxicities After Treosulfan-Based Conditioning in Pediatric Hematopoietic Cell Transplantation: A Systematic Review.",
   "content_text": "Published in Pediatr Blood Cancer on 10 September 2026; matched the OnCo record for Busulfan.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Pediatr Blood Cancer",
    "doi": "10.1002/1545-5017.70652",
    "records": [
     {
      "id": "busulfan",
      "kind": "drug",
      "name": "Busulfan",
      "url": "https://onco.cc/drugs/busulfan/"
     },
     {
      "id": "treosulfan",
      "kind": "drug",
      "name": "Treosulfan",
      "url": "https://onco.cc/drugs/treosulfan/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1038/s41598-026-68286-z#onco-edge-paper",
   "url": "https://doi.org/10.1038/s41598-026-68286-z",
   "title": "Leveraging neural network models for drug repurposing: a case study on cardiac hypertrophy.",
   "content_text": "Published on 10 September 2026 after first appearing as a preprint; matched Lapatinib and Iobenguane I-131.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "doi": "10.1038/s41598-026-68286-z",
    "records": [
     {
      "id": "lapatinib",
      "kind": "drug",
      "name": "Lapatinib",
      "url": "https://onco.cc/drugs/lapatinib/"
     },
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1242/jcs.264827#onco-edge-paper",
   "url": "https://doi.org/10.1242/jcs.264827",
   "title": "Live dynamics of induced cell-cell fusion between mitotic and interphasic cells.",
   "content_text": "Published on 10 September 2026 after first appearing as a preprint; matched State.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "doi": "10.1242/jcs.264827",
    "records": [
     {
      "id": "state-arc",
      "kind": "technology",
      "name": "State",
      "url": "https://onco.cc/technologies/state-arc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1371/journal.ppat.1014014#onco-edge-paper",
   "url": "https://doi.org/10.1371/journal.ppat.1014014",
   "title": "Longitudinal assessment of functional antibodies to a novel influenza virus strain across age groups.",
   "content_text": "Published on 10 September 2026 after first appearing as a preprint; matched State.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "doi": "10.1371/journal.ppat.1014014",
    "records": [
     {
      "id": "state-arc",
      "kind": "technology",
      "name": "State",
      "url": "https://onco.cc/technologies/state-arc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1097/pai.0000000000001353#onco-edge-paper",
   "url": "https://doi.org/10.1097/pai.0000000000001353",
   "title": "Neuroendocrine Differentiation in Synovial Sarcoma-An Immunohistochemical Study of 357 Tumors With 4 Markers: Chromogranin A, Synaptophysin, Insulinoma-associated Protein 1 and Insulin Gene Enhancer Protein ISL-1.",
   "content_text": "Published in Appl Immunohistochem Mol Morphol on 10 September 2026; matched the OnCo record for Synovial sarcoma.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Appl Immunohistochem Mol Morphol",
    "doi": "10.1097/pai.0000000000001353",
    "records": [
     {
      "id": "synovial-sarcoma",
      "kind": "cancer",
      "name": "Synovial sarcoma",
      "url": "https://onco.cc/cancers/synovial-sarcoma/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1016/j.bioactmat.2026.08.052#onco-edge-paper",
   "url": "https://doi.org/10.1016/j.bioactmat.2026.08.052",
   "title": "Oligosaccharide adjuvant-deferred antigen endocytosis promotes cross-presentation.",
   "content_text": "Published in Bioact Mater on 10 September 2026; matched the OnCo record for Nicotinamide.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Bioact Mater",
    "doi": "10.1016/j.bioactmat.2026.08.052",
    "records": [
     {
      "id": "nicotinamide",
      "kind": "drug",
      "name": "Nicotinamide",
      "url": "https://onco.cc/drugs/nicotinamide/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.1111/bjh.70822#onco-edge-paper",
   "url": "https://doi.org/10.1111/bjh.70822",
   "title": "Optimizing cord blood unit selection to improve survival after single-unit unrelated cord blood transplantation for adult myelodysplastic syndrome.",
   "content_text": "Published in Br J Haematol on 10 September 2026; matched the OnCo record for Higher-risk myelodysplastic syndromes.",
   "date_published": "2026-09-10T00:00:00Z",
   "tags": [
    "paper"
   ],
   "_onco": {
    "kind": "paper",
    "date": "2026-09-10",
    "precision": "day",
    "venue": "Br J Haematol",
    "doi": "10.1111/bjh.70822",
    "records": [
     {
      "id": "mds-higher-risk",
      "kind": "cancer",
      "name": "Higher-risk myelodysplastic syndromes",
      "url": "https://onco.cc/cancers/mds-higher-risk/"
     },
     {
      "id": "mds-lower-risk",
      "kind": "cancer",
      "name": "Lower-risk myelodysplastic syndromes",
      "url": "https://onco.cc/cancers/mds-lower-risk/"
     }
    ]
   }
  },
  {
   "id": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/220910Orig1s000ltr.pdf#onco-edge-approval",
   "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/220910Orig1s000ltr.pdf",
   "title": "Approval: Daraxonrasib (US)",
   "content_text": "NDA 220910 approved as Rasonque: adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy.",
   "date_published": "2026-08-26T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-08-26",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "daraxonrasib",
      "kind": "drug",
      "name": "Daraxonrasib",
      "url": "https://onco.cc/drugs/daraxonrasib/"
     },
     {
      "id": "pancreatic",
      "kind": "cancer",
      "name": "Pancreatic ductal adenocarcinoma",
      "url": "https://onco.cc/cancers/pancreatic/"
     },
     {
      "id": "metastatic-pdac",
      "kind": "cancer",
      "name": "Metastatic pancreatic ductal adenocarcinoma",
      "url": "https://onco.cc/cancers/metastatic-pdac/"
     },
     {
      "id": "kras-g12c-pdac",
      "kind": "cancer",
      "name": "KRAS G12C-mutant pancreatic ductal adenocarcinoma",
      "url": "https://onco.cc/cancers/kras-g12c-pdac/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     },
     {
      "id": "colorectal",
      "kind": "cancer",
      "name": "Colorectal cancer",
      "url": "https://onco.cc/cancers/colorectal/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-daraxonrasib-metastatic-pancreatic-adenocarcinoma#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-daraxonrasib-metastatic-pancreatic-adenocarcinoma",
   "title": "FDA approves daraxonrasib for metastatic pancreatic adenocarcinoma",
   "content_text": "On August 26, 2026, the Food and Drug Administration approved daraxonrasib (RASONQUE, Revolution Medicines, Inc.), an inhibitor of the RAS GTPase family, for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy.",
   "date_published": "2026-08-26T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-08-26",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "daraxonrasib",
      "kind": "drug",
      "name": "Daraxonrasib",
      "url": "https://onco.cc/drugs/daraxonrasib/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.64898/2026.09.09.750350#onco-edge-preprint",
   "url": "https://doi.org/10.64898/2026.09.09.750350",
   "title": "Accurate and scalable decontamination of imaging-based spatial transcriptomics via optimal transport",
   "content_text": "Posted on bioRxiv on 15 September 2026; not peer reviewed; matched Single-cell & spatial profiling and Spatial transcriptomics.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "bioRxiv",
    "doi": "10.64898/2026.09.09.750350",
    "records": [
     {
      "id": "single-cell-spatial",
      "kind": "technology",
      "name": "Single-cell & spatial profiling",
      "url": "https://onco.cc/technologies/single-cell-spatial/"
     },
     {
      "id": "spatial-transcriptomics",
      "kind": "technology",
      "name": "Spatial transcriptomics",
      "url": "https://onco.cc/technologies/spatial-transcriptomics/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.21203/rs.3.rs-10990195/v1#onco-edge-preprint",
   "url": "https://doi.org/10.21203/rs.3.rs-10990195/v1",
   "title": "An outcome-blind H&E architecture score is associated with prostate cancer-specific mortality",
   "content_text": "Posted on Research Square on 15 September 2026; not peer reviewed; matched Pathology & radiology foundation models and Prov-GigaPath.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Research Square",
    "doi": "10.21203/rs.3.rs-10990195/v1",
    "records": [
     {
      "id": "pathology-foundation-model",
      "kind": "technology",
      "name": "Pathology & radiology foundation models",
      "url": "https://onco.cc/technologies/pathology-foundation-model/"
     },
     {
      "id": "prov-gigapath",
      "kind": "technology",
      "name": "Prov-GigaPath",
      "url": "https://onco.cc/technologies/prov-gigapath/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.64898/2026.09.04.749312#onco-edge-preprint",
   "url": "https://doi.org/10.64898/2026.09.04.749312",
   "title": "An Oxidative Stress-Associated Seven-Gene Prognostic Signature in Lung Adenocarcinoma: Integrative Transcriptomic Analysis Across Public Cohorts",
   "content_text": "Posted on bioRxiv on 15 September 2026; not peer reviewed; matched AKT and Atlas.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "bioRxiv",
    "doi": "10.64898/2026.09.04.749312",
    "records": [
     {
      "id": "akt",
      "kind": "target",
      "name": "AKT",
      "url": "https://onco.cc/targets/akt/"
     },
     {
      "id": "atlas-aignostics",
      "kind": "technology",
      "name": "Atlas",
      "url": "https://onco.cc/technologies/atlas-aignostics/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.21203/rs.3.rs-10893634/v1#onco-edge-preprint",
   "url": "https://doi.org/10.21203/rs.3.rs-10893634/v1",
   "title": "CD163 Expression as an Independent Prognostic Biomarker in Glioblastoma: A Digital Pathology and Survival Analysis Study",
   "content_text": "Posted on Research Square on 15 September 2026; not peer reviewed; matched Histopathology & immunohistochemistry and Iobenguane I-131.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Research Square",
    "doi": "10.21203/rs.3.rs-10893634/v1",
    "records": [
     {
      "id": "histopathology-ihc",
      "kind": "technology",
      "name": "Histopathology & immunohistochemistry",
      "url": "https://onco.cc/technologies/histopathology-ihc/"
     },
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.21203/rs.3.rs-10804793/v1#onco-edge-preprint",
   "url": "https://doi.org/10.21203/rs.3.rs-10804793/v1",
   "title": "Construct validity and evidence boundaries of a 17-gene transcriptomic proxy for mitoxyperilysis in colorectal aging and cancer Analysis",
   "content_text": "Posted on Research Square on 15 September 2026; not peer reviewed; matched MET.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Research Square",
    "doi": "10.21203/rs.3.rs-10804793/v1",
    "records": [
     {
      "id": "met",
      "kind": "target",
      "name": "MET",
      "url": "https://onco.cc/targets/met/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.21203/rs.3.rs-10936910/v1#onco-edge-preprint",
   "url": "https://doi.org/10.21203/rs.3.rs-10936910/v1",
   "title": "Context-dependent rewiring of autocrine TGFβ/RhoA/ROCK1 under complete vs deprived serum conditions in TNBC transduced cells",
   "content_text": "Posted on Research Square on 15 September 2026; not peer reviewed; matched Iobenguane I-131.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Research Square",
    "doi": "10.21203/rs.3.rs-10936910/v1",
    "records": [
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.21203/rs.3.rs-10681008/v1#onco-edge-preprint",
   "url": "https://doi.org/10.21203/rs.3.rs-10681008/v1",
   "title": "Cost-effectiveness and carbon footprint of cystoscopic surveillance schedules in non-muscle-invasive bladder cancer",
   "content_text": "Posted on Research Square on 15 September 2026; not peer reviewed; matched State.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Research Square",
    "doi": "10.21203/rs.3.rs-10681008/v1",
    "records": [
     {
      "id": "state-arc",
      "kind": "technology",
      "name": "State",
      "url": "https://onco.cc/technologies/state-arc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.21203/rs.3.rs-10604240/v1#onco-edge-preprint",
   "url": "https://doi.org/10.21203/rs.3.rs-10604240/v1",
   "title": "Cranial Radiotherapy Combined with Afatinib in Non-Small Cell Lung Cancer Patients with EGFR G719X+S768I Co-Mutations and Brain Metastases: A Retrospective Study",
   "content_text": "Posted on Research Square on 15 September 2026; not peer reviewed; matched Nintedanib, EGFR and Afatinib.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Research Square",
    "doi": "10.21203/rs.3.rs-10604240/v1",
    "records": [
     {
      "id": "nintedanib",
      "kind": "drug",
      "name": "Nintedanib",
      "url": "https://onco.cc/drugs/nintedanib/"
     },
     {
      "id": "egfr",
      "kind": "target",
      "name": "EGFR",
      "url": "https://onco.cc/targets/egfr/"
     },
     {
      "id": "afatinib",
      "kind": "drug",
      "name": "Afatinib",
      "url": "https://onco.cc/drugs/afatinib/"
     },
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.21203/rs.3.rs-10733698/v1#onco-edge-preprint",
   "url": "https://doi.org/10.21203/rs.3.rs-10733698/v1",
   "title": "Cross-cohort evaluation of thyroid ultrasound deep learning across different outcome definitions: a duplicate-controlled benchmark",
   "content_text": "Posted on Research Square on 15 September 2026; not peer reviewed; matched Ultrasound.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Research Square",
    "doi": "10.21203/rs.3.rs-10733698/v1",
    "records": [
     {
      "id": "ultrasound",
      "kind": "technology",
      "name": "Ultrasound",
      "url": "https://onco.cc/technologies/ultrasound/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.64898/2026.09.13.26362944#onco-edge-preprint",
   "url": "https://doi.org/10.64898/2026.09.13.26362944",
   "title": "Cross-Source Progression Assessment in Advanced Pancreatic Cancer: An Opportunity-Adjusted Six-State Analysis",
   "content_text": "Posted on medRxiv on 15 September 2026; not peer reviewed; matched State.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "medRxiv",
    "doi": "10.64898/2026.09.13.26362944",
    "records": [
     {
      "id": "state-arc",
      "kind": "technology",
      "name": "State",
      "url": "https://onco.cc/technologies/state-arc/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.21203/rs.3.rs-11020454/v1#onco-edge-preprint",
   "url": "https://doi.org/10.21203/rs.3.rs-11020454/v1",
   "title": "DFT-based prediction of anti-cancer activity of some organo-Pt IV complexes",
   "content_text": "Posted on Research Square on 15 September 2026; not peer reviewed; matched Cisplatin, Platinum agents and Carboplatin.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Research Square",
    "doi": "10.21203/rs.3.rs-11020454/v1",
    "records": [
     {
      "id": "cisplatin",
      "kind": "drug",
      "name": "Cisplatin",
      "url": "https://onco.cc/drugs/cisplatin/"
     },
     {
      "id": "platinum",
      "kind": "technology",
      "name": "Platinum agents",
      "url": "https://onco.cc/technologies/platinum/"
     },
     {
      "id": "carboplatin",
      "kind": "drug",
      "name": "Carboplatin",
      "url": "https://onco.cc/drugs/carboplatin/"
     },
     {
      "id": "oxaliplatin",
      "kind": "drug",
      "name": "Oxaliplatin",
      "url": "https://onco.cc/drugs/oxaliplatin/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.20944/preprints202609.1117.v1#onco-edge-preprint",
   "url": "https://doi.org/10.20944/preprints202609.1117.v1",
   "title": "Drug–Drug Interactions in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated with Immunotherapy: A Multicenter Cohort Study",
   "content_text": "Posted on Preprints.org on 15 September 2026; not peer reviewed; matched Immune checkpoint inhibitors, Pembrolizumab and Nivolumab.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Preprints.org",
    "doi": "10.20944/preprints202609.1117.v1",
    "records": [
     {
      "id": "checkpoint-inhibitor",
      "kind": "technology",
      "name": "Immune checkpoint inhibitors",
      "url": "https://onco.cc/technologies/checkpoint-inhibitor/"
     },
     {
      "id": "pembrolizumab",
      "kind": "drug",
      "name": "Pembrolizumab",
      "url": "https://onco.cc/drugs/pembrolizumab/"
     },
     {
      "id": "nivolumab",
      "kind": "drug",
      "name": "Nivolumab",
      "url": "https://onco.cc/drugs/nivolumab/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.21203/rs.3.rs-10997045/v1#onco-edge-preprint",
   "url": "https://doi.org/10.21203/rs.3.rs-10997045/v1",
   "title": "Evaluating Patient Satisfaction with Oncology Pharmacy Services in Regional Referral Centers: A Mixed-Methods Approach",
   "content_text": "Posted on Research Square on 15 September 2026; not peer reviewed; matched Iobenguane I-131.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Research Square",
    "doi": "10.21203/rs.3.rs-10997045/v1",
    "records": [
     {
      "id": "iobenguane-i-131",
      "kind": "drug",
      "name": "Iobenguane I-131",
      "url": "https://onco.cc/drugs/iobenguane-i-131/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.21203/rs.3.rs-10791575/v1#onco-edge-preprint",
   "url": "https://doi.org/10.21203/rs.3.rs-10791575/v1",
   "title": "Evaluation of CBCT-based HU correction for synthetic CT generation in head-and-neck radiotherapy: FOV-stratified and peripheral-region analysis",
   "content_text": "Posted on Research Square on 15 September 2026; not peer reviewed; matched IMRT / IGRT.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Research Square",
    "doi": "10.21203/rs.3.rs-10791575/v1",
    "records": [
     {
      "id": "imrt-igrt",
      "kind": "technology",
      "name": "IMRT / IGRT",
      "url": "https://onco.cc/technologies/imrt-igrt/"
     }
    ]
   }
  },
  {
   "id": "https://doi.org/10.21203/rs.3.rs-11032255/v1#onco-edge-preprint",
   "url": "https://doi.org/10.21203/rs.3.rs-11032255/v1",
   "title": "Germline pharmacogenomic predictors of treatment-related toxicity in non-small cell lung cancer: a systematic review of the discovery-to-implementation gap",
   "content_text": "Posted on Research Square on 15 September 2026; not peer reviewed; matched Nintedanib, PD-1 and KRAS.",
   "date_published": "2026-09-15T00:00:00Z",
   "tags": [
    "preprint"
   ],
   "_onco": {
    "kind": "preprint",
    "date": "2026-09-15",
    "precision": "day",
    "venue": "Research Square",
    "doi": "10.21203/rs.3.rs-11032255/v1",
    "records": [
     {
      "id": "nintedanib",
      "kind": "drug",
      "name": "Nintedanib",
      "url": "https://onco.cc/drugs/nintedanib/"
     },
     {
      "id": "pd1",
      "kind": "target",
      "name": "PD-1",
      "url": "https://onco.cc/targets/pd1/"
     },
     {
      "id": "kras",
      "kind": "target",
      "name": "KRAS",
      "url": "https://onco.cc/targets/kras/"
     },
     {
      "id": "tp53",
      "kind": "target",
      "name": "TP53",
      "url": "https://onco.cc/targets/tp53/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-zanidatamab-hrii-and-tislelizumab-jsgr-her2-positive-gastric-gastroesophageal-junction#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-zanidatamab-hrii-and-tislelizumab-jsgr-her2-positive-gastric-gastroesophageal-junction",
   "title": "FDA approves zanidatamab-hrii and tislelizumab-jsgr for HER2-positive gastric, gastroesophageal junction, or esophageal adenocarcinoma",
   "content_text": "On August 25, 2026, the Food and Drug Administration approved zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals) in combination with fluoropyrimidine- and platinum-containing chemotherapy and tislelizumab-jsgr (Tevimbra, BeOne Medicines USA, Inc.), as first-line treatment for adults with HER2-positive (IHC 3+ or IHC 2+/ISH+) unresectable locally advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma, as detected by an FDA-approved test, and in combination with fluoropyrimidine-, and platinum-containing chemotherapy, as first-line treatment for adults with HER2-positive (IHC 3+) unresectable locally advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma, as detected by an FDA-approved test.: dolutegravir.",
   "date_published": "2026-08-25T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-08-25",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "tislelizumab",
      "kind": "drug",
      "name": "Tislelizumab",
      "url": "https://onco.cc/drugs/tislelizumab/"
     },
     {
      "id": "zanidatamab",
      "kind": "drug",
      "name": "Zanidatamab",
      "url": "https://onco.cc/drugs/zanidatamab/"
     },
     {
      "id": "platinum-etoposide",
      "kind": "drug",
      "name": "Platinum + etoposide",
      "url": "https://onco.cc/drugs/platinum-etoposide/"
     },
     {
      "id": "gastric",
      "kind": "cancer",
      "name": "Gastric & gastro-oesophageal junction cancer",
      "url": "https://onco.cc/cancers/gastric/"
     },
     {
      "id": "esophageal",
      "kind": "cancer",
      "name": "Oesophageal cancer",
      "url": "https://onco.cc/cancers/esophageal/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     },
     {
      "id": "hcc",
      "kind": "cancer",
      "name": "Hepatocellular carcinoma",
      "url": "https://onco.cc/cancers/hcc/"
     },
     {
      "id": "recurrent-metastatic-nasopharyngeal-carcinoma",
      "kind": "cancer",
      "name": "Recurrent and metastatic nasopharyngeal carcinoma",
      "url": "https://onco.cc/cancers/recurrent-metastatic-nasopharyngeal-carcinoma/"
     },
     {
      "id": "cholangiocarcinoma",
      "kind": "cancer",
      "name": "Biliary tract cancer",
      "url": "https://onco.cc/cancers/cholangiocarcinoma/"
     },
     {
      "id": "her2",
      "kind": "target",
      "name": "HER2",
      "url": "https://onco.cc/targets/her2/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-iberdomide-daratumumab-and-hyaluronidase-fihj-and-dexamethasone#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-iberdomide-daratumumab-and-hyaluronidase-fihj-and-dexamethasone",
   "title": "FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone for multiple myeloma",
   "content_text": "On August 13, 2026, the Food and Drug Administration granted accelerated approval to iberdomide (Zenbexus, Bristol-Myers Squibb Company) in combination with daratumumab and hyaluronidase-fihj and dexamethasone for adults with multiple myeloma who have received at least one prior line of therapy including a proteasome inhibitor and an immunomodulatory agent.",
   "date_published": "2026-08-13T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-08-13",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "dexamethasone",
      "kind": "drug",
      "name": "Dexamethasone",
      "url": "https://onco.cc/drugs/dexamethasone/"
     },
     {
      "id": "daratumumab",
      "kind": "drug",
      "name": "Daratumumab",
      "url": "https://onco.cc/drugs/daratumumab/"
     },
     {
      "id": "iberdomide",
      "kind": "drug",
      "name": "Iberdomide",
      "url": "https://onco.cc/drugs/iberdomide/"
     },
     {
      "id": "multiple-myeloma",
      "kind": "cancer",
      "name": "Multiple myeloma",
      "url": "https://onco.cc/cancers/multiple-myeloma/"
     },
     {
      "id": "smouldering-myeloma",
      "kind": "cancer",
      "name": "Smouldering multiple myeloma",
      "url": "https://onco.cc/cancers/smouldering-myeloma/"
     },
     {
      "id": "myeloma-transplant-eligible",
      "kind": "cancer",
      "name": "Newly diagnosed multiple myeloma, transplant-eligible",
      "url": "https://onco.cc/cancers/myeloma-transplant-eligible/"
     },
     {
      "id": "myeloma-transplant-ineligible",
      "kind": "cancer",
      "name": "Newly diagnosed multiple myeloma, transplant-ineligible",
      "url": "https://onco.cc/cancers/myeloma-transplant-ineligible/"
     },
     {
      "id": "plasma-cell-leukaemia",
      "kind": "cancer",
      "name": "Plasma cell leukaemia",
      "url": "https://onco.cc/cancers/plasma-cell-leukaemia/"
     },
     {
      "id": "all-leukemia",
      "kind": "cancer",
      "name": "Acute lymphoblastic leukaemia",
      "url": "https://onco.cc/cancers/all-leukemia/"
     },
     {
      "id": "dlbcl",
      "kind": "cancer",
      "name": "Diffuse large B-cell lymphoma",
      "url": "https://onco.cc/cancers/dlbcl/"
     },
     {
      "id": "hodgkin-lymphoma",
      "kind": "cancer",
      "name": "Hodgkin lymphoma",
      "url": "https://onco.cc/cancers/hodgkin-lymphoma/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-vusolimogene-oderparepvec-wtpg-combination-nivolumab-melanoma#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-vusolimogene-oderparepvec-wtpg-combination-nivolumab-melanoma",
   "title": "FDA grants accelerated approval to vusolimogene oderparepvec-wtpg in combination with nivolumab for melanoma",
   "content_text": "On August 6, 2026, the Food and Drug Administration granted accelerated approval to vusolimogene oderparepvec-wtpg (Tudriqev, Replimune, Inc.), a genetically modified oncolytic viral therapy, in combination with nivolumab for the treatment of adult patients with unresectable advanced cutaneous melanoma who experienced disease progression on a programmed death receptor-1 (PD-1)-blocking antibody-based regimen.",
   "date_published": "2026-08-06T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-08-06",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "vusolimogene-oderparepvec",
      "kind": "drug",
      "name": "Vusolimogene oderparepvec",
      "url": "https://onco.cc/drugs/vusolimogene-oderparepvec/"
     },
     {
      "id": "nivolumab",
      "kind": "drug",
      "name": "Nivolumab",
      "url": "https://onco.cc/drugs/nivolumab/"
     },
     {
      "id": "relatlimab-nivolumab",
      "kind": "drug",
      "name": "Relatlimab + nivolumab",
      "url": "https://onco.cc/drugs/relatlimab-nivolumab/"
     },
     {
      "id": "melanoma",
      "kind": "cancer",
      "name": "Melanoma",
      "url": "https://onco.cc/cancers/melanoma/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     },
     {
      "id": "rcc",
      "kind": "cancer",
      "name": "Renal cell carcinoma",
      "url": "https://onco.cc/cancers/rcc/"
     },
     {
      "id": "hodgkin-lymphoma",
      "kind": "cancer",
      "name": "Hodgkin lymphoma",
      "url": "https://onco.cc/cancers/hodgkin-lymphoma/"
     },
     {
      "id": "colorectal",
      "kind": "cancer",
      "name": "Colorectal cancer",
      "url": "https://onco.cc/cancers/colorectal/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/oncology-cancer-hematologic-malignancies-approval-notifications#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/oncology-cancer-hematologic-malignancies-approval-notifications",
   "title": "Approval: Amivantamab (US)",
   "content_text": "Subcutaneous formulation (PALOMA-3).",
   "date_published": "2026-07-31T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-07-31",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "amivantamab",
      "kind": "drug",
      "name": "Amivantamab",
      "url": "https://onco.cc/drugs/amivantamab/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     },
     {
      "id": "egfr-mutant-nsclc",
      "kind": "cancer",
      "name": "EGFR-mutated non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/egfr-mutant-nsclc/"
     },
     {
      "id": "met-altered-nsclc",
      "kind": "cancer",
      "name": "MET exon 14 and MET-amplified non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/met-altered-nsclc/"
     },
     {
      "id": "egfr",
      "kind": "target",
      "name": "EGFR",
      "url": "https://onco.cc/targets/egfr/"
     },
     {
      "id": "met",
      "kind": "target",
      "name": "MET",
      "url": "https://onco.cc/targets/met/"
     },
     {
      "id": "artera-ai-breast",
      "kind": "drug",
      "name": "ArteraAI Breast",
      "url": "https://onco.cc/drugs/artera-ai-breast/"
     },
     {
      "id": "breast-hr-positive",
      "kind": "cancer",
      "name": "HR-positive / HER2-negative breast cancer",
      "url": "https://onco.cc/cancers/breast-hr-positive/"
     },
     {
      "id": "atezolizumab",
      "kind": "drug",
      "name": "Atezolizumab",
      "url": "https://onco.cc/drugs/atezolizumab/"
     },
     {
      "id": "sclc",
      "kind": "cancer",
      "name": "Small-cell lung cancer",
      "url": "https://onco.cc/cancers/sclc/"
     },
     {
      "id": "hcc",
      "kind": "cancer",
      "name": "Hepatocellular carcinoma",
      "url": "https://onco.cc/cancers/hcc/"
     },
     {
      "id": "hcc-advanced",
      "kind": "cancer",
      "name": "Advanced hepatocellular carcinoma",
      "url": "https://onco.cc/cancers/hcc-advanced/"
     },
     {
      "id": "urothelial",
      "kind": "cancer",
      "name": "Bladder & urothelial cancer",
      "url": "https://onco.cc/cancers/urothelial/"
     },
     {
      "id": "belantamab-mafodotin",
      "kind": "drug",
      "name": "Belantamab mafodotin",
      "url": "https://onco.cc/drugs/belantamab-mafodotin/"
     },
     {
      "id": "multiple-myeloma",
      "kind": "cancer",
      "name": "Multiple myeloma",
      "url": "https://onco.cc/cancers/multiple-myeloma/"
     },
     {
      "id": "myeloma-relapsed-refractory",
      "kind": "cancer",
      "name": "Relapsed or refractory multiple myeloma",
      "url": "https://onco.cc/cancers/myeloma-relapsed-refractory/"
     },
     {
      "id": "bcma",
      "kind": "target",
      "name": "BCMA",
      "url": "https://onco.cc/targets/bcma/"
     },
     {
      "id": "cemiplimab",
      "kind": "drug",
      "name": "Cemiplimab",
      "url": "https://onco.cc/drugs/cemiplimab/"
     },
     {
      "id": "melanoma",
      "kind": "cancer",
      "name": "Melanoma",
      "url": "https://onco.cc/cancers/melanoma/"
     },
     {
      "id": "pdl1-high-nsclc",
      "kind": "cancer",
      "name": "PD-L1-high non-small-cell lung cancer without a driver mutation",
      "url": "https://onco.cc/cancers/pdl1-high-nsclc/"
     },
     {
      "id": "cutaneous-scc",
      "kind": "cancer",
      "name": "Cutaneous squamous cell carcinoma",
      "url": "https://onco.cc/cancers/cutaneous-scc/"
     },
     {
      "id": "advanced-cutaneous-scc",
      "kind": "cancer",
      "name": "Advanced cutaneous squamous cell carcinoma",
      "url": "https://onco.cc/cancers/advanced-cutaneous-scc/"
     },
     {
      "id": "durvalumab",
      "kind": "drug",
      "name": "Durvalumab",
      "url": "https://onco.cc/drugs/durvalumab/"
     },
     {
      "id": "cholangiocarcinoma",
      "kind": "cancer",
      "name": "Biliary tract cancer",
      "url": "https://onco.cc/cancers/cholangiocarcinoma/"
     },
     {
      "id": "intrahepatic-cholangiocarcinoma",
      "kind": "cancer",
      "name": "Intrahepatic cholangiocarcinoma",
      "url": "https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/"
     },
     {
      "id": "extrahepatic-cholangiocarcinoma",
      "kind": "cancer",
      "name": "Extrahepatic cholangiocarcinoma",
      "url": "https://onco.cc/cancers/extrahepatic-cholangiocarcinoma/"
     },
     {
      "id": "encorafenib",
      "kind": "drug",
      "name": "Encorafenib",
      "url": "https://onco.cc/drugs/encorafenib/"
     },
     {
      "id": "colorectal",
      "kind": "cancer",
      "name": "Colorectal cancer",
      "url": "https://onco.cc/cancers/colorectal/"
     },
     {
      "id": "braf-v600e-colorectal",
      "kind": "cancer",
      "name": "BRAF V600E-mutant colorectal cancer",
      "url": "https://onco.cc/cancers/braf-v600e-colorectal/"
     },
     {
      "id": "braf-v600e-nsclc",
      "kind": "cancer",
      "name": "BRAF V600E-mutant non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/braf-v600e-nsclc/"
     },
     {
      "id": "pluvicto",
      "kind": "drug",
      "name": "Lutetium-177 vipivotide tetraxetan",
      "url": "https://onco.cc/drugs/pluvicto/"
     },
     {
      "id": "prostate",
      "kind": "cancer",
      "name": "Prostate cancer",
      "url": "https://onco.cc/cancers/prostate/"
     },
     {
      "id": "prostate-mcrpc",
      "kind": "cancer",
      "name": "Metastatic castration-resistant prostate cancer",
      "url": "https://onco.cc/cancers/prostate-mcrpc/"
     },
     {
      "id": "prostate-mhspc",
      "kind": "cancer",
      "name": "Metastatic hormone-sensitive prostate cancer",
      "url": "https://onco.cc/cancers/prostate-mhspc/"
     },
     {
      "id": "psma",
      "kind": "target",
      "name": "PSMA",
      "url": "https://onco.cc/targets/psma/"
     },
     {
      "id": "nivolumab",
      "kind": "drug",
      "name": "Nivolumab",
      "url": "https://onco.cc/drugs/nivolumab/"
     },
     {
      "id": "rcc",
      "kind": "cancer",
      "name": "Renal cell carcinoma",
      "url": "https://onco.cc/cancers/rcc/"
     },
     {
      "id": "hodgkin-lymphoma",
      "kind": "cancer",
      "name": "Hodgkin lymphoma",
      "url": "https://onco.cc/cancers/hodgkin-lymphoma/"
     },
     {
      "id": "optune",
      "kind": "drug",
      "name": "Optune / Optune Pax",
      "url": "https://onco.cc/drugs/optune/"
     },
     {
      "id": "glioblastoma",
      "kind": "cancer",
      "name": "Glioma & glioblastoma",
      "url": "https://onco.cc/cancers/glioblastoma/"
     },
     {
      "id": "pancreatic",
      "kind": "cancer",
      "name": "Pancreatic ductal adenocarcinoma",
      "url": "https://onco.cc/cancers/pancreatic/"
     },
     {
      "id": "locally-advanced-pdac",
      "kind": "cancer",
      "name": "Locally advanced unresectable pancreatic ductal adenocarcinoma",
      "url": "https://onco.cc/cancers/locally-advanced-pdac/"
     },
     {
      "id": "mesothelioma",
      "kind": "cancer",
      "name": "Mesothelioma",
      "url": "https://onco.cc/cancers/mesothelioma/"
     },
     {
      "id": "pembrolizumab",
      "kind": "drug",
      "name": "Pembrolizumab",
      "url": "https://onco.cc/drugs/pembrolizumab/"
     },
     {
      "id": "msi-high-pdac",
      "kind": "cancer",
      "name": "Mismatch repair deficient (MSI-high) pancreatic ductal adenocarcinoma",
      "url": "https://onco.cc/cancers/msi-high-pdac/"
     },
     {
      "id": "tnbc",
      "kind": "cancer",
      "name": "Triple-negative breast cancer",
      "url": "https://onco.cc/cancers/tnbc/"
     },
     {
      "id": "head-and-neck",
      "kind": "cancer",
      "name": "Head and neck squamous cell carcinoma",
      "url": "https://onco.cc/cancers/head-and-neck/"
     },
     {
      "id": "pylarify",
      "kind": "drug",
      "name": "Piflufolastat F-18 / Pylarify TruVu",
      "url": "https://onco.cc/drugs/pylarify/"
     },
     {
      "id": "relacorilant",
      "kind": "drug",
      "name": "Relacorilant",
      "url": "https://onco.cc/drugs/relacorilant/"
     },
     {
      "id": "ovarian",
      "kind": "cancer",
      "name": "Ovarian cancer",
      "url": "https://onco.cc/cancers/ovarian/"
     },
     {
      "id": "platinum-resistant-ovarian-cancer",
      "kind": "cancer",
      "name": "Platinum-resistant ovarian cancer",
      "url": "https://onco.cc/cancers/platinum-resistant-ovarian-cancer/"
     },
     {
      "id": "advanced-adrenocortical-carcinoma",
      "kind": "cancer",
      "name": "Advanced and metastatic adrenocortical carcinoma",
      "url": "https://onco.cc/cancers/advanced-adrenocortical-carcinoma/"
     },
     {
      "id": "revumenib",
      "kind": "drug",
      "name": "Revumenib",
      "url": "https://onco.cc/drugs/revumenib/"
     },
     {
      "id": "aml",
      "kind": "cancer",
      "name": "Acute myeloid leukaemia",
      "url": "https://onco.cc/cancers/aml/"
     },
     {
      "id": "all-leukemia",
      "kind": "cancer",
      "name": "Acute lymphoblastic leukaemia",
      "url": "https://onco.cc/cancers/all-leukemia/"
     },
     {
      "id": "aml-npm1-kmt2a",
      "kind": "cancer",
      "name": "NPM1-mutated and KMT2A-rearranged acute myeloid leukaemia",
      "url": "https://onco.cc/cancers/aml-npm1-kmt2a/"
     },
     {
      "id": "menin",
      "kind": "target",
      "name": "Menin",
      "url": "https://onco.cc/targets/menin/"
     },
     {
      "id": "satricabtagene-autoleucel",
      "kind": "drug",
      "name": "Satricabtagene autoleucel",
      "url": "https://onco.cc/drugs/satricabtagene-autoleucel/"
     },
     {
      "id": "gastric",
      "kind": "cancer",
      "name": "Gastric & gastro-oesophageal junction cancer",
      "url": "https://onco.cc/cancers/gastric/"
     },
     {
      "id": "cldn18-2",
      "kind": "target",
      "name": "Claudin 18.2",
      "url": "https://onco.cc/targets/cldn18-2/"
     },
     {
      "id": "tarlatamab",
      "kind": "drug",
      "name": "Tarlatamab",
      "url": "https://onco.cc/drugs/tarlatamab/"
     },
     {
      "id": "extensive-stage-sclc",
      "kind": "cancer",
      "name": "Extensive-stage small-cell lung cancer",
      "url": "https://onco.cc/cancers/extensive-stage-sclc/"
     },
     {
      "id": "limited-stage-sclc",
      "kind": "cancer",
      "name": "Limited-stage small-cell lung cancer",
      "url": "https://onco.cc/cancers/limited-stage-sclc/"
     },
     {
      "id": "dll3",
      "kind": "target",
      "name": "DLL3",
      "url": "https://onco.cc/targets/dll3/"
     },
     {
      "id": "cd3",
      "kind": "target",
      "name": "CD3",
      "url": "https://onco.cc/targets/cd3/"
     },
     {
      "id": "teclistamab",
      "kind": "drug",
      "name": "Teclistamab",
      "url": "https://onco.cc/drugs/teclistamab/"
     },
     {
      "id": "trastuzumab-deruxtecan",
      "kind": "drug",
      "name": "Trastuzumab deruxtecan",
      "url": "https://onco.cc/drugs/trastuzumab-deruxtecan/"
     },
     {
      "id": "breast-her2-positive",
      "kind": "cancer",
      "name": "HER2-positive breast cancer",
      "url": "https://onco.cc/cancers/breast-her2-positive/"
     },
     {
      "id": "gastric-her2-positive",
      "kind": "cancer",
      "name": "HER2-positive gastric cancer",
      "url": "https://onco.cc/cancers/gastric-her2-positive/"
     },
     {
      "id": "vepdegestrant",
      "kind": "drug",
      "name": "Vepdegestrant",
      "url": "https://onco.cc/drugs/vepdegestrant/"
     },
     {
      "id": "hr-positive-metastatic-post-cdk46",
      "kind": "cancer",
      "name": "HR-positive metastatic breast cancer after CDK4/6 inhibitors",
      "url": "https://onco.cc/cancers/hr-positive-metastatic-post-cdk46/"
     },
     {
      "id": "estrogen-receptor",
      "kind": "target",
      "name": "Estrogen receptor",
      "url": "https://onco.cc/targets/estrogen-receptor/"
     },
     {
      "id": "vusolimogene-oderparepvec",
      "kind": "drug",
      "name": "Vusolimogene oderparepvec",
      "url": "https://onco.cc/drugs/vusolimogene-oderparepvec/"
     },
     {
      "id": "advanced-melanoma",
      "kind": "cancer",
      "name": "Advanced melanoma",
      "url": "https://onco.cc/cancers/advanced-melanoma/"
     },
     {
      "id": "zenocutuzumab",
      "kind": "drug",
      "name": "Zenocutuzumab",
      "url": "https://onco.cc/drugs/zenocutuzumab/"
     },
     {
      "id": "kras-wild-type-pdac",
      "kind": "cancer",
      "name": "KRAS wild-type pancreatic ductal adenocarcinoma",
      "url": "https://onco.cc/cancers/kras-wild-type-pdac/"
     },
     {
      "id": "her2",
      "kind": "target",
      "name": "HER2",
      "url": "https://onco.cc/targets/her2/"
     },
     {
      "id": "zongertinib",
      "kind": "drug",
      "name": "Zongertinib",
      "url": "https://onco.cc/drugs/zongertinib/"
     },
     {
      "id": "her2-mutant-nsclc",
      "kind": "cancer",
      "name": "HER2-mutant non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/her2-mutant-nsclc/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lutetium-lu-177-vipivotide-tetraxetan-androgen-receptor-pathway-inhibitor-therapy#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lutetium-lu-177-vipivotide-tetraxetan-androgen-receptor-pathway-inhibitor-therapy",
   "title": "FDA approves lutetium Lu 177 vipivotide tetraxetan with androgen receptor pathway inhibitor therapy for metastatic androgen pathway modulation-naïve or -sensitive prostate cancer",
   "content_text": "On July 31, 2026, the Food and Drug Administration approved lutetium Lu 177 vipivotide tetraxetan (Pluvicto, Novartis Pharmaceuticals Corporation) in combination with androgen receptor pathway inhibitor (ARPI) therapy for adults with prostate-specific membrane antigen (PSMA)-positive metastatic androgen pathway modulation-naïve or-sensitive (mAPMN/S) prostate cancer (previously referred to as metastatic hormone-sensitive prostate cancer).",
   "date_published": "2026-07-31T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-07-31",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "pluvicto",
      "kind": "drug",
      "name": "Lutetium-177 vipivotide tetraxetan",
      "url": "https://onco.cc/drugs/pluvicto/"
     },
     {
      "id": "prostate",
      "kind": "cancer",
      "name": "Prostate cancer",
      "url": "https://onco.cc/cancers/prostate/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-zidesamtinib-ros1-positive-non-small-cell-lung-cancer#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-zidesamtinib-ros1-positive-non-small-cell-lung-cancer",
   "title": "FDA approves zidesamtinib for ROS1 -positive non-small cell lung cancer",
   "content_text": "On July 22, 2026, the Food and Drug Administration approved zidesamtinib (Jideytro, Nuvalent, Inc.) for adults with locally advanced or metastatic ROS1 -positive non-small cell lung cancer (NSCLC) who received at least one prior ROS1 tyrosine kinase inhibitor (TKI).",
   "date_published": "2026-07-22T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-07-22",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "zidesamtinib",
      "kind": "drug",
      "name": "Zidesamtinib",
      "url": "https://onco.cc/drugs/zidesamtinib/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     },
     {
      "id": "ros1-positive-nsclc",
      "kind": "cancer",
      "name": "ROS1-positive non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/ros1-positive-nsclc/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-gedatolisib-fulvestrant-or-without-palbociclib-hr-positive-her2-negative-locally#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-gedatolisib-fulvestrant-or-without-palbociclib-hr-positive-her2-negative-locally",
   "title": "FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally advanced or metastatic breast cancer",
   "content_text": "On July 14, 2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity Inc.) in combination with fulvestrant, with or without palbociclib, for adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer without a PIK3CA mutation detected following progression on or after treatment with at least one line of endocrine therapy in the metastatic setting.",
   "date_published": "2026-07-14T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-07-14",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "fulvestrant",
      "kind": "drug",
      "name": "Fulvestrant",
      "url": "https://onco.cc/drugs/fulvestrant/"
     },
     {
      "id": "palbociclib",
      "kind": "drug",
      "name": "Palbociclib",
      "url": "https://onco.cc/drugs/palbociclib/"
     },
     {
      "id": "gedatolisib",
      "kind": "drug",
      "name": "Gedatolisib",
      "url": "https://onco.cc/drugs/gedatolisib/"
     },
     {
      "id": "breast-hr-positive",
      "kind": "cancer",
      "name": "HR-positive / HER2-negative breast cancer",
      "url": "https://onco.cc/cancers/breast-hr-positive/"
     },
     {
      "id": "estrogen-receptor",
      "kind": "target",
      "name": "Estrogen receptor",
      "url": "https://onco.cc/targets/estrogen-receptor/"
     },
     {
      "id": "hr-positive-metastatic-post-cdk46",
      "kind": "cancer",
      "name": "HR-positive metastatic breast cancer after CDK4/6 inhibitors",
      "url": "https://onco.cc/cancers/hr-positive-metastatic-post-cdk46/"
     },
     {
      "id": "pik3ca",
      "kind": "target",
      "name": "PIK3CA / PI3K-alpha",
      "url": "https://onco.cc/targets/pik3ca/"
     },
     {
      "id": "akt",
      "kind": "target",
      "name": "AKT",
      "url": "https://onco.cc/targets/akt/"
     },
     {
      "id": "breast-her2-positive",
      "kind": "cancer",
      "name": "HER2-positive breast cancer",
      "url": "https://onco.cc/cancers/breast-her2-positive/"
     },
     {
      "id": "cdk4-6",
      "kind": "target",
      "name": "CDK4/6",
      "url": "https://onco.cc/targets/cdk4-6/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-traditional-approval-selpercatinib-locally-advanced-or-metastatic-ret-fusion-positive#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-traditional-approval-selpercatinib-locally-advanced-or-metastatic-ret-fusion-positive",
   "title": "FDA grants traditional approval to selpercatinib for locally advanced or metastatic RET fusion-positive solid tumors",
   "content_text": "On July 14, 2026, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and pediatric patients two years of age and older with locally advanced or metastatic solid tumors with a RET gene fusion, as detected by an FDA-approved test, that have progressed on or following prior systemic treatment or who have no satisfactory alternative treatment options.",
   "date_published": "2026-07-14T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-07-14",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "selpercatinib",
      "kind": "drug",
      "name": "Selpercatinib",
      "url": "https://onco.cc/drugs/selpercatinib/"
     },
     {
      "id": "thyroid",
      "kind": "cancer",
      "name": "Thyroid cancer",
      "url": "https://onco.cc/cancers/thyroid/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     },
     {
      "id": "medullary-thyroid-cancer",
      "kind": "cancer",
      "name": "Medullary thyroid cancer",
      "url": "https://onco.cc/cancers/medullary-thyroid-cancer/"
     },
     {
      "id": "papillary-thyroid-cancer",
      "kind": "cancer",
      "name": "Papillary thyroid cancer",
      "url": "https://onco.cc/cancers/papillary-thyroid-cancer/"
     },
     {
      "id": "ret-fusion-nsclc",
      "kind": "cancer",
      "name": "RET fusion-positive non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/ret-fusion-nsclc/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-or-pembrolizumab-and-berahyaluronidase-alfa-pmph-each-enfortumab-vedotin#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-or-pembrolizumab-and-berahyaluronidase-alfa-pmph-each-enfortumab-vedotin",
   "title": "FDA approves pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph each with enfortumab vedotin-ejfv for muscle invasive bladder cancer",
   "content_text": "On July 10, 2026, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex, Merck) each in combination with enfortumab vedotin-ejfv (Padcev, Astellas Pharma) as neoadjuvant treatment (before surgery) followed by adjuvant treatment after cystectomy (surgery to remove the bladder) for adults with muscle invasive bladder cancer (MIBC).",
   "date_published": "2026-07-10T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-07-10",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "enfortumab-vedotin",
      "kind": "drug",
      "name": "Enfortumab vedotin",
      "url": "https://onco.cc/drugs/enfortumab-vedotin/"
     },
     {
      "id": "pembrolizumab",
      "kind": "drug",
      "name": "Pembrolizumab",
      "url": "https://onco.cc/drugs/pembrolizumab/"
     },
     {
      "id": "gemcitabine-cisplatin",
      "kind": "drug",
      "name": "Gemcitabine + cisplatin",
      "url": "https://onco.cc/drugs/gemcitabine-cisplatin/"
     },
     {
      "id": "cisplatin",
      "kind": "drug",
      "name": "Cisplatin",
      "url": "https://onco.cc/drugs/cisplatin/"
     },
     {
      "id": "urothelial",
      "kind": "cancer",
      "name": "Bladder & urothelial cancer",
      "url": "https://onco.cc/cancers/urothelial/"
     },
     {
      "id": "muscle-invasive-bladder-cancer",
      "kind": "cancer",
      "name": "Muscle-invasive and advanced bladder cancer",
      "url": "https://onco.cc/cancers/muscle-invasive-bladder-cancer/"
     },
     {
      "id": "nectin4",
      "kind": "target",
      "name": "Nectin-4",
      "url": "https://onco.cc/targets/nectin4/"
     },
     {
      "id": "msi-high-pdac",
      "kind": "cancer",
      "name": "Mismatch repair deficient (MSI-high) pancreatic ductal adenocarcinoma",
      "url": "https://onco.cc/cancers/msi-high-pdac/"
     },
     {
      "id": "tnbc",
      "kind": "cancer",
      "name": "Triple-negative breast cancer",
      "url": "https://onco.cc/cancers/tnbc/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     },
     {
      "id": "melanoma",
      "kind": "cancer",
      "name": "Melanoma",
      "url": "https://onco.cc/cancers/melanoma/"
     },
     {
      "id": "head-and-neck",
      "kind": "cancer",
      "name": "Head and neck squamous cell carcinoma",
      "url": "https://onco.cc/cancers/head-and-neck/"
     }
    ]
   }
  },
  {
   "id": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-isatuximab-irfc-subcutaneous-injection-multiple-myeloma-indications#onco-edge-approval",
   "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-isatuximab-irfc-subcutaneous-injection-multiple-myeloma-indications",
   "title": "FDA approves isatuximab-irfc for subcutaneous injection for multiple myeloma indications",
   "content_text": "On July 9, 2026, the Food and Drug Administration approved isatuximab-irfc (Sarclisa Escena, Sanofi-Aventis U.S.",
   "date_published": "2026-07-09T00:00:00Z",
   "tags": [
    "approval"
   ],
   "_onco": {
    "kind": "approval",
    "date": "2026-07-09",
    "precision": "day",
    "venue": "FDA",
    "records": [
     {
      "id": "isatuximab",
      "kind": "drug",
      "name": "Isatuximab",
      "url": "https://onco.cc/drugs/isatuximab/"
     },
     {
      "id": "multiple-myeloma",
      "kind": "cancer",
      "name": "Multiple myeloma",
      "url": "https://onco.cc/cancers/multiple-myeloma/"
     },
     {
      "id": "myeloma-transplant-ineligible",
      "kind": "cancer",
      "name": "Newly diagnosed multiple myeloma, transplant-ineligible",
      "url": "https://onco.cc/cancers/myeloma-transplant-ineligible/"
     },
     {
      "id": "cd38",
      "kind": "target",
      "name": "CD38",
      "url": "https://onco.cc/targets/cd38/"
     }
    ]
   }
  },
  {
   "id": "https://www.oncologypipeline.com/apexonco/bicycle-finally-falls#onco-edge-withdrawal",
   "url": "https://www.oncologypipeline.com/apexonco/bicycle-finally-falls",
   "title": "Withdrawal: Zelenectide pevedotin (US)",
   "content_text": "Programme deprioritised after regulatory feedback on Duravelo-2 design.",
   "date_published": "2026-03-01T00:00:00Z",
   "tags": [
    "withdrawal"
   ],
   "_onco": {
    "kind": "withdrawal",
    "date": "2026-03",
    "precision": "month",
    "venue": "FDA",
    "records": [
     {
      "id": "zelenectide-pevedotin",
      "kind": "drug",
      "name": "Zelenectide pevedotin",
      "url": "https://onco.cc/drugs/zelenectide-pevedotin/"
     },
     {
      "id": "urothelial",
      "kind": "cancer",
      "name": "Bladder & urothelial cancer",
      "url": "https://onco.cc/cancers/urothelial/"
     },
     {
      "id": "nectin4",
      "kind": "target",
      "name": "Nectin-4",
      "url": "https://onco.cc/targets/nectin4/"
     }
    ]
   }
  },
  {
   "id": "https://clinicaltrials.gov/study/NCT05388669?tab=results#onco-edge-result",
   "url": "https://clinicaltrials.gov/study/NCT05388669?tab=results",
   "title": "A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor: Phase 3 result",
   "content_text": "For All Regions Other Than the European Union (EU) and Others Accepting Cycle 2 Day 1: Observed Serum Concentration (Ctrough) of Amivantamab at Steady State: Arm A: Lazertinib With Amivantamab SC-CF 206 micrograms per milliliters (mcg/ml) versus Arm B: Lazertinib With Amivantamab Intravenous (IV) Infusion 144 micrograms per milliliters (mcg/ml).",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "ClinicalTrials.gov",
    "records": [
     {
      "id": "nct05388669",
      "kind": "trial",
      "name": "A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor",
      "url": "https://onco.cc/trials/nct05388669/"
     },
     {
      "id": "lazertinib",
      "kind": "drug",
      "name": "Lazertinib",
      "url": "https://onco.cc/drugs/lazertinib/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     },
     {
      "id": "sclc",
      "kind": "cancer",
      "name": "Small-cell lung cancer",
      "url": "https://onco.cc/cancers/sclc/"
     },
     {
      "id": "egfr-mutant-nsclc",
      "kind": "cancer",
      "name": "EGFR-mutated non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/egfr-mutant-nsclc/"
     }
    ]
   }
  },
  {
   "id": "https://clinicaltrials.gov/study/NCT04497844?tab=results#onco-edge-result",
   "url": "https://clinicaltrials.gov/study/NCT04497844?tab=results",
   "title": "A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair: Phase 3 result",
   "content_text": "Breast Cancer Gene (BRCA) Subgroup: Radiographic Progression-free Survival (rPFS) Assessed by Investigator: BRCA Subgroup: Placebo With Abiraterone Acetate Plus Prednisone 25.99 months, hazard ratio 0.515.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "ClinicalTrials.gov",
    "records": [
     {
      "id": "nct04497844",
      "kind": "trial",
      "name": "A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair",
      "url": "https://onco.cc/trials/nct04497844/"
     },
     {
      "id": "abiraterone",
      "kind": "drug",
      "name": "Abiraterone acetate",
      "url": "https://onco.cc/drugs/abiraterone/"
     },
     {
      "id": "niraparib",
      "kind": "drug",
      "name": "Niraparib",
      "url": "https://onco.cc/drugs/niraparib/"
     },
     {
      "id": "prednisone",
      "kind": "drug",
      "name": "Prednisone",
      "url": "https://onco.cc/drugs/prednisone/"
     },
     {
      "id": "prostate",
      "kind": "cancer",
      "name": "Prostate cancer",
      "url": "https://onco.cc/cancers/prostate/"
     },
     {
      "id": "prostate-mhspc",
      "kind": "cancer",
      "name": "Metastatic hormone-sensitive prostate cancer",
      "url": "https://onco.cc/cancers/prostate-mhspc/"
     }
    ]
   }
  },
  {
   "id": "https://clinicaltrials.gov/study/NCT04194775?tab=results#onco-edge-result",
   "url": "https://clinicaltrials.gov/study/NCT04194775?tab=results",
   "title": "A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma: Phase 3 result",
   "content_text": "Overall Survival (OS): Nofazinlimab + Lenvatinib 21.6 months versus Placebo + Lenvatinib 18.5 months.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "ClinicalTrials.gov",
    "records": [
     {
      "id": "nct04194775",
      "kind": "trial",
      "name": "A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma",
      "url": "https://onco.cc/trials/nct04194775/"
     },
     {
      "id": "lenvatinib",
      "kind": "drug",
      "name": "Lenvatinib",
      "url": "https://onco.cc/drugs/lenvatinib/"
     },
     {
      "id": "hcc",
      "kind": "cancer",
      "name": "Hepatocellular carcinoma",
      "url": "https://onco.cc/cancers/hcc/"
     },
     {
      "id": "hcc-advanced",
      "kind": "cancer",
      "name": "Advanced hepatocellular carcinoma",
      "url": "https://onco.cc/cancers/hcc-advanced/"
     }
    ]
   }
  },
  {
   "id": "https://clinicaltrials.gov/study/NCT04351555?tab=results#onco-edge-result",
   "url": "https://clinicaltrials.gov/study/NCT04351555?tab=results",
   "title": "A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-S: Phase 3 result",
   "content_text": "Major Pathological Response (MPR) - IASLC Method: Osimertinib + Chemo 25.6 % versus Osimertinib 24.8 % versus Placebo + Chemo 1.7 %.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "ClinicalTrials.gov",
    "records": [
     {
      "id": "nct04351555",
      "kind": "trial",
      "name": "A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-S",
      "url": "https://onco.cc/trials/nct04351555/"
     },
     {
      "id": "osimertinib",
      "kind": "drug",
      "name": "Osimertinib",
      "url": "https://onco.cc/drugs/osimertinib/"
     },
     {
      "id": "cisplatin",
      "kind": "drug",
      "name": "Cisplatin",
      "url": "https://onco.cc/drugs/cisplatin/"
     },
     {
      "id": "carboplatin",
      "kind": "drug",
      "name": "Carboplatin",
      "url": "https://onco.cc/drugs/carboplatin/"
     },
     {
      "id": "pemetrexed",
      "kind": "drug",
      "name": "Pemetrexed",
      "url": "https://onco.cc/drugs/pemetrexed/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     }
    ]
   }
  },
  {
   "id": "https://clinicaltrials.gov/study/NCT05625399?tab=results#onco-edge-result",
   "url": "https://clinicaltrials.gov/study/NCT05625399?tab=results",
   "title": "A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma: Phase 3 result",
   "content_text": "Adjusted Time-Averaged Nivolumab Serum Concentration Over the First 28 Days (Cavgd28-Nivo) on Natural Logarithmic Scale: Nivo + Rela FDC SC 4.141 ug/ml versus Nivo + Rela FDC IV 3.901 ug/ml.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "ClinicalTrials.gov",
    "records": [
     {
      "id": "nct05625399",
      "kind": "trial",
      "name": "A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma",
      "url": "https://onco.cc/trials/nct05625399/"
     },
     {
      "id": "nivolumab",
      "kind": "drug",
      "name": "Nivolumab",
      "url": "https://onco.cc/drugs/nivolumab/"
     },
     {
      "id": "relatlimab-nivolumab",
      "kind": "drug",
      "name": "Relatlimab + nivolumab",
      "url": "https://onco.cc/drugs/relatlimab-nivolumab/"
     },
     {
      "id": "melanoma",
      "kind": "cancer",
      "name": "Melanoma",
      "url": "https://onco.cc/cancers/melanoma/"
     },
     {
      "id": "advanced-melanoma",
      "kind": "cancer",
      "name": "Advanced melanoma",
      "url": "https://onco.cc/cancers/advanced-melanoma/"
     }
    ]
   }
  },
  {
   "id": "https://clinicaltrials.gov/study/NCT04810078?tab=results#onco-edge-result",
   "url": "https://clinicaltrials.gov/study/NCT04810078?tab=results",
   "title": "A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advance: Phase 3 result",
   "content_text": "Adjusted Geometric Mean Serum Concentration of Nivolumab Over 28 Days (Cavgd28) on Original Scale: Nivolumab SC 77.373 μg/ml versus Nivolumab IV 36.875 μg/ml versus Nivo SC Process C 75.504 μg/ml versus Nivo SC Process D 75.596 μg/ml.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "ClinicalTrials.gov",
    "records": [
     {
      "id": "nct04810078",
      "kind": "trial",
      "name": "A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advance",
      "url": "https://onco.cc/trials/nct04810078/"
     },
     {
      "id": "nivolumab",
      "kind": "drug",
      "name": "Nivolumab",
      "url": "https://onco.cc/drugs/nivolumab/"
     },
     {
      "id": "rcc",
      "kind": "cancer",
      "name": "Renal cell carcinoma",
      "url": "https://onco.cc/cancers/rcc/"
     },
     {
      "id": "clear-cell-rcc",
      "kind": "cancer",
      "name": "Clear cell renal cell carcinoma",
      "url": "https://onco.cc/cancers/clear-cell-rcc/"
     }
    ]
   }
  },
  {
   "id": "https://clinicaltrials.gov/study/NCT04765059?tab=results#onco-edge-result",
   "url": "https://clinicaltrials.gov/study/NCT04765059?tab=results",
   "title": "A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer: Phase 3 result",
   "content_text": "Progression Free Survival (PFS): Treatment Arm A: Osimertinib (AZD9291), Pemetrexed, Cisplatin or Carboplatin 8.4 months versus Treatment Arm B: Placebo for Osimertinib (AZD9291), Pemetrexed, Cisplatin or Carboplatin 4.4 months, hazard ratio 0.43.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "ClinicalTrials.gov",
    "records": [
     {
      "id": "nct04765059",
      "kind": "trial",
      "name": "A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer",
      "url": "https://onco.cc/trials/nct04765059/"
     },
     {
      "id": "osimertinib",
      "kind": "drug",
      "name": "Osimertinib",
      "url": "https://onco.cc/drugs/osimertinib/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     },
     {
      "id": "sclc",
      "kind": "cancer",
      "name": "Small-cell lung cancer",
      "url": "https://onco.cc/cancers/sclc/"
     }
    ]
   }
  },
  {
   "id": "https://clinicaltrials.gov/study/NCT05456191?tab=results#onco-edge-result",
   "url": "https://clinicaltrials.gov/study/NCT05456191?tab=results",
   "title": "A Study to Investigate Tolerability and Efficacy of Asciminib: Phase 3 result",
   "content_text": "Time to Discontinuation of Study Treatment Due to Adverse Event (TTDAE) (From Interim Analysis): Asciminib 16 participants versus Nilotinib 34 participants, hazard ratio 0.45.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "ClinicalTrials.gov",
    "records": [
     {
      "id": "nct05456191",
      "kind": "trial",
      "name": "A Study to Investigate Tolerability and Efficacy of Asciminib",
      "url": "https://onco.cc/trials/nct05456191/"
     },
     {
      "id": "asciminib",
      "kind": "drug",
      "name": "Asciminib",
      "url": "https://onco.cc/drugs/asciminib/"
     },
     {
      "id": "nilotinib",
      "kind": "drug",
      "name": "Nilotinib",
      "url": "https://onco.cc/drugs/nilotinib/"
     },
     {
      "id": "cml",
      "kind": "cancer",
      "name": "Chronic myeloid leukaemia",
      "url": "https://onco.cc/cancers/cml/"
     },
     {
      "id": "cml-chronic-phase",
      "kind": "cancer",
      "name": "Chronic myeloid leukaemia, chronic phase",
      "url": "https://onco.cc/cancers/cml-chronic-phase/"
     }
    ]
   }
  },
  {
   "id": "https://clinicaltrials.gov/study/NCT04717414?tab=results#onco-edge-result",
   "url": "https://clinicaltrials.gov/study/NCT04717414?tab=results",
   "title": "An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomi: Phase 3 result",
   "content_text": "Red Blood Cell-transfusion Independence (RBC-TI) ≥ 12 Weeks (RBC-TI 12): Treatment 23.08 % versus Control 13.33 %.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "ClinicalTrials.gov",
    "records": [
     {
      "id": "nct04717414",
      "kind": "trial",
      "name": "An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomi",
      "url": "https://onco.cc/trials/nct04717414/"
     },
     {
      "id": "luspatercept",
      "kind": "drug",
      "name": "Luspatercept",
      "url": "https://onco.cc/drugs/luspatercept/"
     },
     {
      "id": "myeloproliferative-neoplasms",
      "kind": "cancer",
      "name": "Myeloproliferative neoplasms",
      "url": "https://onco.cc/cancers/myeloproliferative-neoplasms/"
     },
     {
      "id": "primary-myelofibrosis",
      "kind": "cancer",
      "name": "Primary myelofibrosis",
      "url": "https://onco.cc/cancers/primary-myelofibrosis/"
     }
    ]
   }
  },
  {
   "id": "https://www.onclive.com/view/iza-bren-yields-pfs-and-os-benefits-vs-chemo-in-previously-treated-advanced-tnbc#onco-edge-result",
   "url": "https://www.onclive.com/view/iza-bren-yields-pfs-and-os-benefits-vs-chemo-in-previously-treated-advanced-tnbc",
   "title": "BL-B01D1-307: Phase 3 result",
   "content_text": "PFS and OS significantly improved at interim analysis (numbers presented ASCO 2026).",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "onclive.com",
    "records": [
     {
      "id": "bl-b01d1-307",
      "kind": "trial",
      "name": "BL-B01D1-307",
      "url": "https://onco.cc/trials/bl-b01d1-307/"
     },
     {
      "id": "izalontamab-brengitecan",
      "kind": "drug",
      "name": "Izalontamab brengitecan",
      "url": "https://onco.cc/drugs/izalontamab-brengitecan/"
     },
     {
      "id": "tnbc",
      "kind": "cancer",
      "name": "Triple-negative breast cancer",
      "url": "https://onco.cc/cancers/tnbc/"
     }
    ]
   }
  },
  {
   "id": "https://www.cancernetwork.com/view/sonesitatug-vedotin-improves-overall-survival-in-cldn18-2-gastric-cancer#onco-edge-result",
   "url": "https://www.cancernetwork.com/view/sonesitatug-vedotin-improves-overall-survival-in-cldn18-2-gastric-cancer",
   "title": "CLARITY-Gastric 01: Phase 3 result",
   "content_text": "Co-primary endpoints including OS met (July 2026); numbers pending.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "cancernetwork.com",
    "records": [
     {
      "id": "clarity-gastric01",
      "kind": "trial",
      "name": "CLARITY-Gastric 01",
      "url": "https://onco.cc/trials/clarity-gastric01/"
     },
     {
      "id": "cmg901",
      "kind": "drug",
      "name": "Sonesitatug vedotin",
      "url": "https://onco.cc/drugs/cmg901/"
     },
     {
      "id": "ramucirumab",
      "kind": "drug",
      "name": "Ramucirumab",
      "url": "https://onco.cc/drugs/ramucirumab/"
     },
     {
      "id": "gastric",
      "kind": "cancer",
      "name": "Gastric & gastro-oesophageal junction cancer",
      "url": "https://onco.cc/cancers/gastric/"
     },
     {
      "id": "cldn18-2",
      "kind": "target",
      "name": "Claudin 18.2",
      "url": "https://onco.cc/targets/cldn18-2/"
     }
    ]
   }
  },
  {
   "id": "https://www.amgen.com/newsroom/press-releases/2026/09/imdelltra-in-combination-with-imfinzi-demonstrated-landmark-improvement-in-overall-survival-in-first-line-extensive-stage-small-cell-lung-cancer#onco-edge-result",
   "url": "https://www.amgen.com/newsroom/press-releases/2026/09/imdelltra-in-combination-with-imfinzi-demonstrated-landmark-improvement-in-overall-survival-in-first-line-extensive-stage-small-cell-lung-cancer",
   "title": "DeLLphi-305: Phase 3 result",
   "content_text": "Met the primary overall survival endpoint at the pre-specified interim analysis (Amgen, 8 September 2026); progression-free survival and response rate also improved; figures not yet disclosed.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "amgen.com",
    "records": [
     {
      "id": "dellphi-305",
      "kind": "trial",
      "name": "DeLLphi-305",
      "url": "https://onco.cc/trials/dellphi-305/"
     },
     {
      "id": "tarlatamab",
      "kind": "drug",
      "name": "Tarlatamab",
      "url": "https://onco.cc/drugs/tarlatamab/"
     },
     {
      "id": "durvalumab",
      "kind": "drug",
      "name": "Durvalumab",
      "url": "https://onco.cc/drugs/durvalumab/"
     },
     {
      "id": "sclc",
      "kind": "cancer",
      "name": "Small-cell lung cancer",
      "url": "https://onco.cc/cancers/sclc/"
     },
     {
      "id": "extensive-stage-sclc",
      "kind": "cancer",
      "name": "Extensive-stage small-cell lung cancer",
      "url": "https://onco.cc/cancers/extensive-stage-sclc/"
     },
     {
      "id": "dll3",
      "kind": "target",
      "name": "DLL3",
      "url": "https://onco.cc/targets/dll3/"
     }
    ]
   }
  },
  {
   "id": "https://clinicaltrials.gov/study/NCT04334759#onco-edge-result",
   "url": "https://clinicaltrials.gov/study/NCT04334759",
   "title": "DREAM3R: Phase 3 result",
   "content_text": "Stopped early; primary endpoint not met.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "ClinicalTrials.gov",
    "records": [
     {
      "id": "dream3r",
      "kind": "trial",
      "name": "DREAM3R",
      "url": "https://onco.cc/trials/dream3r/"
     },
     {
      "id": "durvalumab",
      "kind": "drug",
      "name": "Durvalumab",
      "url": "https://onco.cc/drugs/durvalumab/"
     },
     {
      "id": "pemetrexed",
      "kind": "drug",
      "name": "Pemetrexed",
      "url": "https://onco.cc/drugs/pemetrexed/"
     },
     {
      "id": "mesothelioma",
      "kind": "cancer",
      "name": "Mesothelioma",
      "url": "https://onco.cc/cancers/mesothelioma/"
     }
    ]
   }
  },
  {
   "id": "https://clinicaltrials.gov/study/NCT04655976?tab=results#onco-edge-result",
   "url": "https://clinicaltrials.gov/study/NCT04655976?tab=results",
   "title": "Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy: Phase 2/3 result",
   "content_text": "Overall Survival (OS) (Arm A Versus Arm C): Cobolimab + Dostarlimab + Docetaxel (Arm A) 11.9 months versus Docetaxel (Arm C) 11.3 months, hazard ratio 0.85.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "ClinicalTrials.gov",
    "records": [
     {
      "id": "nct04655976",
      "kind": "trial",
      "name": "Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy",
      "url": "https://onco.cc/trials/nct04655976/"
     },
     {
      "id": "cobolimab",
      "kind": "drug",
      "name": "Cobolimab",
      "url": "https://onco.cc/drugs/cobolimab/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     }
    ]
   }
  },
  {
   "id": "https://www.astrazeneca.com/media-centre/press-releases/2026/imfinzi-plus-imjudo-combined-with-lenvatinib-and-tace-reduced-the-risk-of-disease-progression-or-death-in-emerald-3-phase-iii-trial.html#onco-edge-result",
   "url": "https://www.astrazeneca.com/media-centre/press-releases/2026/imfinzi-plus-imjudo-combined-with-lenvatinib-and-tace-reduced-the-risk-of-disease-progression-or-death-in-emerald-3-phase-iii-trial.html",
   "title": "EMERALD-3: Phase 3 result",
   "content_text": "PFS HR ~0.70 (interim); OS immature.",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "result"
   ],
   "_onco": {
    "kind": "result",
    "date": "2026",
    "precision": "year",
    "venue": "astrazeneca.com",
    "records": [
     {
      "id": "emerald-3",
      "kind": "trial",
      "name": "EMERALD-3",
      "url": "https://onco.cc/trials/emerald-3/"
     },
     {
      "id": "durvalumab",
      "kind": "drug",
      "name": "Durvalumab",
      "url": "https://onco.cc/drugs/durvalumab/"
     },
     {
      "id": "tremelimumab",
      "kind": "drug",
      "name": "Tremelimumab",
      "url": "https://onco.cc/drugs/tremelimumab/"
     },
     {
      "id": "lenvatinib",
      "kind": "drug",
      "name": "Lenvatinib",
      "url": "https://onco.cc/drugs/lenvatinib/"
     },
     {
      "id": "hcc",
      "kind": "cancer",
      "name": "Hepatocellular carcinoma",
      "url": "https://onco.cc/cancers/hcc/"
     },
     {
      "id": "hcc-intermediate",
      "kind": "cancer",
      "name": "Intermediate hepatocellular carcinoma",
      "url": "https://onco.cc/cancers/hcc-intermediate/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/copiktra#onco-edge-withdrawal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/copiktra",
   "title": "EU withdrawal: Duvelisib",
   "content_text": "Marketing authorisation withdrawn in the European Union in 2026: Authorised May 2021; marketing authorisation withdrawn at Secura Bio's request 16 Feb 2026 (commercial reasons).",
   "date_published": "2026-01-01T00:00:00Z",
   "tags": [
    "withdrawal"
   ],
   "_onco": {
    "kind": "withdrawal",
    "date": "2026",
    "precision": "year",
    "venue": "European Commission (EMA opinion)",
    "records": [
     {
      "id": "duvelisib",
      "kind": "drug",
      "name": "Duvelisib",
      "url": "https://onco.cc/drugs/duvelisib/"
     },
     {
      "id": "cll",
      "kind": "cancer",
      "name": "Chronic lymphocytic leukaemia",
      "url": "https://onco.cc/cancers/cll/"
     },
     {
      "id": "peripheral-t-cell-lymphoma",
      "kind": "cancer",
      "name": "Peripheral T-cell lymphomas",
      "url": "https://onco.cc/cancers/peripheral-t-cell-lymphoma/"
     },
     {
      "id": "pik3ca",
      "kind": "target",
      "name": "PIK3CA / PI3K-alpha",
      "url": "https://onco.cc/targets/pik3ca/"
     }
    ]
   }
  },
  {
   "id": "https://www.ema.europa.eu/en/medicines/human/EPAR/amtagvi#onco-edge-withdrawal",
   "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/amtagvi",
   "title": "EU withdrawal: Lifileucel",
   "content_text": "Marketing authorisation withdrawn in the European Union in 2025: MAA withdrawn 22 Jul 2025 after CHMP signalled a negative opinion (response rate, deaths, manufacturing).",
   "date_published": "2025-01-01T00:00:00Z",
   "tags": [
    "withdrawal"
   ],
   "_onco": {
    "kind": "withdrawal",
    "date": "2025",
    "precision": "year",
    "venue": "European Commission (EMA opinion)",
    "records": [
     {
      "id": "lifileucel",
      "kind": "drug",
      "name": "Lifileucel",
      "url": "https://onco.cc/drugs/lifileucel/"
     },
     {
      "id": "melanoma",
      "kind": "cancer",
      "name": "Melanoma",
      "url": "https://onco.cc/cancers/melanoma/"
     },
     {
      "id": "nsclc",
      "kind": "cancer",
      "name": "Non-small-cell lung cancer",
      "url": "https://onco.cc/cancers/nsclc/"
     },
     {
      "id": "advanced-melanoma",
      "kind": "cancer",
      "name": "Advanced melanoma",
      "url": "https://onco.cc/cancers/advanced-melanoma/"
     }
    ]
   }
  },
  {
   "id": "https://eur-lex.europa.eu/eli/reg/2025/327/oj#onco-edge-law",
   "url": "https://eur-lex.europa.eu/eli/reg/2025/327/oj",
   "title": "European Health Data Space Regulation (EU) 2025/327",
   "content_text": "A 2025 EU regulation that gives patients electronic access to their health records across the Union and creates national bodies that can grant researchers, regulators and companies permission to use anonymised or pseudonymised health data, phased in over the rest of the decade.",
   "date_published": "2025-01-01T00:00:00Z",
   "tags": [
    "law"
   ],
   "_onco": {
    "kind": "law",
    "date": "2025",
    "precision": "year",
    "venue": "European Union, regulation",
    "records": [
     {
      "id": "european-health-data-space",
      "kind": "term",
      "name": "European Health Data Space Regulation (EU) 2025/327",
      "url": "https://onco.cc/terms/european-health-data-space/"
     },
     {
      "id": "gdpr",
      "kind": "term",
      "name": "GDPR and health data",
      "url": "https://onco.cc/terms/gdpr/"
     },
     {
      "id": "oncology-real-world-data",
      "kind": "technology",
      "name": "Oncology EHR and real-world data platforms",
      "url": "https://onco.cc/technologies/oncology-real-world-data/"
     },
     {
      "id": "real-world-evidence",
      "kind": "term",
      "name": "Real-world evidence",
      "url": "https://onco.cc/terms/real-world-evidence/"
     }
    ]
   }
  }
 ]
}